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Abstract 
 
The likelihood of chromosome segregation errors in human oocytes increases 
dramatically from the age of 35. This results in an increased chance of pregnancies 
from older women ending in miscarriage. Oocytes are particularly vulnerable to 
ageing, as it can take five decades for them to undergo growth, from their formation 
during embryogenesis as prophase arrested primordial-stage oocytes.  
Chromosomal stability in oocytes is provided by cohesin. This is loaded onto oocyte 
chromosomes during embryogenesis and removed during anaphase after oocyte 
growth. Recent work in our laboratory indicates that cohesin is predominantly lost at 
the primordial stage. However, questions remain around the timing and mechanism 
of loss. I will seek to address this as well as investigate whether loss of cohesin can 
explain age-related segregation errors in human oocytes. 
My findings indicate that cohesin loss occurs gradually during ageing, and that the 
meiosis-specific cohesin subunit REC8 appears more affected by age than the 
universal sub-unit SMC3. I find that RAD21 is expressed at the primordial-oocyte 
stage, suggesting a potential turnover of RAD21-containing complexes could explain 
this difference. The protease separase, which cleaves cohesin during anaphase, is 
also detectable in the oocyte cytoplasm at the primordial stage. Using an oocyte-
specific separase null mouse, I find that cohesin depletion occurs in the absence of 
separase. Finally, I use human oocytes to test the clinical significance of cohesin 
depletion. My findings indicate that ageing is associated with loss of REC8 from 
between chromatids. However, due to diffuse association of cohesin with chromatin 
in oocytes from older women, no overall reduction in chromosome-associated REC8 
occurs. Thus, in contrast to mice, ageing in human oocytes appears to manifest as 
mislocalisation, rather than reduction of REC8. These findings indicate that ageing 
impacts on cohesin in both mouse and human oocytes but that the outcome 
manifests differently between organisms. 
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Chapter 1. Introduction  
1.1 Meiosis and the maternal age effect 
 
The predominant way that genetic diversity is introduced in to an animal population is 
via sexual reproduction. This is when a female and a male organism produce haploid 
gametes (oocytes and sperm respectively) which then fuse together during 
fertilisation, creating a new life. To produce these haploid gametes, organisms rely 
on a specialised form of cell division called meiosis (Petronczki et al., 2003, Herbert 
et al., 2015, MacLennan et al., 2015). This involves one round of DNA replication 
followed by two rounds of division. This is distinct from mitosis, which involves just 
one round of DNA replication followed by one round of division and is used by all 
other cells in the body (Petronczki et al., 2003).  
For meiosis to be completed accurately, paternal and maternal homologues must 
undergo a reciprocal exchange of DNA after replication to ensure they are physically 
linked together (Kleckner, 2006, Baudat et al., 2013). During the first meiotic division 
(MI), these homologues separate in a reductional division before separating again 
during meiosis II (MII) in an equational division. In mammals, the male and female 
single copy genomes generated during meiosis become separately packaged in 
pronuclei and do not come together in the same nucleus until the resulting embryo 
divides to the two cell stage (Petronczki et al., 2003, Herbert et al., 2015). 
While the accurate completion of the two meiotic divisions is fundamental to 
producing healthy offspring, human oocytes are highly prone to chromosome 
segregation errors (Hassold and Hunt, 2001). This can occur during both divisions 
with too few or too many chromatids remaining in the oocyte. This leads the oocyte to 
be in a state termed as aneuploidy. The consequences of aneuploidy during 
pregnancy are serious as it is the leading cause of miscarriage and stillbirths 
(Hassold and Hunt, 2001). Even in the few cases of aneuploidy where the pregnancy 
can be carried to term, the most likely outcome is for the child to be born with 
developmental or intellectual disabilities (Fragouli et al., 2011, Hassold and Hunt, 
2001).  
While there are several factors that make some chromosomes more susceptible to 
aneuploidy than others (such as their size, with smaller chromosomes more at risk 
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than larger ones), all chromosomes have an increased risk of aneuploidy with 
advancing maternal age (Risch et al., 1986, Hassold and Hunt, 2001)(Figure 1.1). 
This risk is thought to rise to as high as 60% by the time a woman is in her mid-40’s, 
up from an already relatively high chance of 20% at the age of 35 (Kuliev et al., 
2011). By comparison, sperm have an error rate of around 1–2% (Hassold and Hunt, 
2001). Proof that reduced fertility in older women is a consequence of defects in the 
egg comes from In vitro fertilisation (IVF) cycles in which donor eggs from women 
aged <35 years completely rescue the age-related decline in fertility (Sauer, 1998) 
 
 
Figure 1.1 Incidence of trisomy increases with age in human oocytes. Graph 
showing incidence of trisomy against age of the mother at the time of pregnancy. The 
chances of trisomy occurring increases drastically from the age of 35 onwards 
(Hassold and Hunt, 2001).  
Recent demographic trends have led to an increased interest in the relationship 
between maternal age and prevalence of aneuploidy. A study looking at the average 
age of first time mothers from western, southern and northern Europe as well as 
Japan, saw an increase from 24 to 28 years of age between 1970 and 2008 (Schmidt 
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et al., 2012). In the UK over the same time, the number of births to women over 30 
has risen, while those to women under 30 has fallen (Figure 1.2). 
 
Figure 1.2 More women are delaying pregnancy into their 30s. (a) Graph 
showing the average age of first time mothers in the UK from 1960 to present. The 
average age has steadily increased from the 1970s onwards. (b) Graph showing 
number of babies born/1000 women by age. Since the mid-1970s the number of 
babies born to women under 30 has decreased while those born to women over 30 
has increased (eurostat, 2015). 
This delay has had real consequences in terms of pregnancy outcomes. The clearest 
example of this is the increase in the number of Down’s syndrome pregnancies over 
the past 30 years. Down’s syndrome occurs due to trisomy of chromosome 21, 
causing the child to suffer from a spectrum of learning difficulties (Hassold and Hunt, 
2001). While the link between maternal age and Down’s syndrome has been 
understood for several decades (Penrose, 1933), the growing trend for women to 
delay pregnancy until later in life has resulted in a 71% increase between 1989 and 
2008 in Down’s syndrome pregnancies (Morris and Alberman, 2009).  
The demographic trends towards later age of pregnancy also have important social 
and economic ramifications. The delay in motherhood, combined with the increase in 
life expectancy and growing number of pensioners, presents a demographic crisis in 
the developed world (Schmidt et al., 2012). This is highlighted by the fact that by 
2080, it is projected that the percentage of the population in the EU-28 aged over 65 
will have risen from 18.5% in 2014 to 28.7%. This will occur along with a fall in those 
aged between 15–65 from 65.9% to 56.2% (eurostat, 2015).   
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To understand and develop potential solutions to the age-related loss of fertility, it is 
essential to determine why oocytes are so susceptible to aneuploidy. To do this, it is 
necessary to understand the unique and protracted way in which oocytes are formed 
and maintained before they can help create a life. 
1.2 Oogenesis – formation and maturation of oocytes 
 
A key aspect of oocyte biology, distinguishing it from all other cells, is the prolonged 
quiescent state in which oocytes exist before resuming meiosis. Unlike sperm or 
somatic cells, oocytes do not appear to be formed during adult life (Adhikari and Liu, 
2009). Instead, a stockpile of oocytes formed during embryo development provide 
the source of all oocytes ovulated during each woman’s reproductive lifespan. In 
humans, this can be up to five decades, leaving oocytes particularly susceptible to 
age-related problems (Herbert et al., 2015). 
The initial steps in the formation of an oocyte occur several days after conception 
with the production of primordial germ cells (PGCs)(Richardson and Lehmann, 2010). 
These form around E7.25 in the yolk sac of mouse embryos (around 3–5 weeks in 
human embryos (Floros et al., 2018)) and were initially identified due to their high 
alkaline phosphatase activity (Nikolic et al., 2016). To establish a sex-specific 
embryonic gonad the PGCs must enter the genital ridge by migrating from the 
primitive streak to the endoderm, and then into the gonad (E7.5–E10.5). (Richardson 
and Lehmann, 2010).  
After reaching the gonad, the PGCs undergo multiple rounds of mitotic cell division. 
At this point these cells (termed oogonia) do not complete cytokinesis and instead 
form cysts with the oogonia physically linked together through ring canals (E11–E13) 
(Pepling and Spradling, 1998, Pepling and Spradling, 2001). Once they undergo the 
pre-meiotic S phase, these cells enter prophase of meiosis I and undergo reciprocal 
exchange of DNA between the paternal and maternal homologues to form 
crossovers. This results in the formation of a structure called the bivalent 
chromosome which consists of four chromatids (two each from the paternal and 
maternal homologues) (Kleckner, 2006, Lam and Keeney, 2014). The cytological 
manifestations of the sites of crossover formation are known as chiasmata (Kleckner, 
2006, Baudat et al., 2013) (Figure 1.3). 
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 Figure 1.3 primordial oocyte and bivalent chromosome formation during 
mouse embryogenesis. Schematic diagram showing the stages in a female mouse 
in the formation of primordial follicles. PGCs infiltrate the gonads at E10.5 forming 
mitotic cysts. The chromosomes in the PGCs then undergo a reciprocal exchange of 
DNA leading to the formation of bivalent chromosomes. Cells in the cyst then 
separate and 3 days after birth primordial follicles are formed. In humans PGCs are 
present 3-5 weeks after conception with primordial follicles fully formed around 18-20 
weeks after conception. Blue box shows the four stages of prophase that occur to 
create bivalent chromosomes. Green and red DNA strands represent the homolgous 
chromosomes. SPO11 causes DSBs in the paternal and maternal homologues. This 
is followed by formation of the synaptonemal complex constructed of the axial 
element and transverse filaments.  This is then resolved with the formation of 
crossovers from double Holliday junction (dHJ) in diplotene causing homologous 
chromosomes to be physically linked (Pepling and Spradling, 2001, Maheshwari and 
Fowler, 2008, Herbert et al., 2015, Floros et al., 2018). 
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The process of recombination starts with the meiotic topoisomerase-like SPO11 
being targeted by PRDM9 to induce double strand breaks (DSBs) at recombination 
hotspots along the DNA (Baudat et al., 2013). These DSBs are either resolved as 
crossovers or non-crossovers. Non-crossovers are necessary as SPO11 causes 
significantly more DSBs than crossovers. This process is essential, as evidenced by 
the fact that Spo 11-/- mice are infertile, with defects seen 15 days post coitum (dpc) 
(Romanienko and Camerini-Otero, 2000).  
In leptotene, the DNA condenses and forms loops organised along the axial element 
(Lam and Keeney, 2014).The cell enters zygotene, forming transverse filaments 
leading to construction of the synaptonemal complex (SC) in pachytene (Page and 
Hawley, 2004). The SC “zips” the two homologous chromosomes together, using the 
axial element on the DNA and the transverse filaments between them (Heyting, 
1996, Kleckner, 2006, Lam and Keeney, 2014). The DNA DSBs are then repaired 
between homologues leaving double-Holliday junctions (dHJs) that resolve to 
become crossovers in diplotene (Page and Hawley, 2004). The supporting SC is 
removed and the DNA can decondense entering the cell into dictate arrest. The 
establishment of these crossovers is essential for completion of meiosis. Knockout 
mice of the mismatch repair protein MLH1 (which are therefore unable to establish 
crossover) are unable to properly align during the first meiotic division causing them 
to arrest at metaphase (Woods et al., 1999). Crossover location, as well as their 
frequency, is important for bivalent chromosome stability. Crossovers that are close 
to the telomeres or pericentromeres are more likely to result in segregation errors 
during meiotic division than those located further along the chromosome arm (Lamb 
et al., 2005, Oliver et al., 2008).  
Around the time of bivalent chromosome formation, the oocytes in the cyst separate, 
becoming enclosed within a single layer of granulosa cells and can now be termed as 
primordial follicles. They will then remain in this state until either undergoing atresia – 
a process of follicle breakdown - or maturation (Pepling and Spradling, 2001). In mice 
and rats, this process is completed a couple of days after birth (Pepling and 
Spradling, 2001). In primates and ruminants, however, it occurs during foetal 
development (Maheshwari and Fowler, 2008, Adhikari and Liu, 2009).  
It has been widely accepted for many decades that the pool of primordial oocytes 
formed during embryogenesis is the sole source of oocytes in a female’s life 
(Zuckerman, 1951). However, the past 15 years has seen the emergence of the 
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controversial claim that a population of ovarian germline stem cells exist within the 
ovary (Johnson et al., 2004). It was postulated that these so-called oogonial stem 
cells could give rise to primordial oocytes in the adult ovary. This pool could 
potentially be stimulated later in a woman’s life, to extend the duration of fertility. 
While exploitation of such a pool would be a potential solution to loss of fertility with 
age, studies looking at in-vivo cell lineage tracing suggested that there is no new 
production (Zhang et al., 2014). Much of the difficulty in defining whether these stem 
cells exist has related to finding a reproducible way of extracting them from the ovary. 
Extraction using fluorescence-activated cell sorting (FACS) based on expression of 
DDX4 (a germ cell marker) have suggested that the cells being extracted are not in 
fact stem cells (Kerr et al., 2012, Zhang et al., 2015). However, Clarkson et al. have 
recently suggested a DDX4 positive population also expressing the stem cell marker 
ALDH1 in human adult ovarian tissue (Clarkson et al., 2018). It was suggested that 
this population is capable of forming early follicles however this will need further 
investigation before the existence of ovarian stem cells is accepted. 
Once primordial follicles have been established in the ovary in foetal life, they are 
recruited for growth throughout a woman’s life until the pool becomes exhausted 
around the time of menopause. Both inhibition and initiation of growth in primordial 
oocytes is mediated through the PI3K-PTEN-AKT pathway (Makker et al., 2014). 
Prevention of growth is controlled by FOXO3A (a transcription factor), with PTEN 
inhibiting the FOXO3A suppressor AKT (John et al., 2008). Once AKT is activated, 
FOXO3A is shuttled out of the nucleus, allowing for growth. Uncontrolled recruitment 
of primordial-stage oocytes into the growing pool is observed in PtenloxP/loxP;GCre+ 
and Foxo3a-/- mice, showing their essential role in maintaining the primordial pool 
(Castrillon et al., 2003, Reddy et al., 2008). Simultaneously with FOXO3A 
suppression, primordial oocytes undergo growth with AKT activation causing 
suppression of mTORC1 inhibitors TSC1 and 2 (Makker et al., 2014). Once mTORC1 
is released the primordial stage oocyte is then able to grow from having a diameter of 
~10 µm in size to ~100 µm, making it the largest cell in the body (Griffin et al., 2006).  
While there are important changes going on within the oocyte during oogenesis, the 
process leading to an ovulated egg relies on signalling between the oocyte and its 
surrounding cells. Primordial follicles consist of the primordial stage oocyte and a 
single layer of surrounding flattened granulosa cells which help maintain its quiescent 
status (Da Silva-Buttkus et al., 2008). When it is selected for growth, not only does 
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the oocyte increase in size, but the granulosa cells that surround it change as well. 
These go from a flattened structure to becoming cuboidal while undergoing multiple 
rounds of division (Adhikari and Liu, 2009). Once surrounded by a single layer of 
cuboidal cells, it is classed as a primary follicle then becoming a secondary follicle 
after the granulosa cell multiply to form several layers around the oocyte (Orisaka et 
al., 2009) (Figure 1.4). At the primary follicle stage, the oocyte forms a glycoprotein 
layer called the zona pellucida. The interaction between the oocyte and the 
granulosa cells is maintained through the zona pellucida by transzonal processes 
(Albertini et al., 2001).  A thecal layer also forms on the outside of the basement 
membrane (Campbell et al., 2013). The follicle then forms a fluid filled antrum, with 
the antral (also known as Graafian) follicle now ready for ovulation.  
 
 
 
 
Figure 1.4 Primordial to antral follicle formation. Schematic diagram of primordial 
to antral follicle formation. Primordial stage oocytes are surrounded by flattened 
granulosa cells. Once primordial follicles are signalled to initiate growth they undergo 
a transition in to primary follicles and the oocyte is surrounded by a single layer of 
cuboidal granulosa cells. This is followed by more replication of granulosa cells to 
form several layers of granulosa cells and a thecal cell layer. Finally, a fluid filled 
antrum is formed to create the antral follicle (Herbert et al., 2015). 
Primordial-stage oocytes are recruited for growth, developing to the secondary follicle 
stage of development before puberty; however, the follicles are unable to progress 
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any further towards ovulation until after puberty (Hsueh et al., 2015). This is due to 
further progression requiring release of follicle stimulating hormone (FSH) and 
luteinising hormone (LH) (Adhikari and Liu, 2009). This can only happen after 
puberty, with changes to the hypothalmo-pituitary-gonadal axis. Because of this, the 
process towards ovulation can be divided into two broad stages: the initial 
recruitment to growth, which happens before puberty and takes the primordial follicle 
to secondary follicle stage (Hsueh et al., 2015), and the cyclic recruitment stage, 
which occur after puberty and takes primordial follicles through antral formation and 
to ovulation (Figure 1.5). While there will be several antral follicles present during 
each cycle, in mono-ovulatory species such as humans one will become dominant 
and capable of developing to the pre-ovulatory stage  (McGee and Hsueh, 2000). 
This is due to receptivity to a small window of FSH, which only the largest, most 
dominant follicle will be. The other follicles (which are considered subordinate) will 
succumb to atresia (Hsueh et al., 2015). This is surpassed during IVF treatment 
when administration of FSH for 10-12 days prevents atresia, allowing multiple follicles 
to develop the preovulatory stage. 
After puberty, granulosa cell proliferation past secondary follicle stage is FSH 
dependent, as is estradiol production. This in turn drives release of LH from the 
pituitary (Edson et al., 2009). This LH surge causes a breakdown in the junctions 
between granulosa cells and the associated oocyte, resulting in a reduction of cyclic 
adenosine monophosphate (cAMP) within the oocyte and increased levels of CDK1 
and cyclin B1 (Von Stetina and Orr-Weaver, 2011). The breakdown of junctions is 
essential for this function, as it is the granulosa cells that provide the cyclic 
guanosine monophosphate (cGMP) that inhibits PDE3A removal of cAMP (Norris et 
al., 2009).  This drives the transition of the oocyte from prolonged arrest in prophase 
of meiosis I into M-phase of the first meiotic divisions. This transition is marked by 
breakdown of the germinal vesicle (GV) membrane, formation of the metaphase I 
spindle and completion of the first meiotic division, marked by formation of the 1st 
polar body. Finally the follicle ruptures and the egg, now arrested at metaphase of 
meiosis II, and surrounded by a cloud of cumulus cells is released into the oviduct 
(Gook et al., 2003).  
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 Figure 1.5 Recruitment of ovarian follicles during oogenesis. Schematic diagram 
showing recruitment of oocytes during ovulation. Prior to puberty primordial oocytes 
are able to undergo growth but die of atresia. It is only after puberty and with the LH 
surge that the dominant follicle is able to undergo ovulation. The process of 
recruitment stops with exhaustion of the available pool of oocytes (McGee and 
Hsueh, 2000) 
After ovulation, the cells within the follicle differentiate to become progesterone-
secreting luteal cells and the structure is then called the corpus luteum. This is 
formed from the remaining theca and granulosa cells and is necessary to help 
maintain pregnancy. If a pregnancy does not occur the corpus luteum regresses and 
menstrual bleeding occurs (Reed and Carr, 2000).  
Though the process of primordial oocyte growth and ovulation is necessary for 
fertility, the chances of an individual primordial oocyte completing it is in fact very low. 
While prior to birth the ovary contains several million oocytes, only around 500 will 
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ever be ovulated in adult life, with the vast majority instead becoming atretic (Adhikari 
et al., 2016, Broekmans et al., 2007). This is borne out by the fact that in humans, of 
the around 7 million oocytes formed during foetal development, only 1 million are 
present after birth. Due to continued recruitment for growth or atresia, the number of 
primordial follicles is estimated to be around 400,000–600,000 at puberty with 50–
1,000 remaining at the time of menopause (Figure 1.6) (Adhikari and Liu, 2009, 
Broekmans et al., 2007, te Velde et al., 1998). After birth, the rate of primordial 
oocyte loss is thought to occur at around 1000 oocytes per year until the age of 37. 
After 37 this rate then rapidly increases until the time of menopause (Faddy and 
Gosden, 1996, Faddy, 2000). The biological basis for this high level of oocyte loss by 
atresia is unclear. Fertility is maintained following irradiation of knockout mice for 
Puma and Noxa, which mediate cell death following oocyte cell damage (Kerr et al., 
2012). The decline in available oocytes represents one of the pressures exerted by 
ageing on female fertility. 
 
Figure 1.6 Ovarian follicle reserve declines with age. Graph shows number of 
oocyte follicles (y- axis) plotted against age in human ovaries. Rate of the decline 
increases from the mid-30’s onwards until menopause in the 50s (Faddy, 2000). 
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1.3 Oocyte Meiosis: From Germinal Vesicle break-down to fertilisation 
 
The process of meiosis is required to produce haploid gametes (which contain one 
chromatid) from diploid precursors (which contain four chromatids) for the purpose of 
sexual reproduction. While male spermatagonial stem cells produce four individual 
sperm from each round of meiosis, females only produce one egg (Petronczki et al., 
2003). This may seem inefficient, but oocytes must provide all the cytoplasmic 
material necessary for early embryogenesis (such as mitochondria) as well as the 
necessary maternal DNA complement (Schon et al., 2012). 
Prior to resuming meiosis the DNA in oocytes is contained within a large nuclear 
structure called a germinal vesicle. Once CDK1 and cyclin B1 levels have increased, 
resumption of meiosis occurs (Herbert et al., 2015). This manifests itself through two 
distinct processes in the oocyte. The first is germinal vesicle breakdown (GVBD) 
which allows for the DNA contained within to condense and become visible as 
discrete bivalent chromosome structures. The stability of these bivalent 
chromosomes is provided by the cohesin complex, which binds sister chromatids 
together (Nasmyth, 2011, Nasmyth and Haering, 2009, Peters and Nishiyama, 2012).  
The second key feature is the assembly of the MI spindle which is necessary for 
segregation of homologues between the oocyte and the 1st PB (Petronczki et al., 
2003). 
During MI, bivalent chromosomes biorient so that sister centromeres can be bound to 
by microtubules emanating from the same pole (Figure 1.7). This monopolar spindle 
attachment is unique to the first division of meiosis (Watanabe, 2012). The 
mechanism which controls this process in higher eukaryotes is not well understood. 
However, recent work suggests the presence of a meiosis-specific protein called 
MEIKIN that is highly conserved throughout eukaryotes (Kim et al., 2015). This is an 
orthologue of budding yeast monopolin and fission yeast Moa1, which are necessary 
to facilitate monopolar spindle attachment in these organisms (Toth et al., 2000, 
Yokobayashi and Watanabe, 2005).  
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 Figure 1.7 Chromosome segregation in meiosis and mitosis. (a) Schematic 
diagram showing the segregation of chromosomes during meiosis. Oocytes are 
maintained at prophase arrest until GVBD when they enter into metaphase of MI. At 
this stage, bivalent chromosomes must biorientate to allow for monopolar spindle 
attachment to occur. Upon anaphase the reductional division occurs and one set of 
chromosomes are taken into the polar body while the other remains in the oocyte. 
The remaining chromosomes in the oocyte will then undergo bipolar spindle 
attachment and upon fertilisation by the sperm undergo the second round of meiotic 
division which is a reductional division. (b) Schematic diagram showing chromosome 
segregation during mitosis. After prophase mitotic chromosomes biorientate on the 
mitotic spindle. Upon anaphase the chromosomes divide and two new cells are 
formed (this is a diagram based on Herbert et al., 2015).  
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During this period, the microtubules bind to the centromeres and re-adjust until 
monopolar attachment has occurred for each set of homologous chromosomes. This 
has been suggested to take at least one or more rounds of error correction in oocytes 
for the vast majority of chromosomes (Kitajima et al., 2011). Lack of microtubule 
binding and error correction is mediated by the spindle assembly checkpoint (SAC), 
which recognises aberrant spindle binding and signals for correction (Lara-Gonzalez 
et al., 2012). Importantly, the cohesin loaded onto the chromosomes during S-phase 
keeps the homologues of the bivalent chromosomes together in spite of the tension 
which arises from monopolar spindle attachment (Peters and Nishiyama, 2012, 
Herbert et al., 2015). After the kinetochores have established stable microtubule 
attachments, the anaphase-promoting complex (APC/C) is activated (Lara-Gonzalez 
et al., 2012). This causes the paternal and maternal homologues to be pulled apart to 
opposite poles with the cohesin on the chromosome arms being cleaved. One set of 
chromosomes is sent to the polar body for degradation while the other set of dyads 
remains in the oocyte (Figure 1.7) (Herbert et al., 2015). 
 The remaining dyads then biorient their centromeres on the MII spindle (Hauf and 
Watanabe, 2004). These dyads are maintained through centromeric cohesin which is 
protected during MI. This holds dyad sister centromeres together during anaphase I. 
The oocyte remains arrested at metaphase of meiosis II until it is fertilised by the 
sperm. After fertilisation, the second division happens with one set of chromatids 
being pulled to the second polar body and the other remaining in the oocyte with the 
chromatids from the sperm (Herbert et al., 2015) (Figure 1.7).  
Many of the features of meiosis can in some ways be distinguished in mitosis. 
Cohesin stabilises chromosomes and is first removed from the chromosome arms 
before it is removed at the centromeres. Alignment defects are corrected by the SAC 
before segregation can occur. To understand what mechanisms may be responsible 
for the age-related increase in chromosome segregation errors, it is necessary to 
understand the mechanisms behind how chromosomes are stabilised and 
segregated in both mitosis and meiosis.  
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1.4 Chromosome stability in meiosis and mitosis 
1.4.1 Cohesin structure 
 
Chromosomal stability during prophase and metaphase is mediated by the cohesin 
complex. This is a highly conserved ring structure formed of two structural 
maintenance of chromosome (SMC) subunits (called SMC3 and SMC1) and two non-
SMC subunits (Nasmyth and Haering, 2009). These components combine to create a 
ring structure capable of entrapping DNA strands. SMC3 and SMC1 are both large 
proteins of over 1000 amino acids in size that contain a central hinge domain, flanked 
either side by coiled-coil domains (Hirano and Hirano, 2002). The N- and C- terminals 
have nucleotide-binding motifs which associate with one another when the protein 
folds (Peters and Nishiyama, 2012). This happens at the hinge region, with the 
coiled-coil domains forming in an anti-parallel structure. SMC3 and SMC1 interact 
with one another through their hinge domains (Haering et al., 2002). The two 
remaining subunits consist of an α-kleisin subunit, that binds the nucleotide-binding 
regions of the SMC proteins, and a stromal antigen subunit, which directly binds the 
α-kleisin subunit to create the core complex (Figure 1.8). The most widely accepted 
model for how cohesin provides cohesion and stability is that one cohesin ring 
entraps two sister DNAs when the genome is replicated during S phase. This 
maintains cohesion between sister chromatids until anaphase when the cohesin ring 
is opened by separase-mediated cleavage of the α-kleisin subunit (Nasmyth and 
Haering, 2009, Nasmyth, 2011, Peters and Nishiyama, 2012). Recent work looking at 
entrapment of mini-chromosomes by cohesin has also reported this to be the case. 
Using mutations of the cohesin ring Srinivasan et al. were able to show that cohesin 
entraps two strands of DNA within one ring to provide cohesion (Srinivasan et al., 
2018).   
The composite parts of the cohesin ring differ between mitosis and meiosis with only 
SMC3 conserved in both (Nasmyth and Haering, 2009). In mitosis, the variant of 
SMC1 is SMC1α, the α-kleisin subunit is SCC1 (also known as RAD21) and the 
stromal antigen subunit is SCC3 (also known as SA1 and SA2). In meiosis, these 
elements are replaced by SMC1β, REC8 and STAG3 respectively (Nasmyth and 
Haering, 2009) (Figure 1.7). More recently another meiosis specific α-kleisin subunit 
called RAD21L has been described in mammalian germ cells. This is necessary for 
recombination during prophase (Lee and Hirano, 2011).  
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 Figure 1.8 Cohesin structure in meiosis and mitosis. Schematic diagram showing 
the core components of the cohesin ring in meiosis and mitosis. In meiosis, SMC3 
and SMC1β bind to each other at their hinge domain and interact with the α-kleisin 
subunit REC8 at the nucleotide binding domain. STAG3 then interacts with REC8 to 
complete the core complex. Only SMC3 is conserved between both meiosis and 
mitosis. In mitosis SMC1β is replaced with SMC1α and REC8 is replaced by RAD21. 
STAG3 is replaced by SA1/2.  
 
While RAD21 containing cohesin is expressed in mouse oocytes, it is the REC8 
containing cohesin that confers cohesion. This was reported in a study that artificially 
cleaved REC8 in fully grown mouse oocytes during metaphase I (Tachibana-
Konwalski et al., 2010). This resulted in complete resolution of bivalent chromosomes 
to their four constituent chromatids. By contrast, artificial cleavage of RAD21 had no 
effect on the integrity of bivalents. This changes completely, however, after 
fertilisation, where there is a complete switch to RAD21 for chromosomal cohesion 
(Tachibana-Konwalski et al., 2010).  SMC1β is also essential for cohesion in germ 
cells with SMC1β-/- mice showing separation of chromosomes during metaphase 
(Revenkova et al., 2004, Hodges et al., 2005). Interestingly however, the oocytes 
from SMC1β-/- mice displayed progressive loss of bivalent integrity resulting in their 
resolution to individual chromatids after 4 months of age (Hodges et al., 2005). This 
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suggests the presence of non-SMC1β containing cohesin complexes, which may be 
vulnerable to progressive removal during female ageing.  
1.4.2 Cohesin loading and maintenance 
 
The loading of cohesin is mediated by the Kollerin complex which is composed of 
NIPBL (SCC2) and MAU-2 (SCC4) (Ciosk et al., 2000, Peters and Nishiyama, 2012). 
Our current understanding of cohesin loading suggests that it occurs through the 
opening of the SMC1 and SMC3 hinge-region gate (Gruber et al., 2006, Buheitel and 
Stemmann, 2013). This was reported in yeast and later in HeLa cells by artificially 
locking the cohesin ring at specific interfaces. They found that cohesin could not be 
loaded when the SMC1-SMC3 hinge link was closed but could when the SMC and α-
kleisin ones were.  
Cohesin is loaded onto chromosomes during telophase but only become cohesive 
during S-phase after DNA replication (Gerlich et al., 2006). This is when ESCO1 and 
ESCO2 acetylate 2 lysine residues on SMC3 (K105 and K106 in humans) to make 
the cohesin ring cohesive (Zhang et al., 2008) (Figure 1.9). Prior to SMC3 acetylation 
(AcSMC3), cohesin in mitotic cells can be removed by the prophase pathway protein 
WAPL. This interacts with PDS5 (PDS5a/b in higher eukaryotes) to open the 
SMC3/α-kleisin gate, removing the cohesin ring from the DNA (Kueng et al., 2006, 
Chan et al., 2012) . After SMC3 acetylation WAPL is prevented from removing 
cohesin by sororin, which prevents WAPL from interacting with PDS5 (Nishiyama et 
al., 2010, Peters and Nishiyama, 2012) 
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 Figure 1.9 Cohesin loading and establishment. During mitotis G1-phase the 
cohesin complex is loaded onto chromosomes (grey lines) by the Kollerin complex 
comprised of NIPBL and MAU2. This interacts with PDS5 to open the SMC3/SMC1 
interface. Cohesin can be removed by Wapl during this period but once ESCO1/2 
acetylates SMC3 in S-phase, sororin is recruited to PDS5. This prevents any more 
WAPL-mediated removal. Based on a figure from (Haarhuis et al., 2014). 
In mitosis cohesin is renewed after each division. In meiosis, however, it is not 
removed from chromosome arms until anaphase I and from centromeres until 
anaphase II. Crucially, studies in mice indicate that there appears to be no 
replenishment of cohesive cohesin during subsequent stages of oogenesis 
(Tachibana-Konwalski et al., 2010). This was further indicated in a recent study were 
REC8 containing TEV cleavage sites were expressed prior to cohesin establishment 
at S-phase. After this, REC8-MYC was expressed so that if cohesin is turned over 
during meiosis, REC8-MYC should be detected on the DNA. As REC8-MYC cannot 
be cleaved by TEV, this would result in reduced separation when Tev mRNA was 
injected into the oocyte and transcribed. This did not occur, suggesting that there is 
no turnover in REC8 during the prolonged period of prophase arrest (Burkhardt et al., 
2016).  
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It should be noted that while providing cohesion between sister chromatids is a 
primary function, cohesin also has numerous additional functions. A growing body of 
work has focussed on the role cohesin, WAPL and the Kollerin complex plays in 
chromatin organisation. Cohesin associates with the CCCTC binding factor CTCF on 
DNA and is necessary for the transcriptional control and organisation of DNA 
(Parelho et al., 2008, Wendt et al., 2008). Knockout of WAPL results in extension of 
DNA loops in to discrete structures called vermicelli chromosomes (due to the visual 
similarity to the pasta). This phenotype is rescued by knockout of SCC4 (Haarhuis 
et al., 2017). A recent study in to the chromatin organisation of the zygotic genome 
found that cohesin was necessary for organisation of chromatin in to topologically 
associating domains (TADs) and chromatin loops (Gassler et al., 2017) Knockout of 
WAPL resulted in vermicelli formation in the pro-nuclei of these embryos. Cohesin is 
also necessary for helping in the repair of DNA double-strand breaks in both mitosis 
and meiosis (Nasmyth, 2011).  
1.5 Cohesin removal in meiosis and mitosis 
 
1.5.1 prophase pathway  
 
The removal of cohesin in mitotic cells occurs by two independent mechanisms, with 
cohesin on the arm removed first through the APC/C-independent prophase pathway 
(Waizenegger et al., 2000). This involves WAPL opening the cohesin ring at the 
SMC3 and α-kleisin interface and removing it from the DNA (Chan et al., 2012). For 
WAPL to interact with PDS5 during the prophase pathway, sororin must be removed 
by CDK1 and Aurora B phosphorylation, and SA2 must be phosphorylated by PLK1 
(Hauf et al., 2005, Nishiyama et al., 2013)(Figure 1.10). This allows for WAPL to then 
bind to PDS5 and initiate opening of the SMC3/RAD21 interface. 
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 Figure 1.10 Prophase pathway removal of cohesin on chromosome arms 
during mitosis. During S-phase SMC3 is acetylated by ESCO1/2 and sororin is 
recruited to PDS5. This antagonises WAPL and prevents it from opening the 
SMC3/Rad21 interface. Phosphorylation of sororin and SA2 by PLK1, CDK1 and 
Aurora B are necessary for sororin removal and openings of the RAD21/SMC3 
interface. Centromeric cohesin is protected from this by the SGO1-PP2A complex 
which prevents phosphorylation (Haarhuis et al., 2014). 
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To ensure only cohesin on the chromosome arm is removed during the prophase 
pathway, cohesin at the centromeres is protected from removal by the SGO1-PP2A 
complex (Kitajima et al., 2006, Riedel et al., 2006). SGO1 is localised to the 
pericentromere via BUB1 mediated phosphorylation of histone H2A on threonine 120 
(H2A-pT120) and acts to prevent sororin phosphorylation (Kawashima 2010).  SGO1 
is essential for accurate completion of chromosome segregation in mitosis. 
Experiments using RNA depletion in HeLa cells reported mitotic arrest due to an 
inability to maintain cohesion (McGuinness et al., 2005, Salic et al., 2004). SGO1 is 
also necessary for microtubule stability during mitosis (Salic et al., 2004).  
The role of WAPL and sororin in mitosis has been well characterised but not in 
meiosis. A recent study which expressed REC8 and STAG3 in somatic cells found 
that as long as STAG3 was expressed, Rec8 could confer cohesion in mitotic cells. 
Also, this REC8 containing cohesin could have its ring opened by WAPL and was 
protected by sororin (Wolf et al., 2018) . However, recent work in C. elegans 
indicated that while WAPL-1 promotes the removal of COH-3/4 kleisins, it does not 
with REC-8 containing cohesin (Crawley et al., 2016).  
At first, the prophase pathway might seem unnecessary, especially as the remaining 
mitotic cohesin is cleaved by APC/C mediated separase release (Gandhi et al., 2006, 
Nakajima et al., 2007). The prophase pathway is necessary, however, as it offers the 
possibility of recycling cohesin rings for reloading in G1/S phase of the next cell 
cycle, a process that would not be required during meiosis  (Haarhuis et al., 2014).  
 
1.5.2 Spindle assembly checkpoint and the anaphase promoting complex 
 
For anaphase to occur in both mitosis and meiosis, the cysteine protease separase 
must be released from its inhibitor securin to cleave cohesin (Ciosk et al., 1998, Zou 
et al., 1999, Kudo et al., 2006, Wirth et al., 2006). This release is mediated by the 
APCcdc20 which degrades M phase substrates, including securin and cyclin B1 (Figure 
1.11). However, for accurate chromosome segregation to occur, it is necessary for 
the cell to ensure that all chromosomes are orientated correctly and bound by 
microtubules emanating from different poles. This requires centromeric cohesin 
during MII and mitosis and arm cohesin during MI to be maintained until this has 
occurred. To carry out this error correction the cell employs the SAC (Lara-Gonzalez 
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et al., 2012). This is comprised of several checkpoint proteins including MAD1, 
MAD2, BUB1, BUBR1 and MPS1. Upon registering the presence of an incorrectly 
bound centromere MAD1 binds to the kinetochore and recruits MAD2. This forms a 
closed conformation around CDC20 leading to its inhibition along with recruitment of 
BUB1 and BUBR1 inhibiting the APC/C (Lara-Gonzalez et al., 2012).   
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 Figure 1.11 spindle assembly checkpoint control of the anaphase-promoting 
complex in oocytes. Incorrect spindle attachment during metaphase triggers 
recruitment of the spindle assembly checkpoint which inhibits CDC20. This keeps 
CDK1 active through its interaction with cyclin B1 and separase inactive through its 
interaction with securin. Once correct spindle attachment has occurred the APC is 
able to polyubiquitinate cyclin B1 and securin. This inactivates CDK1 and activates 
separase leading to anaphase. Figure based on (Lara-Gonzalez et al., 2012) 
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Oocytes do contain a functioning SAC. The spindle inhibitor nocodazole arrests 
meiosis before anaphase while knockout of BUB1 and depletion of key SAC proteins 
such as MAD2 and BUB1 results in a shortened time to anaphase (Wassmann et al., 
2003, Homer et al., 2005, McGuinness et al., 2009). However, unlike in mitotic cells 
and in sperm where one misattachment activates the SAC,  oocytes do not appear to 
be as sensitive (Musacchio and Salmon, 2007). This was initially reported on in XO 
mice, which only have a single univalent X chromosome. These escapes the SAC 
and do not inhibit anaphase (LeMaire-Adkins and Hunt, 2000). This was further 
supported by later work on oocytes from Sycp3-/- mice. These lack the SC protein 
SYCP3 resulting in a number of univalents. Rather than inhibiting anaphase, these 
univalent chromosomes evade the SAC by establishing bipolar kinetochore – 
microtubule attachments (Kouznetsova et al., 2007).   
The satisfaction of the SAC allows for activation of the APCcdc20 . This leads to 
anaphase allowing for separase mediated removal of cohesin. Prior to activation of 
the APC/C, separase is inhibited in two ways, firstly by its chaperone securin and 
secondly, by CDK1-mediated inhibitory phosphorylation (Zou et al., 1999, Stemmann 
et al., 2001, Chiang et al., 2011). Securin has been shown to inhibit the separase 
protease site by acting as a pseudo-substrate, preventing it from cleaving cohesin 
(Nagao and Yanagida, 2006, Boland et al., 2017). However, the relationship between 
securin and separase is more complicated than securin acting simply as an inhibitor. 
Securin is also necessary for separase function and stability. Indeed, securin-
deficient HCT116 cell lines have a 4 four-fold reduction in separase levels (Jallepalli 
et al., 2001). 
Activation of the APC/C results in the polyubiquitination and degradation of cyclin B1 
and of securin by the 26S proteasome (Lara-Gonzalez et al., 2012, Musacchio and 
Salmon, 2007). Both these steps are necessary for anaphase (Herbert et al., 2003, 
Touati et al., 2012). This frees separase and allows it to cleave the α-kleisin subunit 
of cohesin. The degradation of both cyclin B1 and securin is mediated through the 
presence of conserved destruction-box (D-box) motifs. In contrast to finding in 
xenopus oocytes (Peter et al., 2001, Taieb et al., 2001) homologue disjunction in 
mouse oocytes was found to be dependent on APC/C-mediated degradation of cyclin 
B1 and securin (Herbert et al., 2003). 
In mitosis after anaphase the cell can start the cycle again. However, in oocytes it 
must ensure it does not undergo another round of DNA replication or complete MII 
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before fertilisation (Schmidt et al., 2006). This is mediated by an activity known as 
cytostatic factor which involves inhibition of the APC/C by EMI2 ensuring that the 
remaining centromeric cohesin is not cleaved (Schmidt et al., 2005, Madgwick et al., 
2006).   
1.5.3 Separase mediated cohesin cleavage in meiosis and mitosis 
 
Cohesin in meiosis is removed in a two-step process via separase cleavage (Kudo et 
al., 2009). The first step removes cohesin on chromosome arms before removing it at 
the centromeres in the second (Figure 1.12). Upon activation of the APC/C in MI, 
separase is liberated from securin and cleaves REC8 on chromosome arms. This 
resolves the two homologous chromosomes converting bivalent to dyad 
chromosomes (Herbert et al., 2015, MacLennan et al., 2015). Studies in budding 
yeast have reported that for Rec8 to be cleaved by separase it must first be 
phosphorylated by CK1 and Cdc7 (Ishiguro et al., 2010, Katis et al., 2010). This was 
recently reported to be Aurora B dependent in C. elegans (Ferrandiz et al., 2018). It 
is thought that this requirement for REC8 phosphorylation is conserved in mouse and 
human oocytes also. 
Protection of centromeric cohesin from cleavage during anaphase I is essential for 
biorientation of sister centromeres in metaphase II.  Because phosphorylation of 
Rec8 is required for its cleavage, it can be protected from separase by recruiting a 
phosphatase. In mouse oocytes, this function is fulfilled by an orthologue of SGO1 
known as SGOL2 (Rattani et al., 2013, Llano et al., 2008, Lee et al., 2008). 
According to our current understanding, SGOL2-PP2A prevents  phosphorylation of 
centromeric REC8 which in turn prevents any cleavage by separase (Riedel et al., 
2006, Rattani et al., 2013)(Figure 1.12). The importance of SGOL2 in this role was 
shown through both knockdown and knockout experiments in mice (Lee et al., 2008, 
Llano et al., 2008). Deletion of SGOL2, or disruption of its ability to interact with 
PP2A results in significant chromosome segregation errors and infertility in mice (Lee 
et al., 2008, Llano et al., 2008, Rattani et al., 2013). SGO1 is also expressed during 
meiosis but appears to only result in a minor defect in MI chromosome segregation 
when it is knocked down in fully-grown GV stage oocytes (Lee et al., 2008).  
The mechanisms responsible for SGOL2 localisation have remained elusive for some 
time. While BUB1 is important for recruiting SGO1 to centromeres, knockdown of 
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BUB1 in mouse oocytes resulted in a reductions in time to anaphase but, for the 
most part, only a minor defect in protection of centromeric cohesin (McGuinness et 
al., 2009). SGOL2 localisation has recently been suggested to be dependent upon 
not only BUB1 but also MPS1. This work indicated that knockdown of both MPS1 
and BUB1 was required for total removal of SGOL2 (El Yakoubi 2017). Stabilisation 
of SGOL2 in MI is also thought to depend on MEIKIN (Kim et al., 2015). 
Activation of the APCcdc20 following sperm entry results in a second round of securin 
degradation leading to activation of separase and cleavage of REC8 at centromeres 
(Nabti et al., 2008). It remains unclear exactly how SGOL2 is removed from the 
centromeres to allow for phosphorylation of centromeric REC8. One suggestion is 
that the pulling force exerted on centromeres during MII mechanically forces SGOL2 
away from the centromeric cohesin (Gomez et al., 2007, Lee et al., 2008). Another 
suggested mechanism is that PP2A is inhibited from protecting REC8 
phosphorylation by the action of a chaperone called I2PP2A (Chambon et al., 2013). 
It was reported that when I2PP2A is depleted, sister chromatid segregation is 
prevented. Recent work in yeast has suggested a highly integrated system in which 
removal of Sgo from centromeres to enable “deprotection” of centromeric Rec8 is 
orchestrated by the APCCdc20.  This mechanism enables precise coordination of 
separase activation and deprotection of centromeric Rec8 (Arguello-Miranda et al., 
2017). An implication of this finding is that protection is maintained up until the onset 
of anaphase II.  This is particularly appealing in the case of mammalian oocytes, as it 
would offer additional protection against premature separation of sister centromeres 
during metaphase II arrest. 
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 Figure 1.12 Separase-mediated removal of cohesin during meiosis. Schematic 
diagram showing the two step removal of cohesin in meiosis. Arabic numbers 
indicate what occurs at the centromeres while roman numbers indicate what happens 
on the chromosome arms. (i) During metaphase I separase is inhibited by securin. (ii) 
After APC/C activation securin is degraded and separase is able to cleave 
phosphorylated REC8. (1) At the centromeres the SGOL2-PP2A complex prevents 
phosphorylation of REC8. (2) This protects it from cleavage by separase during 
anaphase I. (3) At metaphase II REC8 can be phosphorylated and (4) cleaved by 
separase allowing for anaphase II to occur (Herbert et al., 2015). 
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Anaphase in mitotic cells also requires separase mediated cleavage of cohesin. After 
correct spindle attachment has been established and the SAC is satisfied, securin 
and cyclin B1 are degraded through polyubiquitination by the APCcdc20 (Lara-
Gonzalez et al., 2012). This releases separase to cleave RAD21 and allows for 
anaphase to occur (Uhlmann et al., 1999, Uhlmann et al., 2000, Hauf et al., 2001).  
 
1.6 Age-related decline in fertility and possibilities of clinical interventions 
 
1.6.1 Molecular mechanisms of age-related chromosome segregation errors 
 
The correlation between incidence of trisomy in oocytes and female age has been 
known for several decades. The initial appreciation of this came from population 
observations of how maternal and paternal age affected the likelihood of a child 
being born with Down’s syndrome. This showed a strong correlation with maternal 
age but no correlation with paternal age (Penrose, 1933). Several potential 
mechanisms for why this occurs was suggested over the subsequent decades. 
These wrestled with the fact that smaller chromosomes seemed distinctly more 
susceptible to trisomy and that the number of crossovers between chromosomes was 
reduced with age (Hassold and Jacobs, 1984).Two of the strongest theories 
suggested were that the prolonged prophase arrest could be causing a deterioration 
in bivalent chromosome structure. Alternatively, there may be a gradient in terms of 
crossover number formation during oocyte production. This theory proposes that 
those oocytes produced, and therefore ovulated first, would have more chiasmata, 
while those produced and ovulated last would have fewer (Henderson and Edwards, 
1968).  
The theory of deterioration during prophase arrest gained significant traction due to 
ground-breaking work carried out by R. Angell in the early 90’s (Figure 1.14) (Angell, 
1991). In this work, she reported that the leading cause of age-related aneuploidy in 
human oocytes was as a result of premature separation of sister chromatids. This 
differed from the orthodoxy at the time that suggested it was from non-disjunction. 
She later showed that premature separation can occur in the first division with the 
oocyte still retaining the correct number of chromatids in a balanced pre-division 
(Angell, 1997) (Figure 1.13). This is then thought to become problematic during the 
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second round of division as the chromatids are no longer physically linked together. 
Her findings were later supported by fluorescence in situ hybridisation (FISH) and 
fixed oocyte imaging studies (Kuliev et al., 2011, Sakakibara et al., 2015).  
 
 
Figure 1.13 Segregation errors during the first meiotic division in oocytes. DNA 
segregation during the first meiotic division requires a reductional division leading to 
one set of chromosomes in the polar body and one set in the oocyte. This can go 
wrong either by premature separation of sister chromatids or via total non-disjunction. 
The likelihood of premature separation occurring rather than total non-disjunction 
increases with age. 
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The more recent studies to determine the frequency and distribution of chromosome 
errors in human oocytes have relied on whole genome amplification and array-based 
comparative genome hybridisation (CGH) of polar bodies (Fragouli et al., 2011, 
Fragouli et al., 2013, Handyside, 2013). These studies indicate that chromosome 15, 
16, 21 and 22 are the most likely to suffer from segregation errors but that all 
chromosomes become susceptible to segregation errors during female ageing. 
Importantly, ageing is also associated with an increase in multiple chromosome 
segregation errors, occurring most often in women in their 40’s (Franasiak et al., 
2014, Handyside et al., 2012, Fragouli et al., 2013) .  
Investigations by our lab and others have strongly suggested that the deterioration of 
oocyte quality during ageing best explains the increase in premature separation of 
sister centromeres. This has focused mostly on the cohesin complex, with REC8 
found to be reduced substantially by 14 months in mouse oocytes (Chiang et al., 
2010, Lister et al., 2010). This leads to a loss of bivalent chromosome stability as well 
as an increase in distance between centromeres (Chiang et al., 2010, Lister et al., 
2010). This is supported by the fact that SMC1β-/- mice also show a loss of bivalent 
chromosome stability (Revenkova et al., 2004, Hodges et al., 2005). As it appears 
that there is no turnover or re-loading of cohesin after establishment during prophase 
arrest, any cohesin lost at this stage is not replaced (Tachibana-Konwalski et al., 
2010, Burkhardt et al., 2016).  
Loss of cohesin with age is also accompanied by loss of the centromeric cohesin 
protector SGOL2 (Lister et al., 2010). Immunofluorescence analysis of SGOL2-PP2A 
localisation suggested that it is loaded onto the MI centromeres after GVBD. This 
presents a model in which cohesion is reduced with age, leading to reduced 
recruitment of the protector SGOL2, leaving it particularly vulnerable to segregation 
errors at anaphase (Figure 1.14). Analysis by our group suggests that REC8 is lost 
during prophase arrest at the primordial oocyte stage of development, again, 
supporting the deterioration of cohesion hypothesis.  
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Figure 1.14. Current model for age-related increase in segregation errors in 
mouse oocytes. Schematic diagram showing the current model for age-related 
segregation errors in mouse oocytes. In oocytes, cohesive cohesin is loaded onto 
DNA after S-phase and maintained throughout oogenesis. SGOL2 is then recruited 
to the centromeres after GVBD and meiosis occurs.  However, as the mouse ages 
REC8 (red dots) becomes reduced in primordial-stage oocytes. After oogenesis has 
occurred, and the oocyte resumes meiosis, the bivalent chromosomes exhibit distal 
association of chromatids as well as an increase in centromeric distance. This also 
results in reduced recruitment of SGOL2 leaving the chromosomes susceptible to 
segregation errors. 
The findings in mice correlate with the phenotype seen in human oocytes. This 
involves an increase in centromeric distance between sister chromatids and a loss of 
chromosomal cohesion (Chiang et al., 2010, Lister et al., 2010, Duncan et al., 2012, 
Lagirand-Cantaloube et al., 2017, Zielinska et al., 2015, Sakakibara et al., 2015). 
How this physically manifests in aneuploidy has been the subject of recent 
investigation. Work using whole oocyte fixation and cold-stabilisation of microtubules 
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in human oocytes suggests uniquely high levels of separation between sister 
centromeres. This leads to hyper-twisted “inverted bivalent” or “half-inverted bivalent” 
conformation, with dyads biorientating instead of monorientating during meiosis I. 
These then fail to segregate as dyads during anaphase, resulting in aneuploidy 
(Zielinska et al., 2015). Another study in fixed human oocytes suggests a different 
mechanism however, with bivalent chromosomes separating into univalent first, 
before biorientating and segregating like MII dyads during anaphase I (Sakakibara et 
al., 2015).  
While loss of chromosomal cohesion is a common feature between humans and 
mice, and the presence of the three essential meiotic cohesin subunits (REC8, 
SMC1β and SMC3) have been identified in humans, it is not known whether a loss of 
these cohesin components is responsible for the increase in segregation errors in 
humans (Garcia-Cruz et al., 2010). Analysis in ovarian sections from women who 
have undergone hysterectomies did not show a significant difference in SMC3 and 
REC8 when analysed per woman (Tsutsumi et al., 2014). Observations of REC8 in 
chromosome spreads from another study seemed to suggest that there was no 
reduction with age (Garcia-Cruz et al., 2010). Importantly, these two sets of findings 
come with large caveats. The first study did not remove soluble cohesin which is 
present in the oocyte but – based on our current understanding of cohesin 
establishment – is not loaded onto the DNA. The second did not show any data and 
the oldest woman in their study was 34. Thus, there has so far been no systematic 
study of the effect of female ageing on chromosome-associated cohesin in human 
oocytes.  
A large barrier to understanding the ageing effect in human oocytes is the current 
source of human oocytes available for use in research. Investigations into human 
oocyte mechanisms have used oocytes not suitable intracytoplasmic sperm 
injections (ICSI) (Webster and Schuh, 2017). These oocytes are not used for ICSI as 
they have not reached metaphase II following ovarian stimulation. These are thought 
to comprise around a fifth of oocytes extracted for ICSI (Reichman et al., 2010). 
While they have provided some key insight in to human meiosis, the fact that they 
failed to mature in vivo raises the possibility that they are not representative of a 
healthy population. 
The “loss of cohesin” model is not the only mechanism that has been suggested as 
the prime-culprit of age-related segregation errors. An alternate theory suggests that 
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it may in fact be as a result of a defective SAC. Key components of the SAC have 
been reported to be reduced with age in mouse and human studies (Baker et al., 
2004, Lagirand-Cantaloube et al., 2017). However, as mentioned previously, while 
the SAC has been reported to inhibit anaphase through inhibition of the APC/C when 
kinetochores are not attached to centromeres, it is unable to detect univalents even 
in younger mice, as the chromosomes biorientate on the MI spindle (Kouznetsova et 
al., 2007). A Study looking at timing of securin degradation and anaphase onset saw 
no difference between young and old mouse oocytes, suggesting no consequential 
loss of SAC proteins (Duncan et al., 2009, Lister et al., 2010, Sebestova et al., 2012). 
The existence of an age-related effect on cytoplasmic proteins affecting segregation 
is also questioned by studies looking at reciprocal GV transfers between young and 
old mice. Comparisons of naturally aged and senescence-accelerated mice produced 
no evidence of rescue of the ageing phenotype in old to young transfers (Liu and 
Keefe, 2004, Cui et al., 2005). This suggests that cohesin loss is a strong candidate 
to explain the age-related increase in premature separation.  
With cohesin depletion being a plausible candidate to explain age-related 
segregation errors, the focus has turned to understanding the underlying 
mechanisms. Potential candidates include, aberrant cleavage of cohesin by the 
protease separase in the primordial-stage oocyte and/or protein damage occurring, 
for example as a consequence of increased reactive oxygen species over time. 
Several factors point to “leaky inhibition” of separase as a candidate for cohesion 
removal. Mnd2 yeast mutants which cannot inhibit the APCAMA1 show premature 
destruction of securin and separase activity during prophase (Oelschlaegel et al., 
2005, Penkner et al., 2005). Also, if separase is present in primordial-stage oocytes, 
CDK1 inhibition will be inactivated as at this stage CDK1 is inhibited by 
phosphorylation (Adhikari et al., 2016). This means that separase would only be 
inhibited by securin. This points to separase as a potential candidate for age-related 
loss of cohesion. 
 
1.6.2 Clinical interventions to address age-related aneuploidy 
 
Since the first child was born using IVF in 1978, assisted reproduction techniques 
(ART) have become well-established clinical procedures (Nagaoka et al., 2012). 
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While these techniques have helped previously infertile parents have their own 
genetically related children, IVF treatment does not overcome age-related dificulties 
in fertility if the woman uses her own eggs (Geraedts et al., 2011, Sauer, 1998). This 
is borne out clinically with Human Fertilisation and Embryology Authority (HFEA) data 
from 2016 showing that only 17% of own egg, partner sperm IVF cycles are from 
women over 40, while donor egg, partner sperm from over-40’s make up 67% 
(HFEA, 2018).This has led to attempts to develop new techniques to detect 
aneuploidy so that the healthiest egg can be selected for fertilisation.   
As mentioned previously, female fertility is shaped by two age-related factors. First is 
the decline in the ovarian reserve of primordial stage oocytes as women get older. 
Second is that the oocytes remaining in the ovary at advanced reproductive age are 
of a poorer quality (Broekmans et al., 2007). Ovarian reserves are currently assessed 
by measuring anti-Müllerian hormone (AMH) levels, which is produced by growing 
follicles (Visser et al., 2006, Grynnerup et al., 2012). Assessment of whether an 
oocyte is aneuploid has focused on the polar bodies which are biopsied before and 
after fertilisation. These are then analysed using CGH sequencing to quantify the 
number of chromosomes in the polar body, thus indicating how many should be in 
the oocyte (Handyside and Xu, 2012). While AMH measurements are readily 
available on the NHS, preimplantation genetic screening tests are only available in a 
small number of clinics.  
These two methods give information on the state of the egg being analysed but do 
nothing to address the underlying problem. Currently, the most likely treatment to aid 
women in maintaining their fertility is to have their eggs vitrified for use at a later date. 
The freezing of oocytes for later use is currently used in the UK for women who are 
undergoing chemo- or radiotherapy but is only available privately for social reasons. 
Analysis of the use of frozen eggs in comparison to freshly extracted oocytes in a 
large scale study reported no significant difference in outcomes (Cobo et al., 2010). 
However, the overall success rate of IVF cycles is dependent on the number of 
oocytes retrieved from the woman as well as her age at the time of donating (Cobo et 
al., 2016). While it is possible to give older women higher doses of hormones to 
stimulate a greater number of oocytes and increase chances of finding a non-
aneuploidy egg, it is thought that high levels of FSH may cause greater chromosomal 
abnormalities (Roberts et al., 2005). This means that women have to decide about 
freezing their eggs many years before they may have even found a partner.  
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From our current understanding of the mouse model there appears to be little scope 
for any other form of clinical intervention in human oocytes. However, whether the 
mouse model is in fact representative of human loss of fertility is currently unclear. 
Using both mouse and human biological material, a primary aim of my PhD project is 
to investigate the potential mechanisms for cohesin loss in primordial stage oocytes 
and to determine the clinical significance of age-related cohesin depletion by 
measuring cohesin levels in human oocytes.  In view of the challenges associated 
with measurement of cohesin levels, I have explored a range of approaches for 
analysing chromosome-bound proteins by immunofluorescence of chromosome 
spreads.   
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Chapter 2. Aims 
2.1 Overall Aim 
The overall aim of this project is to establish the timing and mechanism around 
cohesin loss in primordial-stage mouse oocytes and to investigate the effects of 
ageing on cohesin in human oocyte.  
2.2 Specific Aims 
1) Develop improved methodology for quantification of chromosome associated 
proteins in oocyte ageing studies. This will be done by establishing an 
appropriate immunofluorescent marker to normalise proteins of interest to and 
developing a robust and easily reproducible methodology for carrying out 
analysis. 
 
2) Investigate the effect of ageing on cohesin loss in primordial-stage oocytes. 
Investigate if the protease separase may be responsible for the loss of 
cohesin seen in primordial-stage oocytes through the use of an oocyte-specific 
separase null mouse. Investigate whether cohesin may be afforded any 
protection by the cohesin protectors SGO1 or SGOL2 in primordial-stage 
oocytes.      
 
3) Investigate if the mouse model of cohesin loss during ageing can explain the 
increase in chromosome segregation errors and loss of bivalent stability in 
human oocytes. This will be done in part through establishing a new source of 
human oocytes not dependent upon those rejected from IVF cycles.  
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Chapter 3. Material and Methods 
 
3.1 Mouse strains 
In this project I utilised two genetically altered, without a harmful phenotype, mouse 
strains and one wild type mouse strain. Our collaborators in this project, Nobuaki 
Kudo and Kim Nasmyth provided us with a Separase null conditional knockout 
mouse. This mouse was generated with C57BL/6 background with iCre recombinase 
activity expressed from the Gdf9 promoter. The Separase gene was replaced with a 
version that had the 8 COOH-terminal exon (exon 24 to exon 31) flanked by loxP 
sites (Kudo et al., 2006).  
Our collaborators also provided us with a TG Rec8-Myc line. This mouse has a 
B6CBAF2 background. REC8 is expressed from a bacterial artificial chromosome 
which has nine tandem copies of human c-myc epitope at its C terminus (Kudo et al., 
2009). CD1 wild type mice were used for non-aging experiments.  
For ageing experiments that did not use the REC8-Myc mice I used the mice from the 
separase strain which did not express iCre (Sepf/f mice). These are referred to in this 
work as C57BL/6 mice. 
The mice were housed and bred at the Institute of Genetic Medicine, Newcastle 
University. All CD1 mice used were purchased and imported from Charles River. All 
procedures were carried out in accordance with the regulations of the Home Office.  
3.2 Mouse oocyte harvest 
Mice were culled by cervical dislocation and ovaries were surgically removed using 
watchmaker forceps and bow string scissors. The ovaries were then transported to 
the laboratory in a 15ml falcon tube containing pre-warmed M2 medium (Sigma-
Aldrich, M7167). On a heated stage in a laminar flow hood fitted with a stereoscope, 
fat surrounding the ovary and any remaining fallopian tube was removed from the 
ovary using 29G 1ml insulin needles (BD bioscience, VWR 613-4904) in the lid of a 
60x15mm culture dish (BD bioscience, VWR-734-0007). The ovaries were then 
transferred to a 60x15mm culture dish using M2 supplemented with 200µM 3-
isobutyl-1-methylxanthine (IBMX) (Sigma-aldrich, I7018). Oocytes were released 
from the ovary through maceration of the ovary using the insulin needles. The 
oocytes were collected using hand-held 127-129µm diameter glass denudation 
pipettes (BioTipp, Vitrolife, 14306) and stored at 37°C in 40µl M2+IBMX drops 
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covered in mineral oil (Sigma-Aldrich, M8410) in 35x10mm diameter culture dishes 
(BD bioscience, VWR-734-0005). The oocytes were kept like this until required to 
undergo germinal vesicle break down (GVBD).  
3.3 Mouse oocyte culture 
Prior to oocyte culture (minimum 4 hours but usually overnight) 5x40µl G-IVF 
(Vitrolife, 10136) drops were covered in filtered mineral oil in 35x10mm diameter 
culture dishes and equilibrated in a 5% CO2 incubator at 37°C. To initiate GVBD the 
oocytes were washed repeatedly in each drop of G-IVF and left in the fifth drop. To 
attempt to synchronise GVBD as accurately as possible, GVBD was checked for at 
1hr, 1.5hrs and 2hrs after being left in the final G-IVF drop. Anaphase was adjudged 
to have occurred if the oocyte undergone polar body extrusion. This was checked for 
at 7hrs, 7.5hrs, 8hrs and 8.5hrs after GVBD.  
3.4 Mouse oocyte chromosome spreads 
Prior to spreading 2x40µl drops of acid tyrodes (refer to 3.21), 4x40µl drops of M2 
and 2x40µl drops of 0.5% sodium citrate were pipetted on to the lid of a 50x9mm 
petri dish (BD bioscience, VWR-391-1997) . The number of oocytes to be spread 
were transferred to the acid tyrodes from the culture dish using a stereoscope and a 
glass denudation pipette. After the zona pellucida was observed to have been 
removed, the oocytes were then washed through the 4 drops of M2 to remove any 
residual acid tyrodes. The oocytes were then placed in 0.5% sodium citrate for 2 
minutes to allow swelling.  
Approximately 30 seconds before the spread was carried out, 100µl of 1% PFA (refer 
to 3.21) solution was pipetted on to a pre-labelled polysine slide (Fisher Scientific, 
MNJ-800-010F) and the excess PFA was removed by dabbing on a sheet of blue roll. 
To guide where the oocytes were to be placed, a line was drawn on the back of the 
slide in permanent marker and the slide was placed inside a humidified chamber. A 
few seconds before the 2 minutes are up the oocytes are collected and expelled one 
by one on to the slide along the line and checked to see whether they have ruptured. 
The slide was then kept in the humidified chamber overnight. If spreads were being 
carried out with young and aged mouse oocytes on the same slide, the young mouse 
oocytes were put in sodium citrate first before the aged ones. The young mouse 
oocytes were then drawn up into the pipette first, then a barrier volume of sodium 
citrate was collected before the old mouse oocytes were collected. These were then 
expelled on to the slide so that the older mouse oocytes would be at the top and the 
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younger at the bottom. This allows for both sets to be spread simultaneously but still 
be separately distinguished on the slide.  
The following day a hydrophobic barrier was drawn round the area where the oocytes 
were spread using an Immedge Hydrophobic Barrier Pap pen (Vector Laboratories, 
H-4000) and allowed to dry. The slides with the spreads were then washed 2x 2 
minutes in H2O+0.4% Photoflo (Silverprint, 90662), then 2x 2 minutes in 1xPBS 
(Melford Laboratories, P3206). Slides were stored in 1xPBS at 4°C until they were to 
be stained.  
3.5 Human oocyte retrieval and recording 
All oocytes were retrieved by the clinical team at the Newcastle fertility centre. 
Consent was provided by the women undergoing treatment. Each donation was 
assigned a specific sequential code and was recorded according to HFEA guidelines.  
3.6 Human oocyte stripping and culture 
Human oocytes were transported to the research lab from the clinical lab in G-IVF 
dishes and placed in the 5% CO2 incubator. A 10x HYASE solution (Vitrolife, 10017) 
was diluted to 1x in G-MOPS plus (Vitrolife, 10130) and covered in Ovoil (Vitrolife, 
10029) in an organ culture dish (Scientific laboratory supplies, 353037). The HYASE 
solution was allowed 15 minutes to reach 37°C. Cumulus-oocyte-complex’s (COC) 
were collected using a 9” cotton plugged IVF Pasteur pipette (Origio, PP-9-90PL) and 
placed in HYASE solution and left for 30 seconds. HYASE solution was then washed 
off in G-MOPS and the cumulus cells were removed through pipetting up and down 
using the Pasteur pipette. The oocytes stage of maturation was judged based on 
whether a polar body had been extruded or a whether a GV was visible. The oocyte 
was then placed back in G-IVF for 1.5hrs before being prepared for spreading. If a 
polar body was observed the oocyte was placed back in the incubator for three 
further hours to allow for chromosomes to align on the MII spindle.  
3.7 Human oocyte chromosome spreads 
The procedure for human oocyte chromosome spreads followed a similar method to 
mouse oocyte chromosome spreads with some modifications (refer to 3.4). Rather 
than using acid tyrodes, M2 supplemented with pronase (1mg/ml) (Sigma Aldrich, 
P8811) was used to remove the zona pellucida. This was done on a 37°C heated 
stage. After being washed through 4 drops of M2 the oocytes were placed in 0.5% 
sodium citrate for 5 minutes to allow for swelling.  
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The 1% PFA solution was the same as used in mouse oocyte chromosome spreads, 
but supplemented with 3.4% sucrose (Sigma Aldrich, S1888). This was filtered 
through a 0.45µm syringe filter to remove any debris (VWR International, 514-0075).  
1.5 hours after spreading, the sucrose/PFA solution was re-applied to the slide. The 
spreads were left overnight at room temperature in humidified chambers, and then 
stored at -20°C in a slide box for long term storage.   
3.8 Genotyping 
Ear clippings of recently weaned mice were incubated at 55°C overnight in 250µl of 
lysis buffer (refer to 3.21) supplemented with 2.5µl proteinase K (Roche Diagnostics 
Ltd, 3115887001). The next morning 250 µl of phenol:chloroform (Sigma Aldrich, 
P3803) was added and vortexed at max. speed for 1 minute until white. The cell 
lysate was centrifuged at max. speed (16.9 rcf) for 10 minutes and the supernatant 
moved to a separate tube. DNA precipitation of the supernatant was carried out using 
250 µl of isopropanol and centrifuged at 4°C at max. speed for 30 minutes.  
Without disturbing the pellet, the supernatant was discarded and the remaining pellet 
washed with 500 µl of 70% ethanol (RNase and DNase free) and centrifuged again at 
max. speed for 10 minutes.  This step was repeated again before the eppendorf was 
placed in a hot block for 15 minutes, with the cap open to allow all of the ethanol to 
evaporate.  
Once the evaporation step was complete, 20 µl of 1x TE buffer was added. To 
dissolve the pellet, the eppendorf was incubated at 50°C for 30 minutes.  
PCR-primers used: 
Table 1: Separase Primers 
Primer Direction Sequence PCR product 
size 
5’ – 3’ ACT GAC CGT GAC ATT GAC 
CGT TAC 
529bp 
3’ – 5’  TTCATCACCCAA 
GCTCCAAGCAG 
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Table 2: Gdf9-iCre primers 
Primer Direction Sequence PCR product size 
5’ – 3’ TCT GAT GAA GTC AGG 
AAG AAC C 
~550bp (band shows 
presence of Cre) 
3’ – 5’  GAG ATG TCC TTC ACT 
CTG ATT C 
 
PCR reactants used: DEPC Nuclease free water (Fisher Scientific, 11597065), 10x 
buffer and Taq polymerase (New England Biolabs, M0267S) and dNTPs (New 
England Biolabs, N0447S). Primers purchased from eurofin genomics. 
Table 3: PCR reactant volume 
Reagent  Separase/Gdf9-iCRE (µl) 
 DEPC nuclease free water 19.88 
10x Buffer 2.5 
10mM dNTPs 0.5 
5’ – 3’ Primer 0.5 
3’ – 5’ Primer 0.5 
Taq polymerase 0.13 
Mouse Genomic DNA 1 
 
Table 4: PCR settings 
Step Temperature °C Time (min) No. of Rpts. 
1 94 2 1 
2 94 1 30 
3 58 2 30 
4 72 2 30 
5 72 5 1 
6 4 ∞  
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3.9 Ovary embedding: OCT 
After surgical removal of ovaries and fat removal, ovaries were briefly washed in PBS 
(Life Technologies Ltd, 10010015) and placed in a 10x10x5mm dispomoulds 
(cellpath, GAD-1000-10A) containing room temperature optimum cutting temperature 
matrix media (OCT) (Cellpath plc, KMA 0100-00A). To freeze the solution 2 metal 
blocks were placed in dry ice for 10 minutes to allow them to cool. The dipsomould 
containing the ovaries and OCT were then placed on one cooled metal block and the 
second pre-cooled metal block was placed on top. After the OCT had turned white 
and solid, (signifying that it had been frozen) the embedded ovaries were wrapped in 
tinfoil and stored at -80°C until the time of sectioning.  
3.10 Cryosectioning 
Prior to retrieving OCT embedded ovarian samples from the -80°C freezer, a blade 
(Fisher Scientific, SD3050822) was secured in the cryostat blade block using the 
blade clamp. The cryostat was set to -20°C (Leica CM1860). Two watchmaker 
forceps were also placed inside the machine and allowed to cool.  Ovarian samples 
embedded in OCT were then retrieved from the -80°C freezer on dry ice and 
transported to the cryostat. A small amount of OCT was added to the chuck and the 
OCT embedded sample was placed on top. This was then placed inside the cryostat 
on the fast cooling block and left to freeze for at least 10 minutes. During this time 
polysine slides were labelled. After 10 minutes the chuck was loaded into its holder 
and manoeuvred so the sample was closeto the blade. Once the sample was brought 
close to the blade it was cut in a continuous motion to prevent folding of the tissue 
sections. After a pause of around 5 seconds, the glass anti-roll plate was removed 
and the sample was loaded onto the polysine slide, using a rolling motion starting 
from the bottom of the section. The section was allowed to then dry at room 
temperature before being stored at -20°C for short term storage, and -80°C for longer 
term storage. If there was remaining ovary left after sectioning, a small amount of 
OCT was applied over the sample and the chuck was placed back on the cooling 
block until the OCT went hard and white.  It was then stored as required for future 
use. Sections in which the entire primordial nucleus needed to be accquired were cut 
at 30µm and those for investigating protein expression were cut at 15µm.  
3.11 Ovary embedding: Paraffin Wax 
After surgical removal of the ovaries and fat removal, ovaries were briefly washed in 
PBS and placed in 4% PFA (pH 7.4) overnight at 4°C. The following morning residual 
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PFA was washed off using PBS (Life Technologies Ltd, 10010015). This was 
followed by a process of increasing concentrations of ethanol, intended to dehydrate 
the ovary: 30 minutes in 50% ethanol; 30 minutes in 70% ethanol; 30 minutes in 90% 
ethanol; then 2x 30 minutes in 100% ethanol. The ovaries were then placed in 100% 
xylene (Sigma Aldrich, 534056) for 20 minutes inside a glass snap-top vial. While this 
happened a solution of 50% wax (VWR, 361077E) /50% xylene (Sigma-Aldrich, 
534056) was heated to 60°C in a hot block. After the 100% xylene step the ovaries 
were placed in wax/xylene solution for 15 minutes. They were then incubated in 
100% wax at 60°C 3x20 minutes each. Finally a 10x10x5 dispomould fitted with a 
system I embedding ring (Cellpath, GAB-902-10A) was partially filled with wax. The 
ovary was then placed in the dispomould and the dispomould was then filled 
completely with wax and left to solidify at room temperature.  
3.12 Wax sectioning 
Super frost slides (Fisher Scientific, 10149870) were labelled and a wax box was 
drawn round the outside of the glass. The slides were then placed on a heated 
platform at ~37°C and ddH20 was pipetted inside the box. After this, the wax 
embedded ovary was placed in the clamp of the microtome (Leica, RM2235) and 
locked in place while a microtome blade was inserted into the blade holder.  
Using a fast, continuous motion, sections were cut in quick succession to form 
ribbons of sections. Using the wooden handle of a brush, ribbons were held up to 
prevent them from touching any surfaces before being placed on a black surfaced 
board. Sections were then loaded on to the water covered slides. The first section 
was loaded so that its outer edges would be in contact with the wax strip around the 
slide to hold it in place. The next section was then loaded to overlap with the previous 
to hold them all in place. The water was then allowed to evaporate overnight and 
slides were stored at room temperature in the dark. 
3.13 Chromosome spread immunofluorescence 
Slides with chromosome spreads were incubated for 1 hour at room temperature in a 
block solution of PBTT (1XPBS/0.25% Triton X-100 (Sigma Aldrich, T8787)/0.25% 
Tween-20 (Sigma Aldrich, P9416)) with 10% goat serum (Stratech Scientific, 005-
000-121). The block was removed and the primary antibody was added, made up in 
the same block solution, and incubated overnight at 4°C. 
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The following morning the primary antibody was retrieved and the slides were 
washed at room temperature in a coplin jar on a shaking platform at 75–100 rpm. 
The washes consisted of 1x 10minutes PBS+0.4% Photo-flo; 2x10 minutes 
PBS+0.01% Triton X-100; 1x 10minutes PBS+0.4% Photo-flo and 1x2minutes PBS. 
After the washes the spreads were incubated in secondary antibody made up in the 
block solution for 1 hour in the dark. The washes were then repeated.  
If the conjugated TOPO II antibody was used the spreads would be incubated 
overnight at 4°C in PBTT supplemented with non-immune rabbit IgG (1mg/ml) 
(Sigma Aldrich, I5006).  Washes would be repeated the following day and then the 
spreads would be incubated in the dark overnight at 4°C with the conjugated TOPO II 
antibody in blocking solution. The following morning the washes were repeated and 
the chromosomes spreads mounted in Vectashield mounting media supplemented 
with DAPI  for chromosome visualisation (Vector Laboratories, H-1200) using a No. 
1.5 coverslip (Scientific Laboratory supplies, MIC3246), and sealed shut using a 
rubber solution .  
3.14 Cryosection immunofluorescence 
Slides with cryosections were removed from the -20°C or -80°C freezer and allowed 
to reach room temperature. They were then washed 2x5 minutes in PBS, 1x10 
minutes PBS+1%-Triton, 1x5 minutes PBS at 50rpm on a platform shaker. The 
sections were then fixed for 15 minutes in 4% PFA (pH 7.4) (see 3.21) and then 
washed 2x10 minutes in PBS. Sections were then incubated for 1 hour at room 
temperature in cryobuffer (1xPBS/0.2% Triton X-100/1% DMSO (Sigma-Aldrich 
(D2650)) with 10% goat serum. The block was removed and the primary antibody 
(diluted in the blocking solution) was added. The sections were then stored overnight 
at 4°C. 
The following morning the primary antibody was retrieved and the slides were 
washed 2x10 minutes PBS, 1x10 minutes PBS+1% Lipsol (Fisher Scientific, 
12549965), 1x10 minutes PBS. Sections were incubated with secondary antibody in 
the blocking solution for 1 hr in the dark. After this they were washed 4x10 minutes in 
PBS. If TUNEL was being used, the solution would be applied and the sections 
incubated at 37°C for 1 hour followed by 4x10 minutes PBS washes. DNA was then 
labelled using TO-PRO-3 in PBS for 1 hour at room temperature. After this the 
sections were washed 3x5 minutes in PBS and then mounted in Vectashield 
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mounting media supplemented with DAPI using a No. 1.5 coverslip, and sealed shut 
using a rubber solution. 
3.15 Wax section immunofluorescenece 
Slides loaded with wax sections were incubated 2x10 minutes in xylene, followed by 
2x5 minutes 100% EtOH, 1x5 minutes 70% EtOH, 1x5 minutes 50% EtOH and 1x5 
minutes distilled H20. While this was happening, citric acid buffer solution (see 3.21) 
was warmed in a pressure cooker using an electric hob. The slides were then loaded 
in to a metal rack and placed in the citric acid buffer solution. The lid of the pressure 
cooker was fitted and the temperature increased. When full pressure had be reached 
(signified by the whistling from the pressure cooker) the samples were steamed for 
an additional 8 minutes. After this the pressure cooker was cooled using cold water 
and ice. Slides were then washed in a coplin jar of 3x 5 minutes TBS. A hydrophobic 
barrier was drawn around the sections. A blocking solution of TBS+0.025% Triton 
supplemented with 10% goat serum was used for 1 hour. If a blocking peptide was 
being used then this was incubated with the primary antibody for 1 hour on a shaker 
in the blocking solution. After an hour the block was removed and the primary 
antibody was added and incubated overnight at 4°C. The following morning the 
primary antibody was retrieved and the slides were washed 3x10 minutes in TBS 
followed by 2x5 minutes TBS+0.025% Triton. Sections were then incubated in TBS-
0.025% Triton with 10% goat serum with secondary antibody for 1 hour at room 
temperature. After this the slides were washed 3x10 minutes TBS and mounted in 
Vectashield mounting media supplemented with DAPI using a No. 1.5 coverslip and 
sealed using a rubber solution. 
3.16 Microscope imaging 
The following parameters were used for the imaging of immunofluorescence samples 
by confocal microscopy, both with and without airyscan post processing. 
3.16.1 Nikon A1R confocal microscope 
Immunofluorescence data was collected using a Nikon A1R confocal microscope 
with NIS elements software. Either a Plan Apo 60x/1.40 oil, or an S fluor 40x/1.30 oil 
objective was used. Sequential (Channel series ON)/Simultaneous (Channel series 
OFF) excitation at 405nm, 488nm, 561nm and 642nm was provided by the 405nm 
Cube laser (Coherent Inc., USA), 488nm Argon Laser (Melles Griot, USA), Sapphire 
561nm Laser (Coherent Inc., USA) and Red Diode 642nm Laser (Melles Griot, USA), 
respectively. Emission filters BP 425-475nm, BP 525-555nm, 570-620nm and 662-
45 
 
737nm for were used for detection of DAPI, Alexa 488, Alexa 555 and Alexa 
647/Cy5/ TO-PRO-3 633 signal respectively.  
Frame size: 1024x1024 pixels 
Line average: 2x or 4x 
Z-steps: 0.5µm 
3.16.2 Zeiss LSM880  
Airyscan: Immunofluorescence data was collected using a Zeiss LSM880 with 
Airyscan, a serial array of 32 GaAsP detectors. Images were acquired using either an 
oil Plan-apochromat 63x / 1.4NA or a 40x / 1.3NA objective, with Zen Black 2.3 SP1 
software. Samples were either excited with visible light lasers (488nm, 561nm or 
633nm), or a UV-laser (405nm) corrected with a collimator. Visible light lasers were 
cleaned up by a 488/561/633 beamsplitter and UV-light by a 405nm beamsplitter. 
Emission was collected using the Airyscan detector. Fluorescence was captured 
using multi-bandpass filters: for DAPI this was BP 420-480 + LP 605; Alexa-Fluor 
488 was BP 420-480 + BP 495-550; Alexa-Fluor 555 and -TUNEL was BP 420-480 + 
BP 495-620; and Alexa-Fluor 647/TO-PRO-3 with BP 570-620 + LP 645. Data from 
the Airyscan detector was first processed in Zen Black to improve spatial resolution 
by applying a Wiener filter and pixel re-allocation. Further image processing was then 
performed on these data. 
 
Confocal mode: Immunofourescence data was collected using a Zeiss LSM880 
equipped with Zen Blue and Black software. Using either a Plan-Apochromat 63x / 
1.4 oil or Plan-Apochromat 40x / 1.3 oil objective. Samples were either excited with 
visible light lasers (488nm, 561nm or 633nm), or a UV-laser (405nm) corrected with a 
collimator. Visible light lasers were cleaned up by a 488/561/633 beamsplitter and 
UV-light by a 405nm beamsplitter. Emission filters for BP 420-480, BP 495-550, 
BP560-620  and 645-754 were used for detection of DAPI, Alexa 488, Alexa 
555/TUNEL, Alexa 647/TO-PRO-3 633 signal respectively. 
3.17 Analysis 
3.17.1 Imaris Surface segmentation 
Surface segmentation using Imaris 9.0.2 (Bitplane AG) was carried out to determine 
TOPO II and ACA sum and peak fluorescent intensities. Images acquired by confocal 
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microscopy were loaded into the Imaris software. Chromosomes on the same slide 
were subject to the same thresholding and same surface detail size. The ‘surface 
segmentation’ function was selected and the surface detail size was selected based 
on measurements of the size of the region of interest. A fluorescence intensity 
threshold was set to include the region of interest being investigated. This was then 
maintained for all subsequent oocytes analysed on that slide. If regions of interest 
from two separate surfaces were touching, they could be cut using the ‘cut surface’ 
function under the edit tab on the surface menu. Data was exported as excel files 
using the Statistics tab with the Detailed -> all values drop down selected.    
3.17.2 Volocity 
Volocity Version 6.1.1 (PerkinElmer) was used for the purposes of calculating the 
sum fluorescence intensity within a primordial oocyte as well as the co-localisation 
between two markers in the primordial nucleus.  
Sum Fluorescence Intensity Calculation 
Images were loaded into the Volocity programme and the measurement tab selected. 
Regions of interest (ROI) were drawn free-hand around the primordial oocyte nucleus 
in the xy plane excluding (as best as possible) any surrounding granulosa cells. The 
region was then clipped in z-plane by selecting Edit -> ROI -> Shrink. To calculate 
the sum fluorescence intensity for each channel of interest the following parameters 
were selected: 
- Find Object: 
 Channel – Primary channel of immunofluorescence marker being analysed. 
Threshold set per slide and kept consistent between primordial-stage oocytes 
analysed. 
- Clip to ROI - This ensures measurements are only for values within the region 
of interest.    
- Separate Touching objects - This allows for distinguishing of individual foci 
or structures in the image. Object size guide based on size of object of 
interest. 
This step is then repeated for TO-PRO-3. Finally the Exclude Non-Touching 
parameter was selected. This ensures that only the primary channel of interest 
touching the TO-PRO-3 signal is selected.  
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Co-localisation analysis 
Regions of interest were drawn as in the previous section. The ’Colocalization‘ tab 
was selected. Channel 1 was set to TO-PRO-3 and Channel 2 the protein of interest. 
Thresholds using the same settings for each oocyte were then set to exclude 
background fluorescence and the “Pearson’s Correlation” values under the 
“Threshold statistics” were recorded. 
3.17.3 Linescan analysis 
Confocal images were loaded in to ImageJ and the best focus on the Z-stack was 
selected. The line drawing tool was selected and set to a thickness of 20. This can 
vary but was kept consistent for each set of experiments. Lines were drawn straight 
across the region to be analysed and the graph of fluorescence intensity produced 
using an in house macro (M. Lamb, Institute of Genetic Medicine, Newcastle 
University). Unless specified, individual thresholds were set for each channel of 
interest and the area under the curve was calculated using the code  
(A1+A2)/2*(D1-D2) 
Were A is the fluorescence intensity value, and D is the distance value. The sum of 
the area under the curve values was calculated and this value was used for each 
linescan.  
3.18.4 Inter-centromere distance measurement calculation 
Lines were drawn through sister-centromeres using the line drawing ROI tool on 
ImageJ and the fluorescence intensity graph plotted. The values for the graph were 
then saved as .txt files. Distances were calculated using ExtremaTM software (V. 
Glenis; School of Civil Engineering and Geosciences, Newcastle University). 
3.18 Western blotting 
HeLa cells and mouse fibroblast pellets were treated with RIPA buffer (Life 
Technologies Limited, 89900) supplemented with Halt protease inhibitor to digest the 
cells (Life Technologies Limited, 78425). This was done by adding the RIPA buffer to 
the cell pellet on ice and pipetting the solution up and down to break up the cells 
before storing them at -80°C. Prior to running the lysate on a gel, samples were 
heated to 95ºC for 5 minutes in sample buffer to denature the proteins.  
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Cell lysate was then loaded in to a pre-cast Amersham ECL gel 4-12% (VWR 
international, 28-9898-06 discontinued) and ran on an Amersham ECL gel box for 95 
minutes at 160V. After this the gel was sandwiched with 0.45µm PVDF transfer 
membrane (Thermo scientific, 88518), card, and sponges soaked in transfer buffer 
(see 3.21). Transfers were carried out at 100V for ~100 minutes in a transfer box 
inside a polystyrene box filled with ice. The success of the protein transfer was 
qualified using Ponceau S stain (Sigma Aldrich, 7170). This turned the protein bands 
on the transfer paper dark red if proteins had been transferred.  
The tranfers were then blocked in a 5% milk solution, made up in wash buffer, for 1 
hour before being incubated overnight in primary antibody at 4°C. Residual primary 
antibody was washed off using 3 x 5 minutes washes of PBS-T (PBS 0.1% Tween) 
and the transfers were incubated with secondary antibody for 1 hour. This was 
washed again using 3 x 5 minutes washes of PBS-T. Pierece ECL plus western 
blotting substrate (Thermo Fisher Scientific, 32132) was made up and added to the 
transfer membrane for 5 minutes. Any excess was dabbed off and the blot was then 
wrapped in plastic and kept in the dark. 
To capture the results a single sheet of CL-XPosureTM film (Fisher Scientific, 
10137683) was placed in a dark box along with the parafilm wrapped transfer. This 
was then developed through a tabletop processor (Konica Minolta, SRX-101A). 
 
3.19 Statistics 
Statistic were carried out using GraphPad prism software (GraphPad Software, Inc., 
USA). Normal distribution of data was assessed using either a D’agostino-Pearson 
omnibus normality test or a shapiro-Wilk tests depending on the number of samples. 
The significance of the difference in normally distributed data was then carried out 
using either an unpaired t-test or a one-way ANOVA with post hoc Tukey test. Non-
normally distributed data was assessed through use of Mann-Whitney U test or a 
Kurskal-Wallis test with a post hoc Dunn’s multiple comparison test.  
 
 
 
49 
 
3.20 Antibodies and dyes 
Table 5: Antibodies 
Primary Source Dilution Secondary Source Dilution 
Rabbit-anti-
REC8 
S Keeney 
(gift) 
1:200 Goat-anti-
rabbit Alexa 
Fluor 488 
Fisher 
Scientific UK 
– 10729174 
1:400 
Rabbit-anti- 
human REC8 
JL 
Barbero 
(gift) 
1:50 Goat-anti-
rabbit Alexa 
Fluor 488 or 
555 
Fisher 
Scientific UK 
– 10729174 
Or 
Life 
Technologies 
Ltd - 21429 
1:400 
Rabbit-anti-
Histone H3 
Abcam 
Ab1791 
1:200 Goat-anti-
rabbit Alexa 
Fluor 488 
Fisher 
Scientific UK 
– 10729174 
1:800 
Mouse-anti-
Histone H2B 
Abcam 
Ab52484 
1:50 and 
1:100 
Goat-anti-
mouse Alexa 
Fluor 488 
Life 
Technologies 
Ltd – A11001 
1:800 
Mouse-anti-
MYC Tag, 
clone 4A6, 
Alexa Fluor 
488 conjugate 
Millipore 
UK  
Ltd - 16-
224 
1:50 N/A N/A N/A 
Rabbit-anti-
SMC3 
[EPR7984]  
Abcam  
Plc 
- 
Ab20154
2 
1:25 Goat-anti-
rabbit Alexa 
Fluor 488 or 
555 
Fisher 
Scientific UK 
– 10729174 
Or 
Life 
Technologies 
Ltd - 21429 
1:400 
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Rabbit-anti-
H3K9me3 
Millipore 
UK Ltd – 
07-442 
1:50 
(Cryosect
ions 
) or 1:100 
(chromos
ome 
spreads) 
Goat-anti-
rabbit Alexa 
Fluor 488 
Fisher 
Scientific UK 
– 10729174 
 
1:400 or 
1:800 
Human 
autoantibody 
against 
centromeres  
(CREST) 
Cellon - 
HCT-
0100 
1:50 Goat-anti-
human Cy5 
Jackson 
Immuno 109-
175-003 
1:400 
Purified 
Human-anti-
centromere 
antibody 
(ACA) 
Buck and 
Hickman 
– 15-235-
0001 
1:50 Goat-anti-
human Alexa 
Fluor 555 
Life 
Technologies 
Ltd - 21433 
1:400 or 
1:800 
Rabbit-anti-
Topoisomeras
e II [EPR5377] 
(Alexa Fluor® 
647) 
ABCAM 
Plc - 
ab20099
3 
1:50 N/A N/A N/A 
Rabbit-anti-
RAD21 
ABCAM 
Plc – 
ab992 
1:200 Goat-anti-
rabbit Alexa 
Fluor 488  
Fisher 
Scientific UK 
– 10729174 
1:800 
Rabbit-anti-
SGO1 
JL 
Barbero 
(gift) 
1:50 Goat-anti-
rabbit Alexa 
Fluor 488 
Fisher 
Scientific UK 
- 10729174 
1:400 
Rabbit-anti-
Separase 
Abcam 
Plc – 
ab52158 
1:50 
(paraffin 
wax 
Sections) 
 
Goat-anti-
rabbit Alexa 
Fluor 555 
  
Life 
Technologies 
Ltd - 21429 
1:800 
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1:500 
(Western  
Blotting) 
goat-anti-rabbit 
IgG H+L 
(HRP) 
Abcam Plc – 
ab6721 
1:10000 
Mouse-anti-
DDX4 
Abcam 
Plc – 
ab27591 
1:50 Goat-anti-
mouse Alexa 
Fluor 488 
Life 
Technologies 
Ltd – A11001 
1:800 
 
Table 6: Blocking peptides, dyes and assays 
Dye/Assay/Blocking 
peptide 
Source Dilution 
TO-PRO-3 Thermo Fisher Scientific 
Ltd – T3605 
1:1000 (diluted in 1xPBS) 
Separase blocking 
peptide 
Abbexa – abx161616 1:5 I.F staining 
1:50 western blot 
In situ cell death 
detection kit, TMR red 
Roche Diagnostics Ltd – 
12156792910 
Instruction on kit 
(Diluted in PBS/0.02% 
Trition/0.02% Tween) 
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3.21 Reagents 
 
Acid Tyrodes (100ml): 
0.8g NaCl 
0.02g KCl 
0.024g CaCl.2H2O 
0.01g MgCl2.6H2O 
0.1g glucose 
0.4g polyvinylpyrrolidone  
Dissolve components in 90ml with MilliQ water. Adjust pH to 2.5 with 5M HCl and 
make to 100ml with autoclaved MilliQ water. Filter sterilise and make aliquots of 
200µl. 
Cell Lysis Buffer 200ml: 
20ml 1M Tris-HCl (pH8.5) 
100ml 10mM EDTA 
2ml 20% SDS 
0.234g NaCl 
Make up to volume of 200ml with Milli-Q H2O 
 
Citric acid buffer solution (11mM) (pH 6.0): 
2.1g Citric Acid (Sigma Aldrich - C0759) 
1L ddH2O 
pH using 5M NaOH 
0.5ml of 20% Tween (if cytoplasm is needing removed) 
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1x PBS  
100ml of 10x PBS solution (Melford Laboratories Ltd – P3206) diluted in 900ml of 
ddH2O 
 
1% PFA (25ml): 
0.25g Parformaldehyde (Powder) 
22.5ml of MilliQ ddH2O 
175µl 20% Triton X-100 (0.14% final concentration) 
150µl 0.5M DTT (3mM final conc) 
500μl Aliquoted into eppendorfs and frozen at -20°C for long term storage. 
 
4% PFA (50ml) 
2g PFA (powder) 
0.5ml 1M NaOH 
5ml PBS 10x (Melford Laboratories Ltd – P3206) 
40ml ddH2O 
Adjust pH to 7.4 using 1M HCl. Make volume up to 50ml and filter through 0.45µm 
filter and freeze at -20°C in 1ml aliquots. 
1xTBS 
100ml 1M Tris-HCl pH 7.5 
30ml 5M NaCl  
870ml ddH2O 
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5x Running Buffer (1 litre): 
15.1g Tris 
72g Glycine 
5g SDS 
Dilute to 1x in ddH2O to use 
1xTransfer Buffer (1 litre): 
14.4g Glycine 
3g Tris 
200ml Methanol (add last) 
800ml dH2O 
30ul 10% SDS 
 
1x Wash Buffer (1 litre): 
5ml 1M Tris (pH 7.5) 
2.92g NaCl 
500ul Tween 20 (0.05% final conc) 
Make up to 1L with ddH20 
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Chapter 4. Results: Quantification of chromosome associated proteins 
 
Immunofluorescence imaging can be a highly effective tool in assessing cell state-
dependent changes in protein expression and localisation. To ensure accurate 
representation of any differences in protein expression, it is important to minimise 
experimental variations that may obscure biological findings. There are various 
practical steps that can be taken to do this including having both the control and 
experimental samples on the same slide and imaging them on the same day to 
account for microscope laser power output.  
While these steps can help minimise variation, ideally there would be a standard 
marker that could be used to compare between samples. The use of a standard for 
normalisation is common practice in western blotting and immunofluorescence 
analysis. However, finding a suitable standard for normalisation is not trivial as 
ageing is known to impact on many aspects of the cell (Lopez-Otin et al., 2013). This 
has made it difficult to find an appropriate standard for normalisation in my studies 
looking at oocyte chromosome spreads from young and aged mice. The most 
commonly used standards in these experiments are anticentromere antibodies 
(ACA). These were first discovered in the sera of patients suffering from a form of 
sclerosis called the CREST syndrome (Moroi et al., 1980). These antibodies 
predominantly mark the centromeric proteins CENP-A, CENP-B and CENP-C 
(Earnshaw and Cooke, 1989). However, it has been reported by our group and 
others that immunofluorescence for ACA declines significantly with age (Lister et al., 
2010, Yun et al., 2014). This can mask any measurable changes in chromosome-
associated proteins of interest. To address this long-standing issue I have sought to 
find an alternative marker for studying age-related changes in chromosome 
associated proteins in oocytes. A prime candidate for this is the decatenation enzyme 
topoisomerase II (TOPO II), which is necessary for DNA condensation and 
separation in meiosis (Lee et al., 2006, Li et al., 2013).  
In this chapter I will establish an easy to use and reproducible method using TOPO II 
to help with quantification of chromosome bound proteins in aged mouse oocyte 
studies. 
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4.1 Defining criteria for a good standard. 
 
Before determining if a marker is appropriate for ageing studies, it was important to 
establish criteria that would make it a useful tool for quantification. To address this I 
constructed a checklist to determine the suitability of potential candidates. The 
criteria included whether: (i) its localisation is static during meiosis, (ii) it allows for 
segmentation of the chromosome (distinguishing different structures on the 
chromosome), (iii) it can be used to determine chromosome architecture (number of 
crossovers, number of single sisters, separation of sister centromeres) and (iv) the 
marker is commercially available and compatible with multi-colour imaging with other 
antibodies. 
Based on these criteria several potential candidates can be excluded. Table 7 shows 
candidates that were excluded and the reasons for their exclusion. 
Table 7: Disqualified Candidates for immunofluorescence quantification 
Candidate marker Reasons excluded 
Histone H3 Does not show staining to help 
distinguish different areas of 
chromosome. H3 is thought to reduce 
with aging (Lopez-Otin et al., 2013) 
Histone H2B Could not find suitable antibody 
Condensin Localisation on chromosome changes 
during meiosis (Lee et al., 2011) 
TO-PRO-3 Does not stain in chromosome spreads 
DAPI Required for finding chromosomes on 
slide. 
 
While the condensins would have been useful in determining aspects of chromosome 
architecture, they are dynamic during meiosis (Lee et al., 2011). This renders them 
inappropriate as their localisation will be altered depending on what stage of meiosis 
the oocyte is at.  
While I have used the DNA label TO-PRO-3 (a monomeric cyanine stain which 
stoichiometrically labels DNA) for immunflourescence normalisation in ovarian 
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cryosections it does not label DNA in chromosomes spreads (Bink et al., 2001). DAPI 
cannot be used as it is required for recognition of chromosomes on the slide.  
My search for an appropriate marker led me to the decatenation enzyme TOPO II. 
This antibody is raised against TOPO IIβ but was determined by the manufacturer to 
have some cross-reactivity with TOPO IIα during the course of my project. This 
antibody is commercially available from abcam and so will be easy to acquire for 
other researchers. 
First I sought to investigate whether TOPO II localisation is dynamic, or remains 
constant during progression through the meiotic divisions. To determine whether 
TOPO II localisation changed between the two meiotic divisions, I prepared air-dried 
chromosome spreads of oocytes from CD1 mice at early and late MI and at MII. 
These spreads were immunolabelled with TOPO II and DNA was stained using DAPI. 
Imaging was carried out using confocal microscopy with airsyscan. This provides 
greater resolution of samples through the use of a serial array of 32 GaAsP 
detectors, which collects all emitted photons and reassigns them to their correct 
position. This revealed that TOPO II is enriched at the pericentromere but also 
localises to chromosome arms, albeit with fainter staining (Figure 4.1).  In addition, 
TOPO II localisation does not appear to change between MI and MII. 
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 Figure 4.1 TOPO II localisation remains consistent throughout meiosis. Images 
of 2 months old CD1 mouse early MI (GVBD+3hours), late MI (GVBD+7hours) and 
MII chromosome spreads immunolabelled for TOPO II. TOPO II remains enriched at 
the pericentromere with fainter staining along the chromosome arm. Scale bar 10µm.  
I next sought to investigate whether TOPO II can be used for segmentation of 
bivalent chromosomes allowing for recognition of distinct areas such as the 
pericentromere, axis or chromosome arm. To do this I prepared chromosome 
spreads of oocytes from C57BL/6 mice during M Phase of meiosis I (GVBD +5hrs) 
and immunolabelled them for SMC3 and TOPO II. Due to clear localisation patterns it 
is possible to distinguish different sections of the chromosome based on the intensity 
of staining (Figure 4.2a). This makes it suitable for segmentation to measure 
immunofluorescence (I.F) signals in different chromosomal regions (Figure 4.2b).  
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 Figure 4.2 TOPO II can be used for segmenting different sections of bivalent 
chromosomes. (a) Representative image of a MI chromosome spreads from a 2 
month old C57BL/6 mouse. Scale bar 10µm. Inset (grey box) shows TOPO II and 
SMC3 staining for an individual bivalent chromosome rotated 90º. Red, blue and 
green lines correspond to graphs in same coloured boxes in (b). (b) Shows graphs 
produced from linescans over (i) bivalent arm-lateral (red) (ii) pericentromeric lateral 
(blue) and (iii) full chromatid (green).  
Finally, I wanted to determine whether TOPO II immunolabelling can help in 
detecting changes to bivalent architecture, such as the number of chiasma on a 
chromosome. This is important as it has been established from studies in cases of 
trisomy that the risk of meiotic segregation errors is correlated with the number and 
chromosomal localisation of the chiasma. Absence of chiasma, followed by sub-
telomeric is the greatest risk of causing aneuploidy (Nagaoka et al., 2012). 
Observations in MI spreads of 2 month old C57BL/6 mice immunolabelled with TOPO 
II show that TOPO II immunolabelling helps to distinguish chiasma number as well as 
proximity to the telomere and pericentromere (Figure 4.3).  
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 Figure 4.3. TOPO II is useful for determining bivalent chromosome architecture. 
Representative image of MI oocyte chromosome spreads immunolabelled for TOPO 
II. Boxes show examples of no visible chiasma (green box), single chiasma (blue 
box) and >1 chiasma (red box). 10µm scale bar. 
Attempts to establish if TOPO II could be used for measuring distances between 
centromeres suggets it cannot be used for this purpose. This was due to difficulties in 
consistently resolving the pericentromeric staining on individual sister 
pericentromeres. This is in part due to the TOPO II used in this work being 
conjugated with Alexa Fluor 647 which has a low resolution due to its high 
wavelength. It may be possible to improve this by using a shorter wavelength 
fluorescence tag however this would remove the possibility of imaging another 
protein of interest at a better resolution.  In any case, it would in theory, be possible 
to use ACA to measure inter-kinetochore distance, as this does not depend heavily 
on the strength of the I.F signal.  
Importantly for reproducibility, the TOPO II antibody used in this work is available 
commercially in a conjugated form. This means it can be used in conjunction with 
other antibodies regardless of what species they are raised in. 
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In summary, TOPO II satisfies the criteria of (i) consistent localisation, (ii) 
chromosome segmentation and (iii) resolution of chromosome architecture. (iv) This 
antibody is also commercially available in a conjugated form. Measuring the distance 
between sister centromeres is the only criteria that TOPO II does not satisfy. As there 
was no other clear candidate that would satisfy all these criteria, I proceeded to 
investigate whether TOPO II provides an effective standard for normalisation of 
proteins of interest in ageing experiments. 
4.2 TOPO II is an effective marker for normalising chromosome-bound proteins 
in ageing studies 
 
The most important aspect in determining whether TOPO II can be used for 
normalisation in aged mouse experiments is whether its expression changes with 
ageing. To address this I prepared M phase chromosome spreads at GVBD+5hrs 
using oocytes from 2 month (young) and 15-16 month (aged) old C57BL/6 mice. 
Oocyte chromosome spreads from young and aged mice were prepared on the same 
slide and immunolabelled with antibodies directed towards TOPO II and ACA.  
Chromosomal DNA was stained using DAPI. Chromosomes were imaged by 
confocal microscopy (Fig 4.4). Of the spreads prepared from oocytes from young (n = 
24 oocytes from 3 mice) and aged mice (n =26 oocytes from 4 mice), it was evident 
by eye that ACA is noticeably reduced. This is consistent with previous findings 
(Lister et al., 2010, Yun et al., 2014). By contrast, TOPO II appears to show similar 
intensity at the pericentromeres between young and aged mice. However, TOPO II 
staining on chromosome arms appears much fainter in the aged mice, suggesting 
that this cannot be used for quantitative analysis.  
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 Figure 4.4 TOPO II appears not to be reduced at the pericentromere in aged 
mice MI air-dried chromosome spreads. Representative images from air-dried MI 
chromosome spreads from 2 month and 15 month old C57BL/6 mice immunolabelled 
for TOPO II and ACA with the DNA stained using DAPI. Scale bar 10 µm. Inset 
shows individual TOPO II staining in MI bivalents. Individual chromosomes from 
young and aged mice in the grey and red box respectively. Scale bar 3 µm. (young n 
= 24 oocytes from 3 mice; aged mice n =26 oocytes from 4 mice). 
 
To address whether TOPO II immunofluorescence signal intensity changes with 
ageing, I established a data acquisition pipeline in Imaris using surface segmentation 
to segment pericentromeric TOPO II and ACA (Figure 4.5(a)). To create regions of 
interest (ROI) using surface segmentation, 3-dimensional z-stacks acquired by 
confocal microscopy were uploaded to the Imaris programme. To maintain a 
consistency between the number of z-stacks and to prevent measurement of out of 
focus signal, images were cropped so that only the 3 most in-focus z-steps would be 
measured. Immunofluorescence intensity and surface size thresholds were set and 
used to create the ROI for ACA and pericentromeric TOPO II (Figure 4.5(b) and 
4.5(c)). This threshold was kept consistent for all chromosome spreads on the same 
slide. TOPO II signals from separate pericentromeres that were touching were 
separated using the surface cutter tool. Figure 4.5 shows representative examples of 
the data acquisition pipeline used.   
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 Figure 4.5 Imaris analysis of air-dried chromosome spreads (a) confocal 
acquired images of air-dried chromosome spreads were loaded onto Imaris 
software and (b) the TOPO II and ACA channel were selected. (c) 
Segmentation was carried out using the surface detection tool to give 
regions of interest for the TOPO II and ACA. 
To compare TOPO II staining in oocytes from young and aged females I measured 
the peak fluorescence intensity (F.I) and the sum F.I for TOPO II. Peak fluorescence 
is the intensity of the brightest pixel in the ROI, whereas sum F.I is the summation of 
all the F.I values for each voxel in the region of interest. This information could be 
recalled from Imaris in an excel spread sheet showing this information for each 
channel per ROI (Figures 4.6 and 4.7). Comparisons of the spread in the data 
showed that within oocytes, as well as within ages, the sum F.I values had a greater 
variability than the peak F.I.  
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 Figure 4.6 Peak TOPO II fluorescence intensity values for each oocyte from 
young and aged mice. Graphs showing peak fluorescence intensity of TOPO II in 
young and aged C57BL/6 oocytes from air-dried MI chromosome spreads. Each 
graph represents a slide with experimental repeats separated by the dotted line. 
Each data point represents the peak F.I of TOPO II for each segmented 
pericentromere. Error bars represent the mean ± s.d for each oocyte. Table contains 
the number of oocytes, slides and mice used per experiment.     
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 Figure 4.7 Sum TOPO II fluorescence intensity values for each oocyte from 
young and aged mice. Graphs showing sum fluorescence intensity of TOPO II in 
young and aged mouse oocytes from air-dried chromosome spreads. Each graph 
represents a slide with experimental repeats separated by the dotted line. Each data 
point represents the sum F.I of TOPO II for each segmented pericentromere. Error 
bars represent the mean ± s.d for each oocyte. Table contains the number of 
oocytes, slides and mice used per experiment.     
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To determine whether there is a significant difference between the peak F.I and sum 
F.I in the young and aged mice, the median value for each oocyte was taken and 
normalised to the average value of the 2 month old oocytes on the same slide 
(median pericentromere value per oocyte/ average of median for 2 month oocytes on 
slide*100) (young: 3 mice, 24 oocytes; aged: 4 mice, 26 oocytes) (Figure 4.8a and b). 
An unpaired t-test and a Mann-Whitney U test were used to compare the young and 
aged values for peak F.I and sum F.I respectively. This indicated that while there is a 
significant decrease (p=0.0062) in peak F.I there is no significant difference between 
young and aged for sum F.I (p=0.3279). 
While these findings indicate that the peak F.I value for TOPO II declines with age 
but that the sum F.I does not, this is most likely a result of the variation seen with the 
sum F.I values for TOPO II. A point reflected in that the median value for the peak 
and sum F.I between ages is similar (peak F.I median value 2 month: 99.96%; 15-16 
months: 77.04%; sum F.I median value 2 month: 98.47%; 15-16 months: 77.91%). 
As the sum F.I is dependent upon the area of the pericentromere in question, it is 
likely that differences in pericentromere size will generate a greater variation within 
and between oocytes.  
I next determined whether TOPO II is a more appropriate tool for quantification than 
ACA based on comparisons of the peak and sum F.I for both (Figure 4.8).  The 
results show that while TOPO II shows no significant difference for sum F.I, the Peak 
F.I for TOPO II and the sum and peak F.I for ACA are significantly reduced with age. 
(Peak F.I TOPO II p=0.0062; ACA p<0.0001 sum F.I: Mann-Whitney U test Topo II 
p=0.3279; unpaired t-test ACA p<0.0001). Importantly for normalisation, the median 
values for TOPO II is not as reduced (peak F.I: 2 month: 99.96%; 15-16 months: 
77.04%; median value 2 month sum F.I: 98.47%; 15-16 months: 77.91%) as it is for 
ACA (median value 2 month sum F.I: 98.29% 15-16 months: 56.50%; peak F.I 2 
month: 99.94%; 15-16 months: 65.70%). This suggests that TOPO II is a better tool 
for normalisation than ACA. The reduction in ACA with age also shows that the 
chromosome spreads being analysed are representative of what has previously been 
reported (Lister et al., 2010, Yun et al., 2014).  
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 Figure 4.8 TOPO II is a more appropriate tool than ACA for quantification of 
chromosome-bound proteins in ageing studies. Figure shows graphs of the 
median (a) peak fluorescence intensity and (b) sum fluorescence intensity of TOPO II 
and the median (c) peak fluorescence intensity and (d) sum fluorescence intensity of 
ACA in young and old mice per oocyte. Sum F.I for each oocyte median value was 
normalised to the average F.I of 2 month old mouse oocytes on the slide. Error bars 
represent the mean ± s.d for each age grouping. Mann-Whitney U tests revealed no 
significant difference between young and old (b) TOPO II for sum F.I (p=0.3574). 
Unpaired t-test showed a significant difference between young and old (a) peak F.I 
TOPO II (p=0.0062) and young and old (c) peak and (d) sum ACA (p<0.0001). 
(young n = 24 oocytes from 3 mice; aged mice n =26 oocytes from 4 mice). 
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4.3 SMC3 appears to be reduced using Imaris surface segmentation, but less 
than would be expected on the basis of by eye observations 
 
Next, I sought to determine whether Imaris surface segmentation using TOPO II as a 
normalisation tool can be used to determine depletion of cohesin subunits with age 
(Chiang et al., 2010, Lister et al., 2010). To do this I selected the universal cohesin 
subunit SMC3.   
Representative examples of air-dried M phase (GVBD+5hrs) spreads showing 
immunolabelling for TOPO II and SMC3 with the DNA stained using DAPI indicate 
that, like REC8, SMC3 is also reduced with age (Figure 4.9) (young n = 24 oocytes 
from 3 mice; aged mice n =26 oocytes from 4 mice) (Chiang et al., 2010, Lister et al., 
2010).  
 
Figure 4.9 TOPO II appears unchanged while SMC3 appears to be completely 
absent by 15 months of age. Representative images from air-dried MI chromosome 
spreads from 2 month and 15 month old C57BL/6 mice immunolabelled for TOPO II 
and SMC3 with the DNA stained using DAPI. Scale bar 10µm. Inset shows individual 
TOPO II and SMC3 staining in MI bivalents from young (grey box) and aged mice 
Scale bar 3µm (red box (young n = 24 oocytes from 3 mice; aged mice n =26 oocytes 
from 4 mice). 
To test whether TOPO II used with Imaris surface segmentation can be used to 
reliably measure levels of SMC3, I collected the sum and peak fluorescence intensity 
for SMC3 within the surface region segmented by the TOPO II pericentromere for 
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young and aged mouse oocytes (young: 3 mice, 24 oocytes; aged: 4 mice, 26 
oocytes). The high level of variability in both TOPO II and SMC3 sum F.I (Figure 
4.10) is noticeably reduced after ratioing the value (Figure 4.11).  Peak F.I remains 
relatively more consistent in terms of both the individual values (Figure 4.12) and the 
ratioed values (Figure 4.13) 
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Figure 4.10 TOPO II and SMC3 Sum F.I values in young vs aged C57BL/6 
females per oocyte. Graphs showing sum F.I of TOPO II and SMC3 in young and 
aged mouse oocytes from air-dried chromosome spreads. Each graph represents a 
slide. Individual oocyte TOPO II and SMC3 values are separated by vertical dotted 
lines with experimental repeats separated by horizontal dotted lines. Each data point 
represents either the sum F.I of TOPO II for each segmented pericentromere or the 
sum F.I of SMC3 within that TOPO II region. Error bars represent the mean ± s.d for 
each oocyte. Table contains the number of oocytes, slides and mice used per 
experiment.  
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 Figure 4.11 SMC3: TOPO II Sum F.I ratio in young vs aged C57BL/6 females per 
oocyte. Dot plots showing the ratio of SMC3: TOPO II per segmented TOPO II 
pericentromere for young and aged mouse oocytes. Each graph represents a slide. 
Experimental repeats are separated by dotted lines. Each data point represents the 
ratio of sum F.I of SMC3 to TOPO II per pericentromere. Error bars represent the 
mean ± s.d for each oocyte. Table contains the number of oocytes, slides and mice 
used per experiment. 
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 Figure 4.12 TOPO II and SMC3 Peak F.I values in young vs aged C57BL/6 
females per oocyte. Graphs showing peak F.I of TOPO II and SMC3 in young and 
aged mouse oocytes from air-dried chromosome spreads. Each graph represents a 
slide. Individual oocyte TOPO II and SMC3 values are separated by vertical dotted 
lines with experimental repeats separated by horizontal dotted lines. Each data point 
represents either the sum F.I of TOPO II for each segmented pericentromere or the 
sum F.I of SMC3 within that TOPO II region. Error bars represent the mean ± s.d for 
each oocyte. Table contains the number of oocytes, slides and mice used per 
experiment.  
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 Figure 4.13 SMC3: TOPO II peak F.I ratio in young vs aged C57BL/6 females per 
oocyte. Dot plots showing the ratio of SMC3: TOPO II per segmented TOPO II 
pericentromere for young and aged mouse oocytes. Each graph represents a slide. 
Experimental repeats are separated by dotted lines. Each data point represents the 
ratio of peak F.I of SMC3 to TOPO II per pericentromere. Error bars represent the 
mean ± s.d for each oocyte. Table contains the number of oocytes and mice used per 
experiment. 
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As above (Figure 4.8), I combined the values for the ratios by taking the median 
value of per pericentromere ratios per egg and normalised it to the average of the 
median for the 2 month oocytes on the slide. The results indicates that SMC3 is 
significantly reduced in aged mouse oocytes compared to young when ratioed to 
TOPO II in both the peak and sum F.I (Figure 4.14)(peak F.I: unpaired t-test 
p<0.0001; sum F.I: Mann Whitney U-test p<0.0001).  
 
Figure 4.14 Using TOPO II for normalisation shows SMC3 is significantly 
reduced in aged mouse oocytes. Figure shows graphs of the ratio of (a) peak F.I 
and (b) sum F.I of SMC3: TOPO II for young and aged mouse oocyte chromosome 
spreads. Each data point represents the median value of the SMC3: TOPO II ratio 
normalised to the mean of the median for the 2 month old mouse oocytes on that 
slide. Error bars represent the mean ± s.d for each age grouping. Mann-Whitney U 
tests and an unpaired t-test revealed a significant difference between young and 
aged mice for sum F.I and peak F.I respectively (p<0.0001) (young n = 24 oocytes 
from 3 mice; aged mice n =26 oocytes from 4 mice). 
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4.4 Linescan analysis is a useful tool for quantification in chromosome spreads 
 
While the data from the previous section (Figure 4.14) indicates that SMC3 is 
reduced with age, a comparison of the median values suggests a fold decline of 
0.625 between young and aged mice. By eye observations of SMC3 would suggest a 
greater loss by 15 months. The high value for SMC3 at the pericentromere in aged 
mouse oocytes can be attributed to the Imaris surface segmentation tool. For the 
sum F.I Imaris compiles all the signal for SMC3 I.F. with no thresholding for 
background. This means that any background signal on that channel is also 
collected. As chromosome-bound SMC3 is only present in a small portion of the 
overall TOPO II signal, an ideal tool would allow for independent thresholding of both 
markers of interest. The presence of a signal on the chromosome arms for TOPO II 
in the younger oocytes causes difficulties in thresholding also. To ensure the arm 
staining is not included in the surface, a relatively high thresholds for TOPO II is 
required. This means excluding some pericentromeric TOPO II signal, in particular in 
the older oocytes. 
The peak F.I is also problematic, as it does not distinguish between background and 
“true” SMC3 signal. This means that the value that is assigned as the peak F.I for 
SMC3 could in fact be from a background pixel. 
To address these concerns I developed ‘area-under the curve linescan analysis’. 
This involves using the line drawing tool on the free to download software ImageJ to 
produce a graph of immunofluorescence for each channel of interest that can be 
thresholded independently (Figure 4.15) (Macro developed by M. Lamb). 
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 Figure 4.15 Linescan analysis of Topoisomerase II (a) figure shows a 
representative example of a bivalent chromosome from a young C57BL/6 mouse. 
Yellow line shows the placing of a representative linescan that would be drawn 
across the pericentromere. (b) Shows the corresponding TOPO II graph that results 
from the line scan. After a threshold is set the area under the curve is calculated and 
this value is used for the pericentromere.  
After thresholding, the area under the curve is calculated for each line drawn on 
excel using the formula: 
(A1+A2)/2*(D1-D2) 
Were A is the fluorescence intensity value and D is the distance along the linescan 
value.  
Having applied the line-scanning technique I next wished to test whether it is an 
effective tool for calculating changes in I.F and to compare it with the Imaris 
segmentation approach (Fig 4.14). To do this I performed linescans on the 
pericentromeres of bivalent chromosomes of the spreads analysed in section 4.2 and 
4.3 (young: 3 mice, 24 oocytes; aged: 4 mice, 26 oocytes). Selecting a minimum of 
10 pericentromeres, each one from an individual bivalent chromomosome, I carried 
out linescan analysis. Comparisons of the TOPO II and SMC3 values show a high 
level of variability within oocytes. However, the value for SMC3 appears more 
representative of what can be determined by eye (Figure 4.16). This remains the 
case when the value of SMC3 is ratioed to TOPO II (Figure 4.17). 
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 Figure 4.16 TOPO II and SMC3 area under the curve values in young vs old 
C57BL/6 females per oocyte. Graphs showing area under the curve of TOPO II and 
SMC3 in young and aged mouse oocytes from air-dried chromosome spreads. Each 
graph represents a slide. Individual oocyte TOPO II and SMC3 are separated by 
vertical dotted lines with experimental repeats separated by horizontal dotted lines. 
Each data point represents area under the curve value of TOPO II or SMC3. Error 
bars represent the mean ± s.d for each oocyte. Table contains the number of 
oocytes, slides and mice used per experiment.  
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 Figure 4.17 Ratio of SMC3 to TOPO II in young vs aged C57BL/6 air-dried MI 
chromosome spreads. Dot plots showing the ratio of SMC3: TOPO II per 
pericentromere for young and aged mouse oocytes. Each graph represents a slide. 
Experimental repeats are separated by dotted lines. Each data point represents the 
ratio of area under the curve of SMC3 to TOPO II. Error bars represent the mean 
±s.d for each oocyte. Table contains the number of oocytes, slides and mice used 
per experiment. 
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 Having carried out the linescan analysis I next wanted to determine whether the 
TOPO II values remained similar between young and aged mouse oocyte 
chromosome spreads. To address this I combined the values from the 3 experiments 
as in Figure 4.8. Similar to the sum values, there was no significant difference 
between the young and aged mice TOPO II values (Mann whitey U-test p=0.3279 
and p=0.5414 respectively) (young: 3 mice, 24 oocytes; aged: 4 mice, 26 oocytes) 
(Figure 4.18). The linescan median value is also reduced less than that of the sum 
and peak F.I value (Imaris peak F.I 2 month: 99.96%; 15-16 months: 77.04%, sum 
F.I: 2 months = 97.56%; 15 – 16 months= 77.91%, linescan: 2 months = 102.1%; 15 
– 16 months = 91.43%). These two factors would suggest that the linescan is a more 
effective tool for normalisation compared with the Imaris segmentation approach.  
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 Figure 4.18 comparison of TOPO II Imaris Sum analysis vs linescan analysis. 
Comparison between (a) Imaris peak F.I (b) Imaris sum F.I and (c) linescan analysis 
for TOPO II. An unpaired t-test showed a significant difference in (a) peak F.I 
(p=0.0062). Mann-Whitney U test show that there was no significant difference in 
either the (b) Imaris sum F.I (p=0.3279) or the (c) line scan area under the curve 
(p=0.5414). Error bars represent the mean ± s.d for each age grouping (young n = 24 
oocytes from 3 mice; aged mice n =26 oocytes from 4 mice). 
 
Having established the linescan as an effective tool for quantification between age 
groups I next compared the SMC3 values of the ratios for sum F.I to the line scan 
(Figure 4.19). Mann-Whitney U test showed both had a significant difference 
(p<0.0001) however the median values for the linescan anaylsis appear more 
representative of what could be seen by eye in the confocal acquired images (Figure 
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4.9) (peak F.I 2 month=96.98% 15–16 months=60.69%; sum F.I 2 months = 95.08% 
15–16 months = 60.16%; linescan analysis 2 months =89.32% 15–16 months 
=0.00%). Overall this suggests that for carrying out quantification of chromosome 
associated proteins in ageing studies, use of TOPO II coupled with linescan analysis 
is a useful tool compared to Imaris segmentation.  
 
Figure 4.19 comparison of ratio of SMC3 to TOPO II in Imaris Sum analysis vs 
Linescan analysis. Comparison of ratio of SMC3:TOPO II for (a) Imaris peak F.I (b) 
sum F.I and (c) linescan analysis. (a) Unpaired t-test of SMC3: TOPO II for peak F.I 
showed a significant reduction in SMC3 with age (p<0.0001). Mann-Whitney U test 
show a significant difference for Imaris sum F.I and linescan analysis (p<0.0001). 
Error bars represent the mean ± s.d for each age grouping (young: 3 mice, 24 
oocytes; aged: 4 mice, 26 oocytes). 
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4.5 Discussion 
 
Despite there being clear differences by eye,  accurate quantification of chromosome 
associated proteins in ageing studies has been hampered over the years due to a 
lack of appropriate tools for quantification. To address this I carried out an initial 
investigation of potential candidate markers that could be used. For the markers to 
be considered appropriate tools they had to be (i) static during meiosis (ii) useful for 
segmenting different areas of the chromosome (iii) informative of chromosome 
structure and (iv) commercially available and compatible with staining from widely 
used species. Having excluded various proteins as well as DNA stains based on this 
I selected the DNA catenation enzyme TOPO II. TOPO II is necessary for 
establishing transient double strand breaks in DNA and is expressed in both mitotic 
and meiotic cells (Nitiss, 2009). Importantly, the antibody used in this work is 
available in a conjugated form. Based on the staining protocol used by Shintomi et al. 
this meant I was able to stain using this antibody along with antibodies raised in the 
same species (Shintomi and Hirano, 2011). 
Time series immunofluorescence analysis of topoisomerase II indicates that it 
maintains its localisation throughout MI and in to MII arrest. In oocytes, TOPO II has 
two distinct patterns of staining with a highly enriched area at the pericentromere and 
a fainter but still detectable level of staining on the chromosome arms. This allows for 
clear classification of where another protein of interest is localised on the 
chromosome.  Its localisation along chromosome arms is also useful for not only 
determining the number of crossovers in a bivalent structure but also determining the 
proximity of them to the pericentromere. The number of crossovers and their 
localisation is key to determining the likelihood of a chromosomes to misegregate 
during MI (Hassold and Hunt, 2001). TOPO II may therefore be useful in addressing 
strain to strain variation in premature separation of sister centromeres in mouse 
oocytes  (Danylevska et al., 2014). The one area in which the use of the TOPO II 
antibody was not beneficial was in establishing distance between separated 
centromeres. As the bulk of this work was done using an Alexa-flour 647 tagged 
antibody it may be as a result of using a higher wavelength antibody (resolution is 
calculated based on wavelength divided by numerical aperture).  
To determine whether TOPO II is altered with age, I performed air-dried chromosome 
spreads of 2 month and 15–16 month old C57BL/6 mice. I immunolabelled them with 
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TOPO II as well as ACA and SMC3. The purpose of this was to compare the age-
related decline in TOPO II with that of ACA. We also aimed to compare different 
methods of quantifying the extent of oocytes cohesin depletion during ageing. 
Previous attempts to do this using ACA or CREST were hampered by a marked 
decline in signal intensity during ageing. By eye observations of the TOPO II signal 
suggested that it was unchanged at the pericentromere during ageing, but that its 
intensity was reduced on the chromosome arms. For this reason I confined my 
measurements only at the pericentromere.  
Using Imaris I analysed both the peak fluorescence intensity of the TOPO II signal 
and the sum fluorescence intensity. This analysis revealed that while there is a 
significant difference in peak fluorescence intensity there is no significant difference 
in sum fluorescence intensity. This most likely can be attributed to the high level of 
biological variation within the sum fluorescence intensity data. This is highlighted in 
the lack of a difference in the relative median value between the sum and peak F.I.   
Comparisons between TOPO II and ACA indicated that the age-related reduction in 
ACA for both the sum and peak F.I was greater than the reduction seen in TOPO II. 
Suggesting that TOPO II is a more useful marker for normalisation. 
Next I sought to investigate whether using the sum or peak fluorescence intensity of 
TOPOII would be an effective for measuring depleted proteins. Preliminary 
experiments had suggested that like REC8, SMC3 would be significantly reduced 
with ageing (Chiang et al., 2010, Lister et al., 2010). This would make it a useful 
control to determine whether Imaris measurements of TOPO II are useful for 
quantification. Comparisons of the ratio of SMC3: TOPO II indicated that Imaris 
analysis detects a significant difference. However, by eye observations of SMC3 
would suggest that its fluorescence intensity should be considerably lower. This 
discrepancy is due to the surface segmentation analysis on Imaris. For the sum F.I it 
collects the signal within each voxel where the TOPO II surface is regardless of 
whether it is a true signal or not. This means that a significant portion of background 
fluorescence is picked up and contributes to the overall value when it is not actually 
“true signal” elevating the value. This is also true of the value assigned as the peak 
fluorescence intensity. While this reduces the efficacy of using Imaris surface 
segmentation analysis for measuring punctate signals, it would be a useful tool for 
analysing proteins of interest that are more uniformly distributed. 
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To address these concerns I developed the linescan method of analysis. This 
measures the area under the curve of a graph of fluorescence intensity generated 
from a linescan. This method allows for a more focused approach to the cohesin 
signal as it allows for setting of independent thresholds based on our current 
knowledge of cohesin localisation. Analysis using the linescan method, revealed no 
significant difference in TOPO II signal and a smaller reduction in the median value 
between the young and aged mice. This can be attributed in part to being able to set 
lower thresholds, as there is no interference from the arm staining as in the Imaris 
surface segmentation. Use of the linescan also provided what appeared to be a more 
representative interpretation of the reduction in SMC3.  
There are some important caveats to note from this work before gaining reliable data 
using TOPO II for normalisation. Firstly, the values generated by the linescan 
analysis are still highly variable within and between oocytes. This is difficult to 
overcome as differences between pericentromere size and how chromosomes 
spread out on a slide will always affect this. Secondly, the consistency of TOPO II 
between ages is dependent upon the quality of the chromosome spreads in a way 
that it is not with ACA. If the chromosomal DNA is abnormal then the TOPO II 
staining will be affected. This meant that one slide of data could not be used due to 
difference between the chromosomal DNA morphology between the 2 months and 
15–16 months. Finally, the lack of staining on the chromosome arms requires further 
investigation in aged oocytes. There are two potential reasons for this. The TOPO II 
antibody used in these experiments recognises TOPO IIα and TOPO IIβ. This 
discrepancy could be caused by one of these proteins being affected but not the 
other. Alternatively, the lack of bivalent chromosome structural integrity that occurs 
with age may be affecting the chromosome arms. If the signal was increased this 
may show arm staining over a wider area. This was not investigated as it would have 
resulted in bleaching of the pericentromeric signal.  
With these caveats in mind, the experiments presented in this chapter indicate that 
TOPO II is an effective marker for quantification in ageing studies and that linescan 
analysis is an effective method for determining changes to cohesin sub-units.  I have 
therefore applied this approach in further analysis (Chapter 6) of mouse and human 
oocytes. 
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Chapter 5. Results: Timing and mechanisms of cohesin depletion in 
oocytes 
 
Studies in naturally aged mouse models indicate that fully grown meiosis I oocytes 
exhibit an age-related loss of cohesin (Chiang et al., 2010, Lister et al., 2010), which 
is accompanied by reduced recruitment of cohesin’s protector SGOL2 (Lister et al., 
2010). Together, these findings provide a plausible molecular basis for maternal age-
related aneuploidy, in particular the prevalence of prematurely separated sister 
centromeres observed in mouse and human oocytes from older females (Herbert et 
al, 2015). While age-related cohesin deterioration has been established in mice for 
some time, important questions remain about the timing and underlying mechanisms. 
By understanding this in the mouse it is hoped that we may gain a better insight into 
cohesion dysfunction in human oocytes. 
 
A key aspect to understanding the age-related loss of chromosome stability is that 
the majority of an oocytes existence is spent in primordial follicles, arrested at 
prophase. Based on our current understanding, the lifetime supply of oocytes are 
formed during foetal development (human), or shortly after birth (mouse) (Adhikari 
and Liu, 2009). They are maintained as arrested in prophase of meiosis I within 
primordial follciles, from which they are recruited for growth throughout life  (McGee 
and Hsueh, 2000). Cohesin is established on the chromosomes of oocytes during S-
phase before bivalents are formed during meiotic recombination (Brooker and 
Berkowitz, 2014).  Based on findings in mice (Tachibana-Konwalski et al., 2010, 
Burkhardt et al., 2016), there is no subsequent reloading of cohesive cohesin 
complexes. Thus, cohesin established in oocytes during embryo development must 
be maintained for decades in the case of humans and months in the case of mice.  
 
Using the mouse as a model, Dr. R. Ballesteros-Mejia in our lab found that 
chromosome-bound REC8 is very much reduced in primordial-stage oocytes 
between the ages of 2 and 12 months. However, whether removal of cohesin occurs 
progressively during female ageing, or whether it occurs acutely at advanced age is 
currently unknown. Furthermore, the only study to have looked at other cohesin 
subunits in mouse oocytes did not remove soluble cohesin. Based on R. Ballesteros-
Meija work soluble cohesin does not appear to be affected by age (Tsutsumi et al., 
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2014). It is therefore unclear what the effect of age on other chromosome-bound 
cohesin subunits is.  
 
Potential candidates for investigating the loss of cohesin have naturally focused on 
the proteins and pathways involved in cohesin protection and removal during 
meiosis. If separase is not adequately inhibited, it is possible that “leaky inhibition” of 
separase could progressively cleave cohesin during the prolonged period of 
prophase arrest. Yeast models show that early release of separase from securin in 
prophase, through deletion of the APCAMA1 inhibitor Mnd2, have premature 
separation of chromosomes (Oelschlaegel et al., 2005, Penkner et al., 2005). While 
CDK1 inhibits separase by phosphorylation, CDK1 is not active in primordial-stage 
oocytes, and so would not play a role in suppression of separase at this stage 
(Adhikari et al., 2016).  Work carried out by R. Ballesteros-Meija suggests that 
separase is not responsible for cohesin depletion, however, this was not investigated 
in primordial-stage oocytes, where age-related cohesin loss occurs.   
 
During MI, both SGO1 and SGOL2 localise to the centromeres of bivalent 
chromosomes (Lee et al., 2008). However, knockdown of SGO1 or SGOL2 in fully 
grown oocytes indicated that SGOL2 is the key protector during meiosis I, with 
knockdown of SGO1 showing only mild defects (Lee et al., 2008). This role for 
SGOL2 was confirmed through knockout mice which are infertile and showed high 
levels of premature separation of sister chromatids (Lee et al., 2008, Llano et al., 
2008).  
Evidence from yeast indicates that recruitment of PP2A by Sgo counteracts 
phosphorylation of REC8 and hence prevents its cleavage by separase. This has 
also recently been shown in C. elegans with LAB-1 and PP1 preventing cohesin 
cleavage (Ishiguro et al., 2010, Katis et al., 2010, Ferrandiz et al., 2018). This is likely 
to be conserved in mammalian oocytes but has not yet been tested directly. The 
function of SGO1 during meiosis is less clear as the only information we have to date 
is based on siRNA (Lee et al., 2008). No oocyte specific deletion of SGO1 has so far 
been studied.  Furthermore, we do not know whether SGO1 and/or SGOL2 function 
to protect cohesin during the prolonged prophase arrest.  This is particularly 
interesting in the case of SGO1 whose canonical purpose in mitotic cells is to protect 
centromeric cohesin from removal by the separase-independent prophase pathway 
(Haarhuis et al., 2014).  
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 In this Chapter I aimed to address the temporal and mechanistic basis of cohesin 
loss in ageing.  In relation to timing, I determine whether cohesin depletion during the 
prolonged prophase arrest at the primordial stage occurs gradually during female 
ageing.  To investigate the mechanistic basis, I ask whether separase is expressed 
during prolonged prophase arrest and whether leaky inhibition of separase 
contributes to removal of cohesin in primordial-stage oocytes.  In addition, I ask 
whether SGO proteins, which protect cohesin, are present at the primordial stage 
and whether this is affected by female ageing.  
  
5.1 Identification of primordial-stage oocytes in ovarian tissue 
 
The vast majority of an oocyte’s lifespan is spent arrested at the prophase of MI, 
encapsulated in a primordial follicle (Herbert et al., 2015).  To understand how ageing 
impacts on oocytes it is necessary to study the oocyte at this stage. The optimum 
method for doing this would be to extract live primordial-stage oocytes from the 
ovaries of young and aged mice for western blotting and immunofluorescence 
staining. Studies in mice have suggested that primordial-stage oocytes can be 
extracted from adult ovaries using FACS. Each extraction requires ovaries from 
between 6 to 10 mice aged 7–8 weeks old, and antibody labelling of the oocytes 
(Zhang et al., 2015).  Due to the continuous decline in the number of primordial-stage 
oocytes during female ageing, FACS does not provide a feasible option for studying 
oocytes from older females (Broekmans et al., 2007). While it would still be useful to 
extract primordial-stage oocytes from younger mice, repeated attempts to do this 
based on methodology used to extract germ cells from embryonic ovaries proved 
unsuccessful (Wojtasz et al., 2009). As a result, it was necessary to use histological 
techniques on ovaries to determine and quantify protein expression in primordial-
stage oocytes. 
 
To do this I utilised both paraffin wax and OCT embedded ovarian sections. The 
advantage of paraffin sections is that due to the antigen retrieval step (where the 
sample is boiled in a pressure cooker with citrate buffer pH 6.0 for several minutes, 
breaking up methylene bridges caused during fixation) proteins of interest are more 
likely to be bound successfully by antibodies. However, while paraffin wax embedded 
sections are more suitable for informing whether a protein is expressed and where it 
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localises in the cell, they are less useful in terms of protein quantification and higher 
resolution imaging. For this reason we used OCT embedded ovarian sections for 
quantification of proteins in the primordial stage oocyte. OCT sections also have the 
added advantage of being easier to cut at thicker sections of 30µm which is harder to 
do in wax sections. This allows for greater opportunity to locate whole primordial 
oocyte nuclei.  
 
To help identify primordial-stage oocytes using just DAPI staining and without the 
need for specific markers, it was necessary to train my eye in distinguishing them 
from other cells in the ovary. I did this by using antibodies targeted to DDX4 and 
REC8-MYC for paraffin and OCT embedded ovarian sections respectively. DDX4 
(also known as VASA) is a member of the DEAD-Box family of genes and is 
expressed in germ-cells (Tanaka et al., 2000). REC8 is a meiosis-specific a-kleisin 
subunit of the cohesin complex (Nasmyth and Haering, 2009)(Figure 5.1). To make 
REC8 detection and measurements easier we acquired the REC8-MYC mouse 
strain. This is a transgenic mouse with a B6CBAF2 background. REC8 is expressed 
from a bacterial artificial chromosome which has nine tandem copies of human c-myc 
epitope at its C terminus (Kudo et al., 2009). Work done by R. Ballesteros-Meija in 
our group reported that, consistent with other strains, oocytes from the REC8-MYC 
exhibit age-related depletion of cohesin loss and chromosome segregation errors.  
 
The images in Figure 5.1 show that in both non-growing primordial and primary 
follicles, DDX4 is localised to the cytoplasm, while REC8 is localised to the nucleus. 
Although these two proteins are both expressed after oocyte growth, the number and 
morphology of the surrounding granulosa cells makes it possible to distinguish 
between different stages. While the granulosa cells are cuboidal and form a complete 
ring around primary oocytes, in non-growing primordial follicles the oocytes is 
surrounded by flattened granulosa cells (Adhikari and Liu, 2009). This allows for clear 
distinction between non-growing primordial-stage oocytes and oocytes at later 
stages. It also became clear in searching for primordial-stage oocytes that they tend 
to reside in the ovarian cortex. This allowed me to acquire images quicker by only 
scanning the outer region of the ovarian sections.  
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Figure 5.1 Primordial-stage oocyte recognition in ovarian sections. 
Representative images of (a) paraffin wax and (b) OCT- embedded primordial and 
primary follicles from ovarian sections. (a) Paraffin wax sections were 
immunolabelled with DDX4 and (b) OCT- embedded section with MYC antibody 
targeted to REC8-MYC. DDX4 localises to the oocyte cytoplasm while REC8-MYC is 
localised to the nucleus. Primordial and primary follicles can be distinguished by the 
surrounding granulosa cells. Scale bar 5µm and 10 µm for primordial and primary 
follicles respectively. 
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DNA staining in ovarian sections revealed discrete areas of intense staining in the 
nucleus. Based on our knowledge of chromosome structure after GVBD, the 
pericentromeres of chromosomes are enriched with heterochromatin (Allshire and 
Karpen, 2008). They are also a key area for localisation of proteins essential for 
accurate chromosome segregation. To determine whether the DNA rich areas in the 
primordial-stage oocytes corresponded to the same area in condensed 
chromosomes, I immunolabelled ovarian cryosections with antibodies targeted to 
trimethylation of H3-lysine 9 (H3K9me3) (a marker of heterochromatin) and CREST 
(Becker et al., 2016). DNA was labelled with the monomeric cyanine stain TO-PRO-
3, which stoichiometrically labels DNA (Bink et al., 2001) (Figure 5.2). As can be 
seen in the primordial oocyte, areas enriched by H3K9me3 co-localise with CREST. 
This is the same as observed in condensed chromosomes, which I confirmed by 
immunolabelling metaphase I chromosome spreads with H3K9me3 and CREST 
(Figure 5.2). This suggests that these are the same area of the bivalent chromosome 
in primordial stage oocytes and fully grown oocytes.   
 
Figure 5.2 H3K9me3 and CREST co-localise throughout meiosis on oocyte 
chromosomes. Representative confocal images of a primordial oocyte and a 
metaphase I chromosome spread, immunolabelled with H3K9me3 and CREST. DNA 
is labelled with TO-PRO-3 in primordial stage oocytes and DAPI in the metaphase I 
spread. Scale bar 5µm and 10 µm for primordial follicles and primary follicles 
respectively. 
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5.2 Cell death recognition in primordial stage oocytes 
 
Due to the relatively high levels of cell death by atresia in ovarian primordial follicles, 
it was necessary to distinguish atretic primordial-stage oocytes from healthy ones. To 
do this, I stained ovarian sections using TUNEL (TdT-mediated dUTP-biotin nick end 
labelling) (Figure 5.3) (Gavrieli et al., 1992). This adds labelled nucleoutides to 
fragmented DNA (de Torres et al., 1997). TUNEL-positive cells, which I found to be 
rare, were excluded from analysis.  
 
 
Figure 5.3 Cell death recognition in primordial stage oocytes. Representative 
images of primordial-stage oocytes stained for TUNEL in ovarian sections. Top and 
bottom set of images shows primordial oocyte negative and positive for TUNEL 
respectively.Scale bar 5µm. 
 
5.3 Cohesin is lost progressively from DNA in primordial-stage oocytes 
 
While recent work in our lab indicated that depletion of REC8 occurs predominantly 
at the primordial-stage of oogenesis in aged mice (R. Ballesteros-Meija), it is not 
clear whether cohesin depletion occurs progressively during ageing, or whether it 
occurs acutely at older ages. To address this, I immunolabelled ovarian sections from 
C57BL/6 mice aged 2, 6 and 12 months old with anti-REC8 antibody and labelled the 
DNA using TO-PRO-3. Sections were also stained using DAPI to locate the 
primordial-stage oocytes. While females are still fertile at 6 months, I anticipated that 
it would allow for sufficient time for cohesin depletion to be detected if it occurs 
progressively. Work carried out by R. Ballesteros-Meija showed that primordial-stage 
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oocytes contain a large quantity of soluble cohesin even at 12 months of age. 
Therefore, to study chromosome-bound cohesin it is necessary to remove soluble 
cohesin. To do this, ovarian cryosections were treated with a detergent wash of 1% 
Triton-PBS before fixation and a 1% lipsol-PBS wash after primary antibody 
incubation. This permeabilises the cells in the section and removes the cytoplasm. 
Images were acquired by confocal mode and airyscan mode microscopy on a Zeiss 
lsm880.  Comparison of REC8 fluorescence intensity in primordial-stage oocytes by 
eye suggested that REC8 was reduced in sections from 6 months compared with 2 
months old females. However, this reduction was not as pronounced as the reduction 
seen at 12 months of age (2 months n= 25 oocytes from 3 mice; 6 months n= 23 
oocytes from 3 mice; 12 months n= 22 oocytes from 3 mice) (Figure 5.4).  
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Figure 5.4 REC8 appears reduced in 6 month old mouse primordial-stage 
oocytes. Representative images of primordial-stage oocytes from 2, 6 and 12 
months old C57BL/6 background mice, immunolabelled with an antibody targeted to 
REC8 and withTO-PRO-3 staining the DNA. Scale bar 5µm (2 months n= 25 oocytes 
from 3 mice; 6 months n= 23 oocytes from 3 mice; 12 months n= 22 oocytes from 3 
mice). 
 
To calculate the chromosome associated REC8 in the primordial-stage oocytes I 
used Volocity software. This allows for calculation of fluorescence intensity within a 
hand-drawn region of interest (ROI). The ROI was drawn around the primordial 
oocyte and cropped so as to be as tight to the oocyte nucleus as possible. I then 
used the ‘detect objects’ function and set a fluorescence intensity threshold that was 
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kept consistent per slide for each marker being measured. The ‘sum fluorescence 
intensity’ (sum F.I) for REC8 and TO-PRO-3 for each oocyte was calculated (Figure 
5.5). Sections were cut at 30µm in thickness to increase the likelihood of finding 
primordial-stage oocytes in which the whole nucleus could be imaged. To control for 
experimental variations sections from the 2, 6 and 12 months old mice were mounted 
on the same slide, and labelled and imaged on the same day.  
 
Figure 5.5 REC8 quantification in primordial-stage oocytes (a) Representative 
image of a primordial oocyte immunolabelled with REC8 and TO-PRO-3. (b) TO-
PRO-3 and (c) REC8 are selected through hand-drawing regions of interest around 
the primordial oocyte. The ‘sum fluorescence intensity’ of REC8 and TO-PRO-3 was 
then calculated and values were compared for oocytes from 2, 6 and 12m old 
females. 
 
Because TO-PRO-3 binds stoichiometrically to DNA, I aimed to normalise the sum 
F.I of REC8-Myc to the sum F.I of TO-PRO-3 for each primordial in order to detect 
age-related changes in REC8 levels.  However, I found that TO-PRO-3 F.I varied 
considerably between different experimental groups and this did not appear to be 
age-dependent (Figure 5.6 (a) By contrast, REC8 F.I declined with age, except for 
one experiment in which REC8 levels were comparable between 2 and 6 month old 
ovaries (Figure 5(b)). Interestingly, TO-PRO-3 staining was also elevated in the 6 
month ovaries from that experiment.  The unexpected variation in To-PRO-3 F.I casts 
doubts on the validity of using the sum F.I values for normalisation of REC8 levels.  
Unfortunately, Topo II, which I used successfully for normalisation of the cohesin 
sub-unit SMC3 in chromosome spreads from fully grown oocytes (Chapt 4.4), was 
not detectable in primordial stage oocytes. Calculation of the ratio of REC8 F.I to TO-
PRO-3 F.I for each suggests that by 6 months, a significant portion of chromosome-
bound cohesin in primordial-stage oocytes has already been lost. (Figure 5.6 (c). 
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However, as TO-PRO-3 varied significantly throughout the different age groups, it 
appears to be a poor tool for normalising the fluorescence signal of REC8.  
 
Figure 5.6 Comparison of DNA bound REC8 in 2, 6 and 12 months old 
primordial-stage oocytes. Graphs show (a) sum TO-PRO-3 fluorescence intensity 
(b) Sum REC8 fluorescence intensity and (c) ratio of REC8: TO-PRO-3 for 
primordial-stage oocytes in 2, 6 and 12 months old primordial-stage oocytes. A 
Mann-Whitney U-test test was used to establish p-values with a p-value of less than 
0.05 classed as significant. The number of oocytes and mice used from each age 
group and each experiment is shown in the table above.   
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While there is a decline in the REC8 sum fluorescence intensity in each experiment, 
the variation in TO-PRO-3 within experiments skews the ratio. Because the variation 
in TO-PRO-3 appears to be independent of age I normalised the values relative to 
the median 2 months value for each experiment and combined them over all. This 
revealed much variation between oocytes within each experiment, however it showed 
no significant difference in TO-PRO-3 F.I between 2 months and 6 months, and the 6 
months and 12 months (Figure 5.7(a) Mann Whitney U-test p=0.9877 and p=0.406 
respectively). By contrast, normalisation of REC8 F.I to the median value for the 2 
month old mouse revealed a significant difference in the levels of REC8 detected in 
primordial-stage oocytes from  2, 6 and 12 month old ovaries (Figure 5.7 (b) Mann 
Whitney U-test  2 months vs 6months p<0.0001, 6 months vs 12 months p<0.0001; 
and (Figure 5.7 (c) REC8:TO-PRO-3 ratio (Mann Whitney U-test  2 months vs 6 
months p=0.0133, 6 months vs12 months p<0.0001)). These findings indicate 
significant depletion of chromosome-bound cohesin by 6 months with a further 
depletion by 12 months.   
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Figure 5.7 REC8 is significantly reduced in primordial stage oocyte at 6 months 
of age. Graphs show sum fluorescence intensity for (a) TO-PRO-3 (b) REC8 and (c) 
REC8:TO-PRO-3 relative to 2 months for the 3 experimental repeats used. A Mann-
Whitney U-test test was used to establish p-values with a p-value of less than 0.05 
classed as significant. Error bars represent the mean ± s.d. for each age group. Error 
bars represent the mean ± s.d. for each mouse. (a) 2 months vs 6 months p=0.9877 
and 6 months vs 12 months p=0.406 (b) 2 months vs 6 months p<0.0001 and 6 
months vs 12 months p<0.0001 (c) 2 months vs 6 months p=0.0133, 6 months vs 12 
months p<0.0001. (2 months n= 25 oocytes from 3 mice; 6 months n= 23 oocytes 
from 3 mice; 12 months n= 22 oocytes from 3 mice) 
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To assess whether the loss of cohesin is progressive or occurs at an increased rate 
with age, I plotted the median values of 2, 6 and 12 months REC8:TO-PRO-3 on a 
line graph (Figure 5.8). This graph shows that the loss of REC8 appears to be linear 
with the reduction occurring at a consistent rate.  
 
Figure 5.8 Age-related progressive loss of cohesin occurs in a linear fashion. 
Line graph showing the median values of normalised 2, 6 and 12 months old 
primordial-stage oocytes from ovarian sections. Error bars represent inter-quartile 
values for each set. (2 months n= 25 oocytes from 3 mice; 6 months n= 23 oocytes 
from 3 mice; 12 months n= 22 oocytes from 3 mice) 
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5.4 The cohesin subunit SMC3 is depleted with age in mouse primordial-stage 
oocytes 
 
While it appears that the age-related loss of REC8 in primordial-stage oocytes occurs 
in a progressive manner, I was interested to determine whether other cohesin 
subunits show a similar decline. SMC3 is of particular interest as it is required for 
chromosomal cohesion in somatic cells and during meiosis (Nasmyth and Haering, 
2009). Thus, should RAD21-containing complexes be present on the chromosomes 
of primordial stage oocytes, analysis of SMC3 levels will provide a comprehensive 
picture of cohesin loss during female ageing.  
 
First I sought to determine the localisation of SMC3 in primordial-stage oocytes 
relative to REC8. To address this I co-stained SMC3 and REC8 in ovarian 
cryosections from 2 and 12 months old REC8-MYC mice. 
 
As discussed above, I permeabilised the ovarian sections using a 1% Triton-PBS and 
1% lipsol-PBS solution to minimise soluble cohesin. The DNA was labelled using TO-
PRO-3 (Figure 5.9). Analysis from the linescans indicate that like REC8-MYC, SMC3 
is enriched at the sites of heterochromatin in primordial-stage oocytes (2 months n= 
30 eggs from 3 mice). Interestingly, enrichment of SMC3 at heterochromatin is not 
evident in the surrounding somatic cells in which cohesin complexes consist only of 
RAD21.  
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Figure 5.9 SMC3 is enriched at primordial oocyte heterochromatin. (a) 
Representative images of a primordial stage oocyte from a REC8-MYC mouse 
immunolabelled for REC8-MYC and SMC3; DNA was stained using TO-PRO-3. (b) 
Linescan analysis covering heterochromatic and euchromatic. Scale bar 5µm. (c) 
Areas of the primordial showed that SMC3 localisation tracks the localisation of 
REC8-MYC with increased SMC3 and REC8-MYC at the areas of heterochromatin (2 
months n= 30 eggs from 3 mice). 
 
To determine whether SMC3 is reduced in primordial-stage oocytes, I 
immunolabelled OCT embedded ovarian sections from 2 and 12 months old REC8-
MYC mice. This was done using antibodies targeted to SMC3 and REC8-MYC with 
the DNA stained using TO-PRO-3. Sections were also stained using DAPI to locate 
the primordial-stage oocytes (Figure 5.10). Images were acquired by airyscan and 
confocal mode microscopy on a Zeiss lsm880 microscope.  Consistent with its 
expression in somatic cells, SMC3 was detected in the cells surrounding the oocytes 
(Fig 5.10).  Comparison of the I.F signal by eye suggested that like REC8-MYC, 
SMC3 is also reduced during ageing in primordial stage oocytes, but does not appear 
to be as reduced in the surrounding somatic cells (Fig 5.10).   
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Figure 5.10 Chromatin bound SMC3 levels in primordial-stage oocytes are 
reduced as a function of age. Figure shows single plain images of a primordial 
oocyte in ovarian sections from 2 and 12 months old females. Ovarian sections were 
immunolablled for SMC3 and REC8-MYC, with DNA stained with DAPI. Both SMC3 
and REC8-MYC show a marked reduction in fluorescence intensity in the 12 months 
old mouse compared to the 2 months scale bar 10µm (2 months n= 30 eggs from 3 
mice; 12 months n= 18 eggs from 3 mice).  
 
As above (Figure 5.5), I used Volocity software to quantify the levels of REC8 and 
SMC3 in primordial stage oocytes at different ages (Figure 5.11). The results indicate 
that like REC8-MYC, SMC3 also declines significantly with age (3 experiments 
p<0.05).  
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Figure 5.11 SMC3 is reduced significantly in primordial stage oocyte during 
female ageing. Graphs show dot plots of (a) sum TO-PRO-3 fluorescence intensity 
(b) sum REC8-MYC fluorescence intensity (c) sum SMC3 fluorescence intensity (d) 
ratio of REC8-MYC:TO-PRO-3 (e) ratio of SMC3:TO-PRO-3, for primordial-stage 
oocytes in 2 and 12 months old REC8-MYC mice. Each dot represents an individual 
primordial oocyte. A Mann-Whitney U-test was used to establish p-values with a p-
value of less than 0.05 classed as significant. The number of oocytes and mice used 
from each age group and each experiment is shown in the table above.   
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While these findings indicate a significant decline in REC8 and SMC3 levels in 
primordial stage oocytes between the ages of 2 and 12 months, the effect size 
appears greater for REC8 compared with SMC3. To investigate this further, I 
normalised the results across the 3 experiments, with the 2 month old median value 
as 100% (Figure 5.12). While the difference in SMC3 and REC8-MYC between 
young and old remains significant, the fold reduction of 2.2 for SMC3 is not as high 
as the 11.9 times reduction in REC8-MYC.  
 
 
Figure 5.12 SMC3 is reduced significantly in primordial stage oocyte during 
female ageing, but not as significantly as REC8-MYC.  Graphs show ratio of (a) 
SMC3: TO-PRO-3 and (b) REC8-MYC:TO-PRO-3. Each dot represents an individual 
primordial oocyte relative to 2 month median value for the 3 experimental repeats in 
2 vs 12 months old REC8-MYC mouse ovarian sections. A Mann-Whitney U-test was 
used to establish p-values with a p-value of less than 0.05 classed as significant. 
Mean fold reduction of SMC3 and REC8-MYC was calculated (2 months n= 30 eggs 
from 3 mice; 12 months n= 18 eggs from 3 mice). 
One possible implication of the increased age-related depletion of REC8 compared 
with SMC3, is that primordial stage oocytes also contain RAD21-containing 
complexes. To address this, I determined whether RAD21 can be detected in the 
nuclei of primordial stage oocytes. While I could not find a RAD21 antibody which 
worked in cryosections, staining of RAD21 in wax embedded ovarian sections from 
young CD1 mice suggests the presence of RAD21 in the primordial-stage oocytes 
(Figure 5.13). Thus, it is possible that a fraction of SMC3 is in complex with RAD21.  
Previous work from the Nasmyth lab indicates that cohesion in mouse oocytes is 
orchestrated solely by REC8-containing complexes (Tachibana-Konwalski et al., 
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2010). While the functional significance for cohesion is unclear, it is possible that 
RAD21-containing complexes are replenished. For example, they may be involved in 
DNA damage repair (Nasmyth, 2011). This would explain the lesser extent of oocyte 
SMC3 depletion during female ageing compared with REC8.  Further work is 
required to determine whether Rad21 levels decline or increase with age. 
 
 
Figure 5.13 RAD21 is expressed in a relatively low level in early oogenesis 
oocytes. Wax ovarian sections showing primordial-stage oocytes immunolabelled for 
RAD21 with DNA stained using DAPI. Secondary only controls were used to judge 
staining. Grey and red box show individual primordial-stage oocytes for stained and 
secondary only control respectively Scale bar 5µm. inset scale bar 3µm. 
 
 
5.5 Separase is expressed in primordial stage oocytes 
 
Having determined that chromosome-bound cohesin is lost progressively in the 
nucleus of primordial stage oocytes, I next sought to determine what mechanisms 
could be responsible. One potential mechanisms for the age-related loss of cohesin 
in oocytes would be through leaky inhibition of the cysteine protease separase. 
Separase is responsible for the removal of cohesin from chromosome arms by 
cleaving REC8 during anaphase I. Separase is also necessary for cleaving 
centromeric REC8 during anaphase II and centromeric RAD21 in mitotic cells (Kudo 
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et al., 2006). It is possible that if separase becomes dissociated from its inhibitor 
securin, it may be cleaving cohesin progressively over time.  
 
In budding yeast, separase is expressed in prophase of MI, and cleaves cohesin in 
mnd2Δ mutants, which prematurely degrade securin (Penkner et al., 2005, 
Oelschlaegel et al., 2005). If separase is also expressed in prophase arrested 
oocytes, it is conceivable that leaky inhibition during this time would cause 
progressive loss of cohesin. To determine whether separase is expressed in 
primordial stage oocytes I carried out immunolabelling of paraffin wax ovarian 
sections with antibodies targeted to separase. The antibody was validated to work in 
mouse tissue through western blotting of primary culture mouse fibroblasts (Figure 
5.14a). Control experiments were performed using a blocking peptide to exclude the 
possibility that the signal was due to non-specific binding of the separase antibody. 
To ensure that any separase detected could be attributed to the primordial oocyte 
rather than the surrounding cells, I co-stained with DDX4 to mark the primordial 
cytoplasm. The DNA was stained using DAPI (Figure 5.14b). Results of the line-scan 
indicate that separase localises to the cytoplasm in primordial stage oocytes (n= 2 
CD1 mice: 12 oocytes with no blocking peptide; 9 oocytes with blocking peptide).  
While separase was not detected in the nucleus, I cannot exclude the possibility that 
it localises transiently to the nucleus, or is present at very low levels.  Unfortunately I 
was unable to establish whether securin is also expressed in primordial-stage 
oocytes due to the lack of an appropriate antibody for immunolabelling. Analysis of 
Single-Cell RNA-seq data in human foetal germ cells suggests securin is expressed 
in oocytes during oogenesis (Li et al., 2017).  The presence of securin in primordial-
stage oocytes should be determined as it is necessary for separase stability and 
control.  
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 Figure 5.14. Separase localises to the cytoplasm in primordial stage oocytes. 
(a) Antibody recognition of mouse separase was validated through western blotting of 
mouse fibroblasts, using blocking peptide as a negative control and HeLa cells as a 
positive control. (233 kDa) (b) Representative images of primordial stage oocytes 
from paraffin wax embedded ovarian sections, immunolabelled with antibodies 
targeted to separase (with or without blocking peptide). Ovarian sections were also 
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immunolabelled with antibodies targeted to DDX4. Scale bar 5µm (c) Representative 
line-scan separase peaks with DDX4 while it remains unchanged in those with 
blocking peptide Scale bar 5µm (n= 2 CD1 mice: 12 oocytes with no blocking 
peptide; 9 oocytes with blocking peptide). 
 
5.6 Separase does not appear to be responsible for cohesin loss in primordial 
stage oocytes 
 
While recent work in our lab indicated that cohesin loss in fully grown MI oocytes 
(GVBD+5hrs) cannot be explained by leaky inhibition of separase, the effect of an 
oocyte specific deletion of separase on cohesin at the primordial stage has not been 
tested. As the data above suggests that separase is expressed in the primordial 
oocyte, I next sought to determine whether the reduction in REC8 in primordial-stage 
oocytes could be attributed to mis-regulation of separase. To do this I used the 
separase knockout mouse line developed by Wirth et al. (Wirth et al., 2006). This 
mouse has the wild-type separase gene replaced with a version that has the 8 
COOH-terminal exons (exon 24 to exon 31) flanked by loxP sights. These exons 
contain part of the conserved protease domain that is necessary for REC8 cleavage 
and is removed when iCre is expressed (Figure 5.15).  
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Figure 5.15 Generating oocyte-specific separase knockout mouse. Schematic 
diagram showing strategy for breeding. Sepf/f;Gdf9-iCre males were breed with Sepf/f 
females to produce either Sepf/f;Gdf9-iCre or Sepf/f offspring. Sepf/f males were culled 
and Sepf/f;Gdf9-iCre males were used for breeding. Sepf/f females were used either 
as experimental controls or for breeding while Sepf/f;Gdf9-iCre females were used for 
experiments. Expanded circle shows how the separase gene has loxP sites situated 
at exon 24 and 31. Expression of iCre results in this section being deleted.  
 
To achieve separase knockout specifically in primordial-stage oocytes, floxed regions 
of the separase gene were targeted for deletion by iCre expression driven from the 
Gdf9 promoter (McGrath et al., 1995). Gdf9 is a member of the transforming growth 
factor-β superfamily and is expressed in primordial-stage oocytes (Dong et al., 1996). 
It has been used extensively as a promoter in knockout mice where removal of the 
investigated gene – in this case separase - is required in the resting primordial 
oocyte pool (this does not affect the endogenous Gdf9 gene) (Lan et al., 2004, 
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Burkhardt et al., 2016). Figure 5.15 shows the breeding strategy to generate 
Sepf/f;Gdf9-iCre. As iCre is driven from the Gdf9 promoter, male carriers of iCre are 
fertile with functioning separase. These were used for breeding while Sepf/f males 
were culled. Sepf/f;Gdf9-iCre females were used for experiments with the Sepf/f used 
as experimental controls, or for breeding. Validation of the knockout was carried out 
by R. Ballesteros-Meija. He showed that the Sepf/f;Gdf9-iCre females are able to 
resume meiosis but are incapable of undergoing anaphase.  
 
To investigate if separase is responsible for cohesin loss in primordial-stage oocytes 
I cryo-embedded ovaries from 2 months and 12 months old Sepf/f;Gdf9-iCre and 
Sepf/f mice. These were then sectioned and immunolabelled with antibodies targeted 
to REC8. DNA was labelled with TO-PRO-3 as a quantification control, and DAPI for 
locating primordials in the section (Figure 5.16). Confocal images of primordials from 
Sepf/f and Sepf/f;Gdf9-iCre suggest that the loss of REC8 in primordials occurs even 
in the absence of separase (2 months Sepf/f  n=28 from 3 mice, 12 months Sepf/f  
n=15 from 3 mice 2 months Sepf/f;Gdf9-iCre n=18 from 2 mice, 12 months 
Sepf/f;Gdf9-iCre n=5 oocytes from 2 mice).   
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 Figure 5.16. REC8 appears reduced in Separase null mice with age. 
Representative images of REC8 immunolabelling in 2 and 12 months Sepf/f and 
Sepf/f;Gdf9-iCre primordial-stage oocytes. DNA was stained using TO-PRO-3. In both 
genotypes REC8 appears significantly reduced as a function of age. Scale bar 5µm 
(2 months Sepf/f  n= 28 from 3 mice, 12 months Sepf/f  n= 15 from 3 mice 2 months 
Sepf/f;Gdf9-iCre n= 18 from 2 mice, 12 months Sepf/f;Gdf9-iCre n=5 oocytes from 2 
mice) 
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 A consistant problem in attempting to quantify REC8 in Sepf/f;Gdf9-iCre mice was the 
difficulty in finding primordials at 12 months of age. For both Sepf/f and REC8-Myc 
mice, 3 sections at 30µm thickness was usually sufficient for finding several 
primordials in 12 months old mice. This was not the case for Sepf/f;Gdf9-iCre, which 
would require 5 sections per-slide to find any primordial.  
 
To quantify chromosome-bound REC8 within primordial stage oocytes, I used 
Volocity software to segment primordial-stage oocytes as in Figure 5.5. I then 
calculated the ratio of REC8 to TO-PRO-3 for both Sepf/f and Sepf/f;Gdf9-iCre (Figure 
5.17 and Figure 5.18) and looked at the results when all values are combined across 
the experimental repeats (Figure 5.19) (2 months Sepf/f  n=28 from 3 mice, 12 
months Sepf/f  n=15 from 3 mice 2 months Sepf/f;Gdf9-iCre n=18 from 2 mice, 12 
months Sepf/f;Gdf9-iCre n=5 oocytes from 2 mice). 
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Figure 5.17 Comparison of TO-PRO-3, REC8 and REC8:TO-PRO-3 in Sepf/f 
primordials. Dot plots of comparisons between 2 and 12 months for Sepf/f, each 
experiment showing (a) total TO-PRO-3 fluorescence intensity (b) total REC8 
fluorescence intensity and (c) ratio of REC8: TO-PRO-3 for each primordial oocyte. A 
Mann-Whitney U-test was used to establish p-values, with a p-value of less than 0.05 
classed as significant. Error bars represent the mean ± s.d. for each mouse. The 
number of oocytes and mice used from each age group and each experiment is 
shown in the table above. 
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Figure 5.18 Comparison of TO-PRO-3, REC8 and REC8: TO-PRO-3 in 
Sepf/f;Gdf9-iCre primordials. Dot plots of comparisons between 2 and 12 months 
for Sepf/f;Gdf9-iCre, each experiment showing (a) total TO-PRO-3 fluorescence 
intensity (b) total REC8 fluorescence intensity and (c) ratio of REC8:TO-PRO-3 for 
each primordial oocyte. A Mann-Whitney U-test was used to establish p-values, with 
a p-value of less than 0.05 classed as significant. Error bars represent the mean ± 
s.d. for each mouse. The number of oocytes and mice used from each age group 
and each experiment is shown in the table above. 
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Figure 5.19 REC8 is significantly reduced regardless of the presence of 
separase. Combined values relative to 2 months old for TO-PRO-3, REC8 and 
REC8:TO-PRO-3 for Sepf/f;Gdf9-iCre and Sepf/f. An unpaired t-test was used to 
establish p-values for TO-PRO-3 and REC8:TO-PRO-3. A Mann-Whitney U-test was 
used for REC8. A p-value of less than 0.05 classed as significant. Error bars 
represent the mean ± s.d. (2 months Sepf/f n= 28 from 3 mice, 12 months Sepf/f n= 15 
from 3 mice 2 months Sepf/f;Gdf9-iCre n= 18 from 2 mice, 12 months Sepf/f;Gdf9-iCre 
n=5 oocytes from 2 mice). 
 
The results herein suggest that the decline in REC8 occurs in primordial-stage 
oocytes in both Sepf/f (p<0.0001) and Sepf/f;Gdf9-iCre mice (p=0.0002). This 
suggests that regardless of the presence of functioning separase, REC8 is lost with 
ageing. These results are in agreement with the work carried out by R. Ballesteros-
Meija in aged Sepf/f;Gdf9-iCre and Sepf/f fully grown mouse oocytes at metaphase I 
(GVBD+5hours). These results indicated a reduction in REC8 in Sepf/f;Gdf9-iCre at 
12 months, similar to that in the control Sepf/f. This combined work suggests that 
separase is most likely not responsible for the progressive loss of cohesin in 
primordial stage oocyte development.  
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5.7 Are the protectors of cohesin compromised in primordial-stage oocytes 
from older females?  
 
The findings from R Ballesteros-Meija work and mine suggest that age-related 
cohesin loss occurs by a separase independent mechanism. I next asked whether 
the age related loss of cohesin happens as result of the cohesin protectors being 
compromised during prophase arrest. SGO1 and SGOL2 are both expressed in fully 
grown mouse oocytes, with SGOL2 playing the key role in recruitment of PP2A and 
cohesin protection in mammalian meiosis (Lee et al., 2008, Rattani et al., 2013). 
While SGO1 knockdown caused a significant difference in misalignment 14 hours 
after GVBD, its knockdown at the GV stage was reported not to result in segregation 
errors (Lee et al., 2008). As we have seen from R. Ballesteros-Meija and my own 
work, the loss of cohesin occurs well before this stage and so any loss of protection 
should be looked for in primordial-stage oocytes. 
Analysis of transcriptomic data from single cell RNAseq of human germline cells 
shows expression of SGO1 and SGOL2 in germline cells, suggesting that both are 
expressed in early development (Figure 5.20) (Li et al., 2017).  
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 Figure 5.20 SGO1 and SGOL2 appear to be expressed during oogenesis in 
humans. Graphs showing transcriptomic analysis of SGO1 and SGOL2 during 
oogenesis as well as in somatic cells. Both transcriptomes appear to be expressed 
throughout oogenesis with SGOL2 expressed most at the later stages of oocyte 
development (Li et al., 2017). 
Repeated attempts to immunolabel SGOL2 in primordial-stage oocytes in paraffin 
wax and OCT embedded sections did not indicate any clear staining. While it is 
possible that this could be as a result of experiment specific antibody failure, results 
from Lister et al. 2010 show that SGOL2 is localised in the nucleolus of GV stage 
oocytes. This is then recruited to the centromeres during early metaphase I (Lister et 
al., 2010). Thus, while SGOL2 appears to be sequestered in the nucleoli in fully 
grown oocytes, we cannot rule out the possibility that it is present on chromosomes 
in primordial stage oocytes. 
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To investigate SGO1 localisation I immunolabelled ovarian sections with antibodies 
targeted to SGO1 (2 months n=29 eggs from 3 mice). SGO1 is clearly enriched on 
regions of heterochromatin in primordial-stage oocytes. This enrichment appears to 
be maintained through GV stage and resumption of meiosis (Figure 5.21). 
 
Figure 5.21 SGO1 is enriched at oocyte chromocentres and pericentromeres 
throughout oogenesis. Confocal images of representative Primordial Follicle, 
Germinal Vesicle and metaphase I oocytes. Scale bar 5µm. Inset of metaphase I 
shows an individual bivalent chromosome with SGO1 localising to the 
pericentromeres. Scale bar 3µm    
 
To investigate whether ageing has any impact on SGO1 in primordial-stage oocytes, 
I carried out immunolabelling with antibodies targeted to SGO1 on ovarian sections 
from 2 months and 12 months old C57BL/6 mice (2 months n=29 eggs from 3 mice; 
12 months n=18 eggs from 3 mice). Representative images of primordial stage 
oocytes from young and aged mice suggest that by 12 months the localisation of 
SGO1 to heterochromatin is lost, with SGO1 more prevalent on areas of euchromatin 
(Figure 5.22).  
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Figure 5.22 SGO1 appears to have reduced localisation to the heterochromatin 
with age. Representative images of primordial-stage oocytes from 2 and 12 months 
old C57BL/6 mice, immunolabelled for SGO1 and the DNA stained using TO-PRO-
3.SGO1 localisation to heterochromatin appears reduced with age mice. Scale bar 
10µm (2 months n= 29 eggs from 3 mice; 12 months n= 18 eggs from 3 mice). 
 
To determine the significance of this reduced localisation I used the Volocity software 
co-localisation function, to determine the co-localisation between SGO1 and 
heterochromatin regions marked by TO-PRO-3. ROIs were drawn round primordial-
stage oocytes and the Pearsons co-efficient value calculated. This suggest that 
SGO1 becomes mislocalised as a result of ageing in primordial-stage oocytes (mean 
Pearsons co-efficient: 2 months - 0.58; 12 months - 0.35) (2 months n= 29 eggs from 
3 mice; 12 months n= 18 eggs from 3 mice) (Figure 5.23).  
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 Figure 5.23 SGO1 becomes mislocalised with age in primordial-stage oocytes. 
(a) Co-localisation analysis was carried out with regions of interest (Red circles) 
drawn around primordial-stage oocytes in z-stacks. The fluorescence intensity for 
SGO1 and TO-PRO-3 in each pixel was plotted against each other in a scatter plot 
and the Pearsons co-efficient calculated. (b) Dot-plots showing the Pearsons co-
efficient for each primordial oocyte (SGO1vsTO-PRO-3) in the 3 experimental 
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repeats. A Mann-Whitney U test was used to test significance (p<0.05) between the 2 
and 12 months. Error bars represent mean and ± s.d. (c) shows a combined dot-plot 
of the Pearsons co-efficient from all 3 experiments. Unpaired t-test show that there is 
a significant reduction in correlation between SGO1 and TO-PRO-3 between 2 and 
12 months (p<0.0001). (2 months n= 29 eggs from 3 mice; 12 months n= 18 eggs 
from 3 mice) 
 
I next sought to determine whether this mislocalisation from heterochomatin is 
accompanied by a global loss of SGO1 in primordial-stage oocytes. To do this I used 
Volocity software as in Figure 5.5 to calculate the sum fluorescence intensity of Sgo1 
and TO-PRO-3 in each primordial oocyte. The data shown in Figure 5.24 indicates 
that SGO1 was significantly reduced in only 1 of the 3 pairs of mice included in this 
experiment. This suggests that the mislocalisation seen in Figure 5.23 does not 
always result in an overall loss of SGO1 in the primordial oocyte.  
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Figure 5.24 SGO1 does not appear to be reduced overall in primordial-stage 
oocytes. Dot plots from each experiment showing (a) sum TO-PRO-3 fluorescence 
intensity (b) sum SGO1 fluorescence intensity and (c) ratio of SGO1 to TO-PRO-3. 
Each primordial oocyte is represented by an individual dot. Error bars represent 
mean and ± s.d. A Mann-Whitney U-test was used to establish p-values with a p-
value of less than 0.05 classed as significant. The ratio of SGO1:TO-PRO-3 showed 
no significant difference in 2 of the 3 experiments. 
 
The results in this section suggest SGO1 localisation is affected by ageing but that it 
does not cause a total loss of the protein. While I was unable to establish if PP2A is 
expressed in primordial-stage oocytes, this work suggests that if SGO1 does provide 
protection against the prophase pathway in meiosis then this protection could be 
compromised with age.  
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5.8 Discussion 
 
The age-related loss of cohesin in oocytes presents a viable model for the increase 
in premature separation of sister centromeres in meiosis (Chiang et al., 2010, Lister 
et al., 2010). While this has been understood in mouse oocytes for some time, the 
mechanisms involved in cohesin loss have remained elusive.  
 
Oocytes differ from sperm in that they are produced well before puberty and undergo 
a prolonged prophase arrest which can last several decades in humans and several 
months in mice (Herbert et al., 2015). It was until recently unclear whether cohesin 
depletion occurs during the prolonged prophase arrest experienced by oocytes from 
older females, or whether cohesin is lost as a consequence of the intense metabolic 
activity associated with oocyte growth. It is conceivable that this may result in 
increased reactive oxygen species (ROS) generation in oocytes of older women, 
leading to damage to cohesin. Work done by R. Ballesteros-Meija in our group 
however, suggests that the loss of cohesin occurs before the growth phase, at the 
primordial follicle stage. While this was an important finding it does not tell us 
whether this loss occurs progressively over time, or if non-REC8 containing forms of 
cohesin are in the nucleus. To gain a greater understanding of what mechanisms 
could be involved it was first necessary to define the time frame in which cohesin is 
lost.  
 
Studies on primordial-stage oocytes have been hampered due to the difficulty in 
distinguishing them from other cells in the ovary. This is made even more difficult in 
ageing studies as the number of primordial-stage oocytes decreases as a result of 
ovarian exhaustion (Adhikari and Liu, 2009). To address this it was necessary to first 
train my eye in the recognition of primordial stage oocytes in both cryo- and paraffin 
wax embedded sections. This was done through the immunolabelling of proteins 
present only in meiotic cells. I then validated whether I had selected one correctly 
based on whether it showed any staining. As has been described in previous 
publications, primordial-stage oocytes can be distinguished from more developed 
follicles due to the presence of a single layer of flattened granulosa cells and the 
absence of a ring of cuboidal cells (Adhikari and Liu, 2009). This allowed me to spot 
them by eye without the need for continued use of these markers. 
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 Imaging of DNA in cryosections of primordial-stage oocytes, revealed discrete areas 
of DNA enrichment. I sought to define how the DNA in the primordial oocyte is 
compacted compared to in fully grown oocytes after GVBD. Antibody staining using 
the heterochromatin marker H3K9me3 and the marker of centromeric proteins 
CREST, showed that they co-localised in primordial-stage oocytes. This revealed that 
the future pericentromeres of primordial-stage oocytes form clusters during prophase 
before DNA condensation. As so many proteins which are necessary for accurate 
chromosome segregation localise to the pericentromere during meiosis, it is 
important to distinguish this region from the rest of the DNA, as its integrity is 
essential for the two sequential divisions (Herbert et al., 2015).  
 
Another issue in terms of studying primordial-stage oocytes is the high level of cell 
death that is known to occur. To ensure that the primordial-stage oocytes being 
measured are not in fact atretic, I used the cell death marker TUNEL to label any 
potentially dead primordial-stage oocytes in the ovary. During the course of this work, 
however, I only encountered a few TUNEL-positive primordial-stage oocytes. This 
contrasts with previous findings in the lab and the basis for this is currently unclear. 
In humans, primordial oocyte atresia was modelled at around 1000 a month after 
puberty. This number increased around 37 years of age until menopause (Faddy and 
Gosden, 1996, Faddy, 2000). It is possible that in this work, the ages being used 
avoided periods of higher cell death.  
 
Having established how to locate primordial stage oocytes as well as distinguish their 
DNA morphology, I sought to compare chromosome-bound REC8 through 
immunolabelling in cryosections from 2, 6 and 12 months old mice. The results 
indicated, that when all experiments are combined, that REC8 is lost by a significant 
amount by 6 months of age, with further reductions by 12 months. After plotting the 
median value of each REC8: TO-PRO-3 for each age group, it appeared that the loss 
of REC8 occurs in a linear fashion rather than an accelerated one with ageing. While 
this progressive loss with age is in agreement with the results in Chiang et al. 2010, 
they saw an accelerated loss happening with age in fully grown MI oocytes (Chiang 
et al., 2010). While it is possible this is occurring, previous difficulties in accurately 
quantifying proteins on chromosome whole-oocyte fixations and spreads, due to 
changes in chromosome morphology, mean there may be some discrepancies. This 
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is borne out by the fact that in their results, they see an increase in REC8 between 
12 and 15 months.  
 
This result provides information in regards to what mechanisms could be involved in 
cohesin loss.  It suggests that the mechanism leading to loss of cohesin is acting 
throughout the mouse’s life. It would be interesting to see if loss of cohesin in human 
primordial-stage oocytes occurs in a similar fashion. It is clear from observations of 
trisomy rates that there is a breaking point around 35 years of age when aneuploidy 
becomes significantly more likely (Hassold and Hunt, 2001). The only study to look at 
this in human ovarian sections did not remove soluble cohesin, obscuring any age-
related affected on chromosome-bound cohesin (Tsutsumi et al., 2014).  
 
The results in these experiments cast some doubt on the effectiveness of TO-PRO-3 
as a tool for normalising proteins of interest to. It is unclear why this is the case as 
DNA labelling should remain consistent with age. This does not negate the work 
previously carried out in our lab which suggested it to be an effective tool. Indeed, the 
subsequent experiments in this Chapter, it often remains consistent within an 
experiment. It is also not appropriate to remove normalisation from the analysis as 
regions of interest can vary based on how easy the primordial is to segment from the 
surrounding somatic cells. As the variation in TO-PRO-3 appears to be agnostic to 
age, and is often lost when the data from individual experiments are combined its use 
is still required for analysis of primordial oocytes.  
 
I next investigated whether SMC3 is also lost in primordial stage oocytes similarly to 
REC8. SMC3 is the only conserved component between both mitotic and meiotic 
cohesin and its acetylation by ESCO1 and ESCO2 is key for establishing cohesive 
cohesin (Minamino et al., 2015). While REC8 is undoubtedly the key α-kleisin subunit 
in meiosis, it is not clear if other cohesin complexes may be present in the primordial 
oocyte during this time. Work carried out in SMC1β knockout mice indicated that 
even in its absence, single chromatids do not start to appear until 4 months of age 
(Hodges et al., 2005). To investigate if SMC3 is also depleted in a similar manner to 
REC8, I co-stained SMC3 with REC8 in REC8-MYC mice. SMC3 and REC8 co-
localise together in primordial-stage oocytes, with both showing discrete staining at 
areas of enriched heterochromatin. This is absent from the surrounding somatic cells 
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which show an absence of SMC3 in areas of heterochromatin compared to the 
euchromatin.  
 
Quantification of SMC3 indicated that by 12 months it was significantly reduced in 
primordial-stage oocytes, similar to REC8. However, comparisons of the magnitude 
of the decline suggest that REC8 is lost to a greater extent. While it is worth noting 
that there are technical reasons for this difference in decline (such as encroachment 
from the surrounding somatic cells or variations in background), it cannot be 
excluded that there may be other cohesin complexes in the oocyte.  
 
To address whether there may be other cohesin complexes present I carried out 
immunolabelling for RAD21 in paraffin wax sections. This showed a small but 
detectable amount of RAD21 in primordial-stage oocytes. The significance or 
purpose of this RAD21 is unclear. Experiments in which all REC8 was artificially 
cleaved during metaphase I in mouse oocytes indicated that acute and complete loss 
of REC8 results in resolution of bivalents to their four constituent chromatids. When 
this was replicated for RAD21 there was no separation showing it does not provide 
significant cohesion (Tachibana-Konwalski et al., 2010). It would be interesting to 
determine how RAD21 levels are affected by ageing in primordial-stage oocytes.   
 
Observations of the SMC3 in the surrounding granuolsa cells also suggests that they 
do not suffer the same loss of cohesin as the oocyte does. It remains unclear 
whether the granulosa cells which surround the oocyte must be maintained along 
with the oocyte until they are recruited to undergo growth. As they are so crucial for 
signalling and ovulation it would be interesting to investigate whether they are turned 
over at all during development and, if not, what affect ageing has on them? 
 
Previous work in our group looking at an age-related reduction of cohesin in fully 
grown oocytes from separase null mice showed that separase is not responsible for 
cohesin loss. However, this was not investigated in primordial-stage oocytes were 
the age-related loss of cohesin occurs. Several factors led us to select leaky 
inhibition of separase as a likely culprit for cohesin loss. Separase is undoubtedly the 
key orchestrator of cohesin cleavage in meiosis (Kudo et al., 2006). Our 
understanding from Mnd2 mutants in yeast, which have destruction of securin during 
prophase arrest, also suggests that separase can act during prophase (Penkner et 
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al., 2005, Oelschlaegel et al., 2005). Using immunofluorescence staining, I was able 
to detect separase in the cytoplasm of primordial-stage oocytes in paraffin wax 
embedded sections. This indicates that separase is present in primordial stage 
oocytes. 
 
Staining of ovarian sections for REC8 in Sepf/f;Gdf9-iCre and Sepf/f mice showed that 
REC8 was reduced with ageing regardless of whether separase is expressed or not. 
Interestingly, however, attempts to find primordial-stage oocytes in Sepf/f;Gdf9-iCre 
mice was on the whole harder than in Sepf/f. This requires more investigation 
including counts of primordial-stage oocytes in sections, however it is an intriguing 
prospect. It is understood that cohesin is necessary for DNA repair (Nasmyth, 2011) . 
If this cohesin was perhaps removed by separase after DNA repair (which would not 
be present in the knockout) its absence could lead to increased cell death over time 
due to DNA damage not being fixed.  
 
With separase not appearing responsible for cohesin loss during prophase arrest, it 
is possible that cohesin is being removed through a separase independent 
mechanism. It would also be possible that cohesin is being damaged by reactive 
oxygen species, and due to the lack of turnover in cohesin it is not replaced. These 
are potential mechanisms which should be further investigated. 
As the age-related loss of cohesin appeared to be separase-independent, it was 
therefore pertinent to ask whether cohesin is provided with any protection during 
prophase arrest. Cohesin protection is entrusted to SGOL2 after GVBD (Rattani et 
al., 2013, Llano et al., 2008, Lee et al., 2008). While it would appear that both SGOL2 
and Sgo1 are expressed in oocytes during oogenisis, the results in this section 
suggest that it is only SGO1 that localises to the heterochromatic regions of 
primordial-stage oocytes. A co-localisation that appears to be maintained in fully 
grown prophase arrested oocytes as well as during M phase of meiosis I. Co-
localisation analysis of SGO1 at the pericentromeres however, showed that this 
becomes compromised with ageing in primordial-stage oocytes. While the overall 
level of SGO1 appears unaffected by age, the fraction co-localising with 
heterochromatin is markedly reduced and this is accompanied by increased staining 
on euchromatin. Localisation of SGO1 is dependent upon phosphorylation of H2A-
T210, which allows docking of SGO1 at the pericentromeres (Tang et al., 2004, 
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Kitajima et al., 2005, Kawashima et al., 2010). It would therefore be interesting to see 
if changes in chromatin or BUB1 or both are responsible for mislocalisation of SGO1 
during female ageing. Also, to determine whether PP2A is present as it is required for 
SGO1 to protect cohesin (Kitajima et al., 2006, Riedel et al., 2006).  
The results in this section suggest that cohesin is lost progressively in primordial-
stage oocytes via a separase independent mechanism. Also, that other non-REC8 
containing cohesin complex are present in the primordial-stage oocyte. 
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Chapter 6. Results: Effects of ageing on chromosome-bound cohesin in 
human oocytes 
 
The age-related depletion of chromosome-bound cohesin in mouse oocytes, 
provides a plausible molecular basis for the increase in chromosomal segregation 
errors seen in human oocytes (Lister et al., 2010, Chiang et al., 2010). While the 
clinical significance of cohesin depletion has not been directly tested, several 
observations in human oocytes are consistent with findings in the mouse. Firstly, the 
age-related segregation errors in human oocytes appear to be as a result of a 
lack of chromosomal cohesion (Angell, 1991, Sakakibara et al., 2015). This is 
reflected in the tendency towards premature separation of sister centromeres 
leading to single chromatid rather than whole chromosome errors in oocytes from 
older women (Pellestor et al., 2003). Secondly, a number of studies on human 
oocytes have reported that the distance between sister centromeres increases as 
a function of age. This is often used as a proxy measurement for depletion of 
centromeric cohesin (Zielinska et al., 2015, Sakakibara et al., 2015, Lister et al., 
2010, Lagirand-Cantaloube et al., 2017, Duncan et al., 2012, Chiang et al., 2010, 
Patel et al., 2015).  
To date, there is only one report (Tsutsumi et al., 2014), of direct measurements 
of cohesin in human oocytes. This was performed on ovarian sections and 
reported only a modest decline, which was not detected until an advance age (49 
years old) (Tsutsumi et al., 2014). However, soluble cohesin was not removed in 
this study and recent findings in our lab indicate that the quantity of soluble 
cohesin remains unchanged with age (R. Ballesteros-Meija). Another study 
looking at air-dried chromosome spreads claimed to see no significant difference 
in REC8 between younger and older women in immunofluorescence analysis. 
However this study did not involve a systematic comparison of cohesin levels in 
oocytes obtained from younger and older women; the oldest woman in the study 
was 34 years old (Garcia-Cruz et al., 2010).  
One reason for the continued difficulty in determining whether cohesin is affected 
by age is a lack of appropriate sample material. The predominant source of 
oocytes used for research into female human meiosis are those that fail to 
mature following ovarian stimulation and can therefore not be used for ICSI 
(Webster and Schuh, 2017). In all, 15-20% of oocytes obtained following ovarian 
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stimulation are either still arrested in prophase of meiosis I (GV stage) or in M 
phase (MI). While these “ICSI-reject” oocytes have been intensively investigated, 
it is not known whether this population of oocytes reflects the “wildtype”. For 
example, whatever caused delayed progression through the meiotic divisions, 
might also affect chromosome segregation. More generally, our knowledge of 
oocyte aneuploidy, particularly at advanced female age, is derived from high-risk 
cases undergoing IVF treatment. We therefore aimed to obtain a supply of 
oocytes from volunteer donors ranging in age from 18 to 45 years old with no 
previous history of infertility. In this Chapter, I present an analysis of reproductive 
ageing in our population of volunteer donors. The work also represents the first 
systematic investigation of age-related changes to chromosomal cohesin in fully 
grown human oocytes.  
 
6.1 ICSI-reject vs oocytes retrieved from non-patient donors: retrieval strategy 
 
To circumvent using ICSI-reject oocytes for future research, we established an 
oocyte donation programme involving volunteer, non-patient donors at Newcastle 
Fertility Centre. We sought to retrieve oocytes before they had completed the first 
meiotic division, and ideally at the GV stage, before entering M phase of meiosis 
I. During IVF treatment, the transition from prophase to M phase of meiosis is 
triggered by administration of human chorionic gonadotrophan (hCG).  Oocytes 
are normally harvested 36-38 hours after hCG injection, when the majority(~80%) 
have completed the first meiotic division, which is ascertained by the presence of 
the first polar body.  Our strategy to obtain oocytes before completion of meiosis I 
was to reduce the interval from hCG injection to oocyte harvest.  Because the 
time course of meiotic progression in human oocytes in vivo is unknown, the 
initial stages of the project involved some trial and error to identify the optimal 
time to obtain immature oocytes, ranging from 12-37 hours post-hCG injection. 
Figure 6.1 shows the oocyte retrieval schemes used for ICSI-reject oocytes and 
non-patient donor oocytes. 
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 Figure 6.1 Stimulation regimes used for obtaining oocytes from human donors. 
Figure shows schematic of the two stimulation regimes used for obtaining 
oocytes. ICSI-reject oocytes consist of the small population of immature oocytes 
collected at 37 hours post hCG administration. These are not suitable for ICSI 
due to the lack of a polar body. Non-patient donor eggs were collected 12- 37 
hours post hCG with the oocyte collection regime timed to the woman’s natural 
cycle rather than with hormonal suppression. 
 
According to our current understanding, the decline in fertility during female 
ageing is a consequence of the combined effects of (i) depletion of the ovarian 
reserve of primordial follicles (also known as ovarian ageing (Broekmans et al., 
2007) and (ii) the increased incidence of aneuploidy (Herbert et al., 2015). To 
investigate the decline in ovarian reserve in our population of donors, I analysed 
a number of measures of ovarian function (Figure 6.2). This included levels of 
anti-Müllerian hormone (AMH), which is produced by growing follicles and is taken 
as a measure of ovarian reserve. AMH levels become progressively lower as 
women approach the menopause (Visser et al., 2006). I also analysed the effect 
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of female age on the number of antral follicles detected by ultrasound scan 
before the hCG injection. As would be expected, follicle number and AMH 
declined as a function of female age. The strongest relationship is a negative 
correlation between AMH and the age of the woman (r= -0.6218). Consistent with 
this, there is also a negative correlation between follicle number and age (r= -
0.5118) and a positive correlation between follicle number and AMH (r= 0.5067 
respectively) (Figure 6.2). I excluded the number of oocytes retrieved in this 
comparison, as this varied, depending on the time interval from hCG injection to 
oocyte harvest.   
 
Figure 6.2 Age, follicle number and AMH levels are correlated in non-patient 
donor population. Figure shows dot plots of (a) AMH vs age, (b) follicle number vs 
age, (c) follicle number vs AMH. Pearson’s co-efficient for each graph shows a 
strong correlation with (a) and (b) having a negative correlation (r= -0.6218   and 
r= -0.5118respectively) and (c) showing a positive correlation between AMH and 
follicle number (r= 0.5067). (25 donors)  
6.2 The number of oocytes retrieved and the stage of meiosis they have 
reached is dependent on age and post-hCG retrieval time   
 
Prior to this study, our understanding of obtaining immature oocytes from women 
has relied on what we can infer from oocytes retrieved for IVF treatment. A 
primary measure of success of the donation scheme is the number of oocytes 
retrieved.  Consistent with the findings above, the number of oocytes retrieved 
declines with age (p=0.0282) (Figure 6.3).  
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 Figure 6.3 More oocytes are retrieved from younger women in non-patient 
donor scheme but numbers vary significantly within age groups. Figure shows 
the comparison of oocytes retrieved from non-patient donors. Each dot 
represents the number of follicles collected in a retrieval for each of the 3 age 
categories (≤30: 24 donations, 35-39: 7 donations and ≥40: 27 donations). Error 
bars represent the mean ± s.d for each age group. A one-way ANOVA was used to 
establish significance with a p-value of less than 0.05 classed as significant 
(p=0.0282). 
However, the data indicate a pronounced spread within each age group (Figure 
6.3). I therefore determined the effect of the interval from hCG injection to oocyte 
harvest for the youngest (≤30 years) and oldest (≥40 years) donors. My findings 
indicate a non-significant trend towards an increased oocyte yield as the interval 
from hCG injection to oocyte harvest is increased (Figure 6.4). This is consistent 
with the oocyte becoming more easily detachable from the granulosa cell layers 
as the differentiation programme within the Graafian follicle proceeds in 
preparation for release of the egg at the time of ovulation.  
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 Figure 6.4 A trend towards a positive correlation between the number of 
oocytes harvested and the hours post hCG injection. Comparisons of the number 
of non-patient donor follicles retrieved from (a) women ≤30 (b) ≥ 40. Error Bars 
represent the mean ± s.d for each age group. A one-way ANOVA and a Kruskal-
Wallis test was used to establish p-value for ≤30 and ≥40 age categories 
respectively. A p-value of less than 0.05 was classed as significant. (a) ≤ 30 years old 
post hCG retrieval times of 18-20 hours n=4 donations; 23-26 hours=6 donations;  
30-32 hours=10 donations and 36-37 hours=2 donations (b) ≥40  years old post hCG 
retrieval times of 23-26 hours=10 donations;  30-32 hours=10 donations and 36-37 
hours=6 donations  
I next determined the relationship between maturation status of the oocyte and 
the time interval from hCG injection to oocyte harvest (Figure 6.5). The stage of 
meiosis was determined by the presence of a GV or a polar body when the 
oocytes were released to the research team immediately after the oocyte retrieval 
procedure.   
In reflection of the challenging nature of harvesting oocytes at earlier times post-
hCG, there was a clear operator effect. In this regard, our lead research clinician 
Dr Meena Choudhary had considerably more success than her clinician 
colleagues. As a result, analysis of maturation stage was only carried out on 
oocyte retrieval perfomed by Dr Choudhary. 
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Interestingly, we found that the majority (53.47%) of oocytes from women aged 
≤30 years had completed the first meiotic division by 30-32 hours post hCG injection 
and a small fraction (3.92%) had done so at 23-26 hours after hCG (Figure 6.5 (a)).  
A proportion of oocytes (30.77%) from the older age group (≥40 years) had also 
completed meiosis I by 30-32 hours post hCG (Figure 6.5 (b)).  This effect was not as 
marked as in the younger women and may be explained by technical reasons related 
to the timing at which the maturation status was assessed.   
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 Figure 6.5 Reducing post-hCG retrieval time results in a greater number of MI 
oocytes. Stack charts of the stage of maturation of oocytes retrieved at post hCG 
retrieval times for women aged (i) ≤30 and (ii) ≥40 years old. (i) ≤30 years old 
post hCG retrieval times of 18-20 hours (3 donations, 8 oocytes) 23-26 hours (6 
donations, 54 oocytes) 30-32 hours (8 donations, 104 oocytes) and 36-37 hours 
(2 donations, 19 oocytes). The number of MII oocytes retrieved increases with 
longer +hCG retrieval time. (ii)  ≥40 years old post hCG retrieval time 23-26 hours 
(9 donations, 28 oocytes) 30-32 hours (9 donations, 39 oocyte) 36-37 hours (5 
donations, 32 oocytes). The number of MII oocytes retrieved increases with 
longer +hCG retrieval time. 
136 
 
The finding that a considerable proportion of oocytes have already transitioned to 
meiosis II at 30-32 hours post-hCG is surprising. The normal practice in IVF clinics is 
to harvest oocytes 36-38 hr after hCG injection and to inseminate, either by 
conventional IVF or ICSI, some hours later. Thus, human oocytes undergoing 
IVF/ICSI treatment may remain arrested at meiosis II for >10 hours before sperm 
entry. It would be interesting to determine whether this contributes to oocyte 
aneuploidy.  
Analysis of maturation status of oocytes at various times post-hCG also revealed a 
surprising low proportion of GV stage oocytes at the earlier time points (Figure 6.5). 
This likely reflects a difficulty in detaching those oocytes that had not yet resumed 
meiosis from the follicle’s mural granulosa cells during aspiration of the follicular fluid.  
It is possible that this problem could be overcome by using an oocyte retrieval needle 
designed to scrape the wall of the follicle.   Interestingly, the proportion of GV stage 
oocytes was comparatively large when oocytes were retrieved at 37 hours post hCG. 
This may be indicative of follicle atresia, which involves granulosa cell apoptosis 
(Hsueh et al., 1994). Under these conditions, the oocytes may become more easily 
detachable from the surrounding layers of granulosa cells.  
The results of this section highlight the challenges associated with obtaining 
healthy immature human oocytes.  The findings indicate that progression through 
meiosis in vivo occurs in an asynchronous manner and that a considerable 
proportion of oocytes transition from meiosis I to meiosis II within 30 hours of 
hCG injection.  Moreover, the findings indicate that efficient retrieval of GV stage 
oocytes will require modification of conventional oocyte retrieval practices. Using 
the current techniques, there is a trade-off between maturation status and the 
number of oocytes harvested.   
6.3 Pilot Study: Cohesin is mislocalised but not reduced overall in MI oocytes 
of ICSI-reject oocytes 
 
Before carrying out any experimentation on the non-patient donor oocytes, we 
carried out a pilot study using ICSI-reject oocytes. The rationale for this is based 
on cost: ICSI-reject oocytes come at no cost to the research budget whereas 
each non-patient donor cycle costs ~£1500. Thus, ICSI-rejects provide a useful 
resource for resolving technical problems, antibody optimisation, and for gaining 
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some indication as to whether chromosome-bound cohesin is affected by ageing. 
Carrying out quantitative work in human oocytes comes with unique challenges 
relative to mouse work. This centres mostly on when and how many oocytes are 
available at a given time. This means it is difficult to conduct parallel experiments 
with young and old donors on the same slide.  
My starting point was to determine whether ageing is accompanied by a loss of 
bivalent chromosome structural integrity in the ICSI-reject oocytes. Observations 
in mouse oocytes indicated an increase in distally associated chromosomes in 
which homologues were tenuously attached at the telomeres. In addition, the 
distance between oocyte sister centromeres also increased during female ageing 
at 14 months of age (Chiang et al., 2010, Lister et al., 2010). Consistent with this, 
previous reports from studies on oocytes indicate a significant increase in 
distance between sister centromeres with advancing female age, suggesting a 
loss of cohesin (Duncan et al., 2012, Lagirand-Cantaloube et al., 2017, 
Sakakibara et al., 2015, Zielinska et al., 2015).  
In collaboration with my colleague Dr Lisa Lister, we performed chromosome 
spreads of ICSI-reject oocytes and immunolabelled them for REC8 and CREST, 
staining the DNA with DAPI. We classified women ≤30 years as our younger 
group and women ≥35 years as our older age group. We chose 35 years old as 
the age boundary for the older group because several lines of evidence indicate 
that the incidence of oocyte chromosome segregation errors increase from the 
mid-thirties onwards (Nagaoka et al., 2012). Confocal images of chromosome 
spreads suggested that bivalent chromosomes of meiosis I oocytes are not held 
together as tightly in the oocytes from older women compared to younger women. 
There was evidence of premature resolution of bivalents to dyad chromosomes 
and to single chromatids (Figure 6.6) 
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Figure 6.6 Categories of bivalent chromosome structures and defects. Figure 
shows images of bivalent chromosomes in MI oocyte chromosome spreads for a 
woman aged 26 and 37 years old. Scale bar 10µm. Boxes show zoomed in 
examples of 4 different structural forms of bivalent chromosomes found in MI 
oocytes. These are: stable bivalents (grey box), unstable bivalents (red box), 
premature disjunction (blue box) and single chromatids (purple box) (≤30 n=14 
oocytes from 11 donations, mean age of donor per oocytes donated: 26.00 s.d: 
±1.83; ≥35 n=10 oocytes from 9 donors mean age of donor per oocytes donated: 
37.50 s.d: ±1.76) 
To quantify this, I confined the analysis to oocytes in which bivalent 
chromosomes could be clearly distinguished from one another. I classified the 
bivalents into four different structural forms based on their morphology (Figure 
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6.6). These were stable bivalents (where the chromatids in the chromosome are 
all tightly held together), unstable bivalents (where all 4 chromatids are in close 
proximity to one another but their attachment to one another appears loose), 
premature disjunction to dyad chromosomes and single chromatids. Analysis of 
the prevalence of these four different configurations indicates a pronounced age-
related increase in unstable bivalents (5.6% vs 37.8% for women aged ≤30 and 
≥35 years respectively) and a reduction in stable bivalents (90.7% vs 48.5% for 
women aged ≤30 years and ≥35 years respectively) (Figure 6.7). Premature 
resolution of bivalents into dyads and single chromatids was also more prevalent 
in the older age group (Figure 6.7) (premature disjunction: 3.8% vs 10.3% for 
women aged ≤30 years and ≥35 years respectively; premature separation: 0% vs 
3.1% for women aged ≤30 years and ≥35 years respectively)  
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 Figure 6.7 Ageing is accompanied by a loss of bivalent chromosome structural 
integrity in ICSI-reject oocytes. Stack graphs showing the proportion of bivalent 
chormosomes structures per oocyte for women (a) ≤30 and (b) ≥35 years old. 
Bivalent chromosomes were classified as either stable, unstable, prematurely 
disjoined or separated into single chromatids. (≤30 n=14 oocytes from 11 
donations mean age of donor per oocytes donated: 26.00 s.d: ±1.83; ≥35 n=10 
oocytes from 9 donors mean age of donor per oocytes donated: 37.50 s.d: ±1.76)  
 
We next sought to analyse if the distance between sister centromere in the 
chromosome spreads of our ICSI-reject population increased with age. The 
cohesin located at the centromeres of chromosomes is essential for maintaining 
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dyads during anaphase I and for biorientation during metaphase II (Hauf and 
Watanabe, 2004, Herbert et al., 2015). Any loss of centromeric cohesin could be 
particularly consequential in raising the likelihood of segregation errors. To 
quantify the inter-centromere distance, linescans were drawn between sister 
centromeres and the distance between the points of peak fluorescence for 
CREST was calculated (Figure 6.8). This indicated that, as women get older, the 
inter-centromere distance increases (0.7µm vs 1.1µm for ≤30 and ≥35 years 
respectively; p=0.0007) Together these findings from ICSI-reject oocytes indicate 
that human oocytes, like mouse oocytes exhibit deterioration of bivalent stability 
during female ageing (Chiang et al., 2010, Lister et al., 2010). 
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 Figure 6.8 Inter-centromere distance increases with age in MI human oocytes 
from ICSI-reject oocyte population (a) Representative image of a bivalent 
chromosome from a 26 year old and a 41 year old woman showing an example 
linescan across the centromeres. Scale bar 3μm. (b) Corresponding linescan 
shows two peaks for the CREST signal representing both centromeres. 
ExtremaPlus software was used to calculate the distance between the two peaks. 
(c) Comparison of median inter-centromere distance per oocyte for women aged 
≤30 and ≥35. An unpaired t-test was used to establish significance with a p-value 
of less than 0.05 classed as significant. This showed a significant increase in 
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inter-centromeric distance (p=0.0007). Measurements carried out by L.M. Lister. 
Error bars show mean ± s.d. (≤30 n=23 oocytes from 17 donations mean age of 
donor per oocytes donated 26.09 s.d. ± 1.70; ≥35 n=21 oocytes from 17 
donations, mean age of donor per oocytes donated: 37.05 s.d. ±1.66).  
The observations of the loss of bivalent stability and increased inter-centromeric 
distance with age is consistent with depletion of chromosome associated cohesin 
during female ageing. To test this, we prepared chromosome spreads from ICSI-
reject oocytes and stained for the meiotic cohesin subunit REC8. However, 
because of large variation in the intensity of the REC8 signal within age groups, 
quantification was difficult to achieve. It was therefore necessary to minimise 
variation due to differences in experimental conditions. For this, we created a 
stockpile of vitrified ICSI-reject oocytes. This ultra-rapid method of 
cryopreservation is used to maintain viability of oocytes in clinical IVF practice 
(Gook and Edgar, 2007). 
Vitrified oocytes were warmed in batches consisting of oocytes donated by 
younger and older ICSI patients. This enabled us to spread them on the same 
slide. Spreads were immunolabelled with antibodies targeted to REC8 and 
CREST; DNA was stained using DAPI (Figure 6.9). Consistent with our 
observations using unmatched spreads, there was large variation in the intensity 
of the REC8 signal between oocytes from the same age group (Figure 6.9).  
While oocytes from older women frequently displayed bright staining for REC8 on 
the chromosomes, enrichment between sister centromeres and arms was much 
reduced (Figure 6.9).  While these differences were clearly evident by eye, 
quantification of the difference between young and old was challenging. 
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 Figure 6.9 REC8 appears mislocalised in MI oocytes with age. Images of MI 
oocyte air-dried chromosome spreads from younger and older female’s 
immunolabelled with REC8 and CREST. DNA was labelled using DAPI. Images 
show that in older women REC8 is no longer localised to the chromosome axis. 
Scale bar 10µm. Inset shows individual bivalent chromosomes immunolabelled 
for CREST and REC8. Scale bar 3µm. Chromosome spreads carried out by L. M. 
Lister (<30 n=9 oocytes from 8 donations mean age of donor per oocytes 
donated: 25.67 S.d: ±2.24; >35 n=9 oocytes from 8 donations mean age of donor 
per oocytes donated: 37.67 S.d: ±2.07).  
To quantify this mislocalisation, I analysed the immunofluorescence intensity of 
REC8 between centromeres in relation to the REC8 overlapping the CREST 
signal (Figure 6.10). This analysis included spreads from the batch staining and 
others that had been spread and imaged on different days. I excluded oocytes 
from donors that showed highly de-condensed chromatin or the oocytes from the 
≤30 age category that showed high levels of bivalent instability and non-
disjunction as they were not reflective of the majority of the younger population. 
linescans of REC8 and CREST indicated that in oocytes from younger women the 
REC8 signal peaks between the CREST foci (Figure 6.10). By contrast, in 
oocytes from the older age group, the REC8 peak was generally absent from 
between the CREST foci. Instead REC8 overlapped the CREST foci, frequently 
extending beyond them showing a diffused distribution (Figure 6.10).  This differs 
from mouse oocytes, were ageing was associated with a more global depletion of 
Rec8 (Chiang et al., 2010, Lister et al., 2010).  
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 Figure 6.10 REC8 is mislocalised in oocytes from older women. (a) 
Representative bivalent chromosome from women aged 26 years old and 39 
years old with linescans. Linescans were drawn across MI chromosome sister 
centromere pairs and graphs produced of the fluorescence intensity across the 
line. Scale bar 3 µm. (b) The central REC8 F.I value between the CREST peaks 
(red star) was collected and a percentage of its value against the F.I of the REC8 
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signal on the two peaks of CREST (yellow stars) was generated. (c) Graph shows 
the median % value of the inter-centromere REC8 vs CREST co-localised REC8. 
Mann-Whitney U-test shows a significant decrease in inter-centromere REC8 
relative to REC8 on the centromere with age (p<0.0001). Error bars show mean ± 
s.d.  (≤30 n=13 oocytes from 10 donors, mean age of donor per oocytes donated: 
25.44 s.d: ±2.07; ≥35 n= 17 oocytes from 14 donors mean age of oocytes 
donated: 37.56 s.d: ±2.07). 
 
Next, I sought to determine whether there is an overall loss of REC8 at the 
centromeres. To do this I carried out linescan analysis on the MI chromosome 
spreads from the batch staining. These oocytes had been spread and imaged on 
the same day with the same microscope settings used. Figure 6.11 shows the 
analysis used to quantify the CREST and REC8 signal. Ideally, it would be 
possible to set independent threshold for each marker using the linescan 
analysis, but the morphology of human bivalent chromosomes means that the 
REC8 value at the centromere can be infringed by REC8 signal from other parts 
of the chromosome. Also the variation in CREST signal between younger and 
older women made it difficult to set an independent threshold for the CREST 
signal. As a result, the REC8 values used are from the initial point from where the 
CREST increases to when it decreases after the second peak. 
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 Figure 6.11 Area under the curve analysis used for REC8 and CREST 
quantification. Figure shows representative analysis of REC8 and CREST at 
centromeres of chromosome spreads from a 23 and a 36 year old woman. Scale 
bar 10µm, inset scale bar 3 µm. Blue box indicates the area under the curve that 
was collected for CREST and REC8 at the point where the initial CREST signal 
could be detected. Spreads and imaging carried out by L.M. Lister (< 30 n=9 
oocytes from 8 donations mean age of donor per oocytes donated: 25.67 s.d: 
±2.24; >35 n=9 oocytes from 8 donations mean age of donor per oocytes 
donated: 37.67 s.d: ±2.07).   
Comparisons of the area under the curve values for REC8 and CREST on a slide 
by slide basis as well as the ratio of REC8 to CREST showed a high level of 
variation within the younger and older age groups (Figure 6.12 and Figure 6.13 
respectively). 
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Figure 6.12 REC8 and CREST area under the curve values per oocyte from 
younger and older ICSI-reject donors. Dot plots of REC8 and CREST for each 
oocyte on each slide used in the warmed from vitrification oocyte set. Each dot 
represents the area under the curve value for the REC8 or CREST signal per 
individual centromere. The age of the donor of each oocyte analysed is written 
under the values. Error bars show mean ± s.d.  (< 30 n=9 oocytes from 8 
donations, mean age of donor per oocytes donated: 25.67 s.d: ±2.24; > 35 n=9 
oocytes from 8 donations, mean age of donor per oocytes donated: 37.67 s.d: 
±2.07).  
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Figure 6.13 REC8: CREST ratio per oocyte from younger and older ICSI-reject 
donors Dot plots of the ratio of REC8: CREST ratio for each oocyte on each slide 
used in the warmed from vitrification oocyte set. Each dot represents the area 
under the curve ratio of REC8: CREST per individual centromere. The age of the 
donor of each oocyte analysed is written under the values. Error bars show mean 
± s.d.  (under 30 n=9 oocytes from 8 donation, mean age of donor per oocytes 
donated: 25.67 s.d: ±2.24; over 35 n=9 oocytes from 8 donations, mean age of 
donor per oocytes donated: 37.67 s.d: ±2.07).  
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 To determine whether there is a significant change in cohesin levels during 
ageing, the median value for REC8 and CREST of centromeres per oocyte was 
calculated and normalised to the younger donor (Figure 6.14). The results 
indicate that there is no significant difference for REC8 and CREST with ageing 
(Mann-Whitney U test: p=0.4122 and 0.1051 respectively). When a ratio of REC8 
to CREST is used, there appears to be a non-significant increase in REC8 in the 
oocytes from older women compared to the younger ones (p=0.4612). The 
results for CREST are at odds with by eye observations between good quality 
chromosome spreads of young and old oocytes. In good quality spreads, older 
donors CREST is quite clearly reduced in a similar way to in mouse oocytes (Yun 
et al., 2014). This is indicative of the problem of relying on ICSI-reject oocytes for 
quantification analysis. 
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 Figure 6.14 Normalising of Flourescence intensity to under 30 year olds 
chromosome spreads on same slide does reveals no significant difference 
between age groups for REC8 or CREST. Dot plot showing median value for 
each oocyte chromosome spread for (a) REC8 (b) CREST and (c) REC8: CREST 
ratio. Median values for over 35 were normalised to those from women under 30 
on the same slide. Error bars show ± s.d. Mann-Whitney U test revealed no 
significant difference in area under the curve analysis for (a) REC8 (p=0.4122) 
(b) CREST (p=0.1051) and (c) REC8:CREST (p=0.4612). (under 30 n=9 oocytes 
from 8 donations, mean age of donor per oocytes donated: 25.67 s.d: ±2.24; over 
35 n=9 oocytes from 8 donations, mean age of donor per oocytes donated: 37.67 
s.d: ±2.07). 
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The results from this pilot study inform us of several key aspects in attempting to 
understand the relationship between ageing and REC8 in human oocytes and the 
use of ICSI-reject oocytes. Firstly, the high levels of REC8 associated with 
chromatin in aged oocytes makes quantification difficult as it is not possible to 
distinguish cohesive cohesin between sister centromeres from “spurious” cohesin 
diffusely scattered on the chromatin.  It is not clear whether the latter is actually 
bound to chromatin or whether it is due to reduced dissipation of cytoplasm 
during the spreading procedure in oocytes from the older women.   Secondly, 
there is a high level of variation in REC8 and CREST F.I within age groups. This 
complication is not mitigated by the spreads from young and old ICSI-reject 
oocytes being spread on the same slide. While the data from Figure 6.14 
suggests CREST is not significantly reduced with age, this data is skewed by 
chromosome spreads from young oocytes that appear to be of a poor quality. 
Finally, quantifying REC8 at centromeres in MI oocytes is difficult due to cohesin 
from other parts of the chromosome. To avoid these issues we required new 
methods of acquisition and analysis. 
 
6.4 Strategy for carrying out investigation into cohesin in human oocytes 
 
The chromosome spreads used in the batch staining of the pilot study were 
conducted using vitrified oocytes. While vitrification is an essential tool for storing 
oocytes and embryos for IVF, the technique is particularly expensive and requires 
a high level of technical ability to carry it out without losing oocytes in the 
vitrification or warming processes. The main benefit of vitrification for this work is 
that it allows for eggs from women of different ages to be obtained on different 
days, spread on the same slide and imaged together. However, the precious 
nature of these human oocytes means that no more than three oocytes will be 
spread at any one time on one slide to avoid any being lost. This makes it difficult 
to use the methods for compiling results used in Chapter 4. For these reasons I 
sought a more cost effective solution which would reduce the chances of oocyte 
loss and allow for storage over a prolonged periods of time with minimum 
damage to the proteins and DNA in the chromosome spread. Our idea to address 
this was through freezing of chromosome spreads rather than short term storage 
in PBS at 4°C. This required modification of our current methods used for 
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chromosome spreads. Based on chromosome spreads used for yeast, I sought to 
test out if using sucrose as a cryo-protectant would help in the longer term 
storage (Grubb et al., 2015). Air-dried chromosome spreads from metaphase II-
arrested mouse oocytes were frozen overnight before being warmed in PBS at 
room temperature the next day. The spreads were then immunolabelled with 
antibodies targeted to ACA and TOPO II and the DNA was stained using DAPI 
(Figure 6.15.)   
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Figure 6.15 Sucrose in PFA with re-application 1.5 hours later appears best for 
freezing air-dried oocyte chromosome spreads. Figure shows example images 
of chromosome spreads prepared from mouse oocytes immunolabelled with 
TOPOII and ACA with DNA stained using DAPI. Letters beside image correspond 
to experimental procedure used before freezing. Scale bar 10µm. 
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The findings from this experiment indicated that the best spreads were those that 
had no sucrose (Figure 6.15A) and those that had sucrose re-applied after an 
hour and a half (Figure 6.15C). As a consistent problem with human oocyte 
spreads is high levels of cytoplasm, I also carried out a lipsol (a detergent) wash 
between PFA steps to see if this could help reduce background (Figure 6.15 D 
and E). However, the lipsol appeared to damage the areas of heterochromatin in 
the spreads. It also resulted in reduced number of oocytes located on each slide. 
This was most likely due to the oocytes not being adequately adhered to the 
slides and so they were being washed off by the lipsol. I concluded that the 
optimal technique was the re-application of sucrose/PFA.  
I next determined whether this method of freezing with sucrose would be 
appropriate for more prolonged periods of time. This was confirmed on a group of 
ICSI-reject chromosome spreads that had been frozen for several months. The 
slides were washed in PBS and immunolabelled with antibodies targeted to 
REC8, ACA and TOPO II. DNA was stained using DAPI. Of the 9 oocytes spread, 
7 out of 9 were present on the slide showing good retention after sucrose/PFA 
solution re-application (Figure 6.16). 
 
Figure 6.16 ICSI-reject frozen chromosome spread shows clear staining after a 
prolonged period at -20ºC. Representative Airyscan processed image of an 
oocyte chromosome spread fixed using 3.4% sucrose/1% PFA with re-application 
1.5 hours later and frozen at -20◦C. Staining and spread is consistent with those 
spread in just 1% PFA solution and stored at 4◦C.Scale bar 10µm (imaging by 
L.M Lister). 
 
Having accumulated a significant number of chromosome spreads from non-
patient donors, we began batch staining for REC8, ACA and TOPO II. These 
were imaged using a Zeiss lms880 with airyscan post-processing. 
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 To determine whether slides stained and imaged on different days could be 
combined as one data set, I carried out the linescan analysis and compared the 
area under the curve between batches of the <30 category of MII spreads (Figure 
6.17). These were imaged on a Zeiss lsm880 microscope rather than the Nikon 
A1R confocal which should have a more consistent laser power output. While 
there was no difference in the area under the curve values for TOPO II intensity 
between experiments (p=0.6227), REC8 and the ratio of REC8: TOPO II showed 
a significant decrease (p=0.0027 and p=0.0153 respectively). While biological 
variation cannot be ruled out, this suggests that using the lsm880 can still result 
in significant variation in laser power output between days and so combining all 
values would not be suitable. 
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 Figure 6.17 Significant difference in REC8 fluorescence intensity between air-
dried MII oocyte chromosome spreads from younger women imaged on 
different days. Dot plots showing the area under the curve values for (a) TOPO II 
and (b) REC8 and the (c) REC8:TOPO II ratio. (i) Shows the area under the 
curve values and the REC8:TOPO II ratio for each pericentromere per oocyte. (ii) 
Shows comparisons of the median values of each oocyte compared between the 
two experiments imaged on different days. A Mann-Whitney U test revealed a 
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significant difference between REC8 area under the curve and the ratio of REC8: 
TOPOII for experiments imaged on different days (p=0.0027 and p=0.0153 
respectively). TOPO II area under the curve showed no significant difference. 
Error bars show mean ± s.d. (Exp 1. n=11 oocytes from 4 donors; exp2. n=7 
oocytes from 4 donors) 
 
The next test of our methodology was to investigate if protein detection through 
I.F was significantly affected by long term freezer storage of the spreads. 
Observations of the TOPO II and REC8 between the under 30 chromosome 
spreads suggest no obvious impact based on when the chromosomes were 
spread (Figure 6.18). This shows that long term freezing and then imaging in 
batches is an appropriate methodology for approaching long term studies using 
chromosome spreads. 
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 Figure 6.18 Antibody detection of proteins of interest is not affected by long 
term freezing Dot plots showing the area under the curve values for (a) TOPO II 
and (b) REC8 per MII oocyte air-dried chromosome spread. Each dot represents 
the area under the curve value per pericentromere. Table shows corresponding 
colour code and date the chromosome spread was carried out per donation. Error 
bars show mean ± s.d. (Exp 1. n=11 oocytes from 4 donors; exp2. n=7 oocytes 
from 4 donors) 
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6.5 REC8 is mislocalised from the chromosome axis, but not reduced with age 
in human oocytes at MII 
 
The results from the pilot study in MI oocytes indicated that overall, cohesin does 
not appear to be reduced during female ageing. However, its localisation 
changes so that it is not enriched between centromeres. Because ICSI-reject 
oocytes may not provide a good representation of human oocytes progressing 
through meiosis in a normal time frame, I investigated whether an age-related 
loss of cohesin occurs in oocytes from our non-patient donor population. To make 
quantification easier I looked at MII stage oocytes. These are easier to measure 
due to the localisation of REC8 in the centromeric region, reducing the chance of 
interference from non-centromeric REC8. 
Air-dried MII chromosome spreads were removed from the freezer and washed in 
PBS to remove residual fixative. They were then immunolabelled with antibodies 
targeted to TOPO II, ACA and REC8. The DNA was labelled using DAPI and 
slides were imaged using the Zeiss lsm880 with Airyscan. For metaphase II 
arrested eggs, dyads with intact centromeres can be identified by the location of 
TOPO II and ACA as well as the DNA structure (Fig 6.19). 
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 Figure 6.19 structure and defects in dyads from MII oocytes. Figure shows 
representative sum-stack z-projection images of MII air-dried oocyte chromosome 
spreads from a 24 year old and a 43 year old woman. Scale bar 10µm. Images 
show immuno-labeling for TOPO II and ACA with the DNA stained using DAPI. 
Inset show zoomed in examples of an intact centromere (Dyad – grey box) and a 
separated sister centromere (red box). Scale bar 3µm (<30 n=23 eggs from 6 
donors, mean age of oocytes donated: 26.57 s.d: ±1.95; >35 n=8 eggs from 6 
donors, mean age of oocytes donated: 41.00 s.d: ±2.07). 
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Oocytes from the younger (<30 years) women showed a low incidence of 
abnormalities, only 3/23 oocytes showed separation of centromeres affecting a single 
chromosome (Figure 6.20) (<30 years old n= 23 oocytes from 6 donors; >35 years 
old n=8 oocytes from 6 donors). By contrast, analysis of MII oocytes (n=8) from the 
older non-patient donors revealed that 7/8 contained prematurely separated 
centromeres and multiple chromosomes were affected in 4/8 oocytes (Figure 6.20).   
Interestingly, the oocytes from the 43 year old donor showing a high level of 
separation belonged to a cohort of 12 oocytes retrieved from this woman. This is an 
extraordinarily high number of oocytes for a woman of this age and the finding of 
extensive abnormalities indicates that ovarian ageing and cohesin depletion occur by 
parallel but independent pathways.  Should this finding prove to be consistent, it 
raises a question over the use of commercially available kits sold to women to assess 
their ovarian age. Such a measure could lull women into a false sense of 
complacency about when to start a family.   
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 Figure 6.20 Separation of sister centromeres increases with age in MII oocytes 
from non-patient donor population. Stacked bar graphs showing number of 
intact (grey) and separated centromeres (red) per oocyte. Healthy oocytes should 
contain 46 intact centromeres per oocyte. Age of the donor of the oocyte and the 
number of donors is written below the graphs (<30 n=23 eggs from 6 donors, 
mean age of oocytes donated: 26.57 s.d: ±1.95; >35 n=8 eggs from 6 donors, 
mean age of oocytes donated: 41.00 s.d: ±2.07). 
Consistent with findings in mouse (Chiang et al., 2010, Lister et al., 2010) and in 
ICSI reject oocytes, analysis of the distance between centromeres increases with 
advancing female age in the non-patient donor population (Figure 6.21). The 
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mean distance for oocytes from young women was 1.78µm compared with 
2.31µm for those aged >35 years (Figure 6.21). 
 
Figure 6.21 Inter-centromere distance increases with age in MII chromosome 
spreads from non-patient donors. Dot plot showing a comparison of the median 
distance values between CREST signals of MII dyads. Unpaired t-test shows a 
significant increase in distance in the women over 35 indicating a reduction in 
chromosomal cohesion (p=0.001). (<30 n=23 oocytes from 6 donors, mean age of 
oocytes donated: 26.57 s.d: ±1.95 Avg distance: 1.78µm s.d: ± 0.322; >35 n=10 
oocytes from 8 donors, mean age of oocytes donated: 41.30 s.d: ±2.07 Avg 
distance: 2.31µm S.d: ± 0.35). 
 
Comparisons of airyscan-processed images indicated that once again, REC8 was 
still present on the chromosomes of older women but that, in contrast to the 
oocytes from the younger women, it is not enriched between sister centromeres 
(Figure 6.22). Importantly, it was evident from these MII oocytes that the diffused 
distribution of cohesin on the chromosome arms of the meiosis I ICSI-reject 
oocytes was not present.  This raises the possibility that the diffusely distributed 
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cohesin is cleaved during anaphase I. However, it will be important to determine 
whether the “scattered” arm cohesin is also a feature of meiosis I oocytes from 
the non-patient donors.   
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 Figure 6.22 REC8 appears to mislocalise to chromosome kinetochore in 
chromosome spreads from women over 35. Representative Airyscan processed 
images of MII chromosome spreads from a 26 years old and 42 year old woman. 
Spreads were immunolabelled with antibodies to REC8, ACA and TOPO II. DNA 
was labelled using DAPI. Scale bar 10µm. Inset boxes show enhanced images of 
dyads from the younger (grey box) and older woman (red box). Scale bar 2µm 
(under 30 n=23 oocytes from 6 donors, mean age of oocytes donated: 26.57 s.d: 
±1.947; over 35 n=10 oocyte from 8 donors mean age of oocytes donated: 41.30 
s.d: ±2.070). 
 
As in the meiosis I chromosome spreads from the pilot study (Figure 6.10), it 
appears that REC8 in oocytes form older donors is not enriched between sister 
centromeres, but is instead present in the general region of the centromeres, 
overlapping and extending beyond the ACA foci (p<0.0001) (Figure 6.23).  
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 Figure 6.23 Cohesin is mislocalised from the inter-chromatid domain as a 
result of ageing in MII oocytes.  (a) Example images of MII chromosome spreads 
from a 24 year old and a 38 year old woman. Linescans show ACA and REC8 
immunoflourescence relative to position on the corresponding linescan. Scale bar 
10µm, inset Scale bar 3µm (b) Dot plot of the % of axial REC8 to REC8 located on 
the centromeres. Unpaired t-test showed a significant difference (p<0.0001) showing 
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reduction in inter-chromatid REC8 to the REC8 on the chromosome DNA. (under 30 
n=23 oocytes from 6 donors, mean age of oocytes donated: 26.57 s.d: ±1.947; over 
35 n= 10 oocyte mean age of oocytes donated: 41.30 s.d: ±2.070) 
To determine whether the reduction in REC8 between sister centromeres in MII 
oocytes is associated with an overall decline in the level of REC8, I drew 
linescans across the centromeres of each and set independent thresholds based 
on an overall observation of both young and old sets within a batch (Figure 6.24). 
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 Figure 6.24 Linescan analysis of non-patient donor oocytes. (a) Representative 
example of MII chromosome spreads from a 26 year old and 42 year old donor 
immunolabelled for REC8 and TOPO II. DNA was stained using DAPI. Scale bar 
10µm. Inset shows example dyads. Scale bar 3µm (b) Linescans were drawn across 
pericentromeres and used to establish the area under the curve for each dyad. 
(under 30 n=21 oocytes from 6 donors, oocyte mean age: 26.43 S.d: ±1.86; over 35 
n=8 oocytes from 6 donors, oocyte mean age: 41.00 S.d: ±1.95). 
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Area under the curve values for REC8 and TOPO II per centromere per oocyte 
were calculated (Figure 6.25) and the ratio of REC8: TOPO II was established 
(Figure 6.26). This showed that REC8 and TOPO II in the oocytes from the 
women over 35 appeared more abundant that in the oocytes from the younger 
women.  
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 Figure 6.25 REC8 and TOPO II area under the curve values for younger and 
older women from non-patient donor population Dot plots show the area under 
the curve values for REC8 and TOPO II in younger and older female oocytes from 
air-dried chromosome spreads. Each graph represents a batch of staining. Individual 
oocyte REC8 and TOPO II are separated by vertical dotted lines with each batch 
separated by horizontal dotted lines. Each dot represents an area under the curve 
value for REC8 or TOPO II. Errors bars represent the mean ± s.d for each oocyte. 
Table contains the number of oocytes and number of donations per batch.  
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 Figure 6.26 REC8: TOPO II ratio for younger and older women from non-patient 
donor population. Dot plots showing the ratio of REC8: TOPO II per 
pericentromere for younger and older women. Each graph represents a batch of 
staining. Experimental repeats are separated by dotted lines. Each data point 
represents the ratio of the area under the curve of REC8 to TOPO II. Error bars 
represent the mean ±s.d for each oocyte. Table contains the number of oocytes and 
number of donations per batch. 
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To combine the experiments across the 3 batches, I normalised the median 
values per oocyte to the average of the medians for the under 30 age group. This 
indicated that REC8 in the older donors is increased in the region of the 
pericentromeres. However, when REC8 is normalised to TOPO II, there is no 
significant difference in REC8 between the under 30 age group and the over 35 
(p=0.7014) (Figure 6.27). This suggests that REC8 around the centromeres is not 
reduced with age in human oocytes. However, the enrichment of Rec8 between 
centromeres appears to be diminished in MII oocytes from the older women. This 
is consistent with the finding that premature separation of sister centromeres is 
strongly correlated with age in human oocytes (Pellestor et al., 2003). 
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 Figure 6.27 REC8:TOPO II ratio does not show a significant difference between 
younger and older women in MII air-dried chromosome spreads. Comparisons 
between young and old donors of the median area under the curve values per 
oocyte for (a) TOPO II (b) REC8 normalised to the average of the median per 
oocyte for the under 30 years old donors. An unpaired t-test and a Mann Whitney 
U test were used to determine the significance of the difference between TOPO II 
and REC8 respectively. TOPO II exhibited no difference (p=0.0537) while the 
values for REC8 area under the curve suggested that there is more REC8 on the 
pericentromeres of older women compared to younger women. (c) When REC8 is 
normalised to TOPO II this significant difference is lost with an unpaired t-test 
showing no significant difference between younger and older donors (p=0.7014). 
(under 30 n=21 oocytes from 6 donors, oocyte mean age: 26.43 S.d: ±1.859; over 
35 n=8 oocytes from 6 donors, oocyte mean age: 41.00 S.d: ±1.947) 
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6.6 Discussion 
 
A woman’s age at the time of pregnancy is the greatest determinant of whether she 
will have a healthy child or a pregnancy ending in miscarriage (Hassold and Hunt, 
2001). This is due to an age-related reduction in chromosomal cohesion leading to 
premature separation of sister centromeres (Angell, 1991, Angell, 1997, Pellestor et 
al., 2003, Sakakibara et al., 2015). Work using naturally aged mice indicated an age-
related depletion of the cohesin complex (Lister et al., 2010, Chiang et al., 2010). 
However, whether human oocytes exhibit a similar age-related effect had, until now, 
not been directly tested.   
One of the difficulties in determining loss of cohesin in human oocytes is the lack of a 
reliable source of healthy oocytes.  Studies in mice extract oocytes through 
maceration of the ovary to release GV oocytes which can then be synchronised to 
resume meiosis using a phosphodiesterase inhibitor, such as IBMX, to inhibit entry 
into M Phase (Bornslaeger et al., 1986). Human studies on the other hand have 
relied on the small population of oocytes considered unsuitable for ICSI (Webster 
and Schuh, 2017). These account for around 15-20% of oocytes retrieved during egg 
collection and are rejected based on the absence of a polar body (Reichman et al., 
2010). These oocytes are at GV and MI stage and it is unclear why they have not 
proceeded through meiosis like the majority of other oocytes. This means that the 
majority of work carried out in human oocytes has depended upon potentially 
abnormal biological material.  
To address this we established an oocyte donation scheme were women would 
donate their oocytes exclusively for use by our research team. This would include MII 
oocytes as well as any MI or GV stage oocytes. The women donating in this project 
showed a consistent trend of having lower follicle counts and AMH levels with age. 
These factors show that the women who donated in this study are representative of 
the wider population of women. 
Initial comparisons of the number of follicles provided to research irrespective of hCG 
retrieval time showed an expected decrease in the number of follicles retrieved with 
age. There was, however, quite a noticeable spread in the numbers of follicles 
retrieved in all age categories. When the number of follicles retrieved was broken 
down in to retrieval time post hCG there was a non-significant trend towards greater 
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oocyte retrieval at later hCG times. This means that future work in this field will 
require development of new techniques for collecting these smaller follicles. In part, 
the lack of a significant difference in oocyte retrieval numbers is down to advances 
being made in the collection of small follicles within our study. 
As we sought oocytes at GV and MI stage, we reduced the hCG retrieval time. 
Interestingly our results in the 30 and under age category indicates that while a 
greater proportion of MI oocytes are found when the interval from hCG to oocytes 
harvest is reduced, there was a non-significant trend towards a higher proportion 
of GV-stage oocytes at later time points. The most likely explanation is that GV 
stage oocytes collected at the later times post-hCG are coming from follicles that 
are undergoing atresia, making the oocyte easier to aspirate with the follicular 
fluid. By contrast, healthy GV stage oocytes are expected to be tightly attached to 
the follicles mural granulosa cells.  
To investigate whether cohesin is reduced with age in human oocytes, we 
launched a pilot study using data from previously acquired MI human oocyte 
chromosome spreads and those from a stockpile of vitrified oocytes, from which 
air-dried chromosome spreads were prepared. Initial analysis showed that in our 
population of ICSI-reject oocytes, bivalent stability decreases with age, with 
bivalents showing premature resolution to dyad chromosomes and sometimes to 
single chromatids. Measurements of the distance between sister centromeres 
also increases with age. This was indicative of a reduction in cohesin seen in 
previous studies. Compromise of bivalent chromosome structure has been 
highlighted in both mice and humans as being significant in causing chromosome 
segregation errors (Lister et al., 2010, Sakakibara et al., 2015, Zielinska et al., 
2015). Observations in whole fixed human oocytes reported that an increase in 
age resulted in an increase in split bivalent kinetochores. These split 
kinetochores are more susceptible to merotelic attachment and subsequent 
segregation errors (Zielinska et al., 2015).  
 After attempts to quantify REC8 using spreads that were imaged separately, we 
tried to control for experimental variation by preparing a batch of chromosome 
spreads from our stockpile of vitrified oocytes which were stained and imaged at 
the same time. I.F staining indicated that there was still clear staining for REC8 in 
the older women. This differs from mouse oocytes which display a total loss of 
REC8 with age (Lister et al., 2010, Chiang et al., 2010). Closer observations of 
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the images however suggested that the REC8 is mis-localised in oocytes from 
older women. Instead of being enriched in the inter-chromatid domain, REC8 
showed a diffused distribution on the chromosomes without any enrichment in 
any location. To validate this observations I calculated the average REC8 
fluorescence intensity on the CREST signal compared to directly between the 
CREST signal. Comparisons between young and old showed that a significant 
difference existed between over 35s were REC8 was located more on the actual 
chromosomes than between them.  
The results of the pilot study informed us of several key features. Firstly, that 
measuring REC8 is complicated by the presence of non-axial REC8 on the 
chromosome arms. This produces a high value for REC8 in quantitative analysis 
but does not appear to provide any actual cohesion. Secondly, avoiding CREST 
as a tool for normalisation would be optimal. Third, attempting to spread oocytes 
from younger and older women on the same slide is ineffective as the numbers 
will always be too small. Finally the variation seen in the raw value numbers may 
be as a result of using ICSI-reject oocytes.  
Analysis of the MII oocytes from the non-patient donors showed that they had an 
expected phenotype of an increase in segregation errors as well as an increase 
in inter-centromeric distances. What is more, the non-axial REC8 localisation 
continues to exist on the chromosomes, but only at the centromeres. This would 
suggest that the cohesin that mislocalises to the DNA is removed during 
anaphase in a similar manner to arm cohesin removed during anaphase I. It also 
suggests that this mislocalisation cannot be attributed to cytoplasmic cohesin 
sticking to the DNA during spreading. Comparisons of total fluorescent intensity 
however, showed that there was no overall reduction in REC8 at the MII stage of 
meiosis. 
The results of this Chapter suggest some discrepancies between how ageing 
effects mouse and human oocytes. While in mice there is a loss of chromosome-
bound cohesin during prophase arrest, in human oocytes it appears to be 
mislocalied. While this seems contradictory between the two organisms there are 
potential mechanisms that could explain both and warrant investigating. It is 
possible that the cohesin ring could be opening or becoming damaged but not 
actually removed from the DNA in human oocytes where as in the mouse it would 
be.  
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It should be noted however that the work in this Chapter has only looked at 
REC8. Future work should also analyse AcSMC3, as this is indicative of cohesive 
cohesin. If this showed a similar patterns of localisation to the REC8 then it would 
be informative of whether this mislocalised cohesin is providing any actual 
cohesion.  
The results in this Chapter show for the first time that that while cohesin is 
affected by ageing in human oocytes, it differs from the effect that occurs in mice. 
This suggests some discrepancies between the human and the mouse models 
that will require further investigation.  
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Chapter 7. Discussion and Conclusion 
7.1 Discussion 
 
Despite the continued increase in human life expectancy and health over the past 
few centuries, the decline in female fertility by the fourth decade of life followed by 
the menopause in the fifth has remained stubbornly persistent (Lambalk et al., 2009). 
The reason for this loss of fertility, is due to a continuous depletion of available 
oocytes, with the remaining few having a reduced ability to accurately segregate their 
chromosomes  (Herbert et al., 2015). If one of these poorer quality oocytes is 
fertilised, the likelihood of the pregnancy ending in miscarriage or the child being 
born with birth defects is severe (Hassold and Hunt, 2001). Investigations into mouse 
and human oocytes have revealed that ageing results in a loss of bivalent 
chromosome stability due to a loss of chromosomal cohesion (Chiang et al., 2010, 
Lister et al., 2010, Duncan et al., 2012, Patel et al., 2015, Sakakibara et al., 2015, 
Zielinska et al., 2015, Lagirand-Cantaloube et al., 2017). This is thought to increase 
the chances of aneuploidy, with premature separation of sister chromatids being the 
leading cause (Angell, 1997, Sakakibara et al., 2015). In mouse oocytes, this has 
been strongly linked to a loss of chromosome-bound cohesin during the prolonged 
prophase arrest (Chiang et al., 2010, Lister et al., 2010). The question remains, 
however, around what mechanisms are responsible for this loss of cohesin in mouse 
oocytes. It is also not known whether a loss of cohesin with ageing is responsible for 
the increase in segregation errors in human oocytes. 
Part of the difficulty in establishing which proteins are affected by ageing relates to a 
lack of appropriate tools for quantification. One of the most effective methods for 
assessing changes to chromosome-bound proteins is the use of air-dried 
chromosome spreads. Yet, due to the large number of proteins affected by ageing, 
normalisation of the protein of interest to a standard marker has proved difficult. To 
address this I sought out a marker that would be effective for this purpose. This led 
me to the DNA catenation enzyme TOPO II. This appeared to be an appropriate tool 
as it showed consistent localisation through meiosis, could be used for segmentation 
of sections of chromosomes, and was informative of chromosome architecture. 
Importantly for reproducibility, the antibody targeted to TOPO II is commercially 
available and conjugated, so can be used by other researchers with any combination 
of other antibodies. 
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Comparisons of TOPO II, ACA and SMC3 using the software programme Imaris 
shows that while both decline with age, TOPO II is less affected. Use of both the 
peak F.I and Sum F.I in Imaris analysis was useful for determining loss of the 
universal cohesin subunit SMC3. However, the reduction did not appear 
representative of what could be seen by eye. To address this, I established a new 
form of analysis. This measures the area under the curve across a linescan for 
TOPO II and the protein of interest. This allowed for independent thresholds to be set 
and for a more representative interpretation of the data. The combination of TOPO II 
and linescan analysis should provide an easy-to-use methodology for further 
research in this field. 
The finding by our group and others indicating that a loss of chromosome-bound 
REC8 in mouse oocytes occurs during the prolonged prophase arrest of oogenesis, 
is crucial to understanding which mechanisms could be responsible for cohesin loss 
(Tsutsumi et al., 2014). It is also important as it informs of the viability of potential 
interventions to maintain female fertility. However, it was not clear whether this loss 
occurs progressively with age, or whether other forms of cohesin are present in the 
primordial oocyte. Using protein quantification on cryosections for REC8 and SMC3 I 
showed that the loss of cohesin is progressive, and that there is a universal loss of 
chromosome-bound cohesin in primordial-stage oocyte with age. However, the fold 
decline in SMC3 was noticeably less than that of REC8. Staining for RAD21 in 
primordial-stage oocytes suggests that it is expressed in the primordial oocyte 
nucleus. It therefore cannot be ruled out that the difference in the fold decline in 
REC8 and SMC3 may be down to RAD21 containing cohesin in primordial-stage 
oocytes. It will be necessary to carry out ageing studies to find if this RAD21 is 
reduced or loaded with ageing. The prospect of non-REC8 containing cohesin 
complex in the primordial-stage oocytes is particularly interesting considering SMC3 
appeared to be undetectable with age in metaphase I oocytes in Chapter 4. It may be 
possible that any non-REC8 containing cohesin complexes are removed before 
resumption of meiosis. Two recent findings from our group suggest this may be 
possible. The first is that PLK1 is expressed in fully grown oocytes but not primordial 
stage oocytes, and that when PLK1 is inhibited using BI2536 in GV stage oocytes, 
more cohesin is seen on the chromosomes than compared to controls (work carried 
out by R. Ballesteros-Meija and C. Lodge). This may represent a function for the 
prophase pathway before resumption of meiosis.   
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Having determined that cohesin is progressively lost with ageing, I next sought to 
establish what mechanisms could be involved in this loss. For this, I investigated 
whether leaky inhibition of separase could be actively cleaving cohesin over time. 
This was investigated previously in our group in fully grown oocytes but not in 
primordial-stage oocytes, where cohesin loss occurs. Several reasons pointed to 
separase as a potential cause of cohesin loss. Firstly, separase is responsible for 
REC8 cleavage during both stages of meiosis (Kudo et al., 2006, Kudo et al., 2009). 
Secondly, experiments in yeast where separase is released from securin during 
prophase show it is capable of cleaving cohesin (Oelschlaegel et al., 2005, Penkner 
et al., 2005). Thirdly, during prophase in oocytes, CDK1-mediated phosphorylation of 
separase would be inhibited as CDK1 is suppressed (Adhikari et al., 2016). Through 
use of an oocyte-specific separase null mouse on the Gdf9 promoter, I showed that 
leaky inhibition of separase is not the cause of cohesin loss in primordial-stage 
oocytes. This would suggest that cohesin is lost via another mechanism in oocytes. 
However, the lower prevalence of primordial-stage oocytes in separase null mice 
compared to separase-wild type mice suggests a possible role for separase during 
prophase arrest. As cohesin is necessary for DNA damage repair, if separase is 
required for removal of that cohesin, a lack of separase may trigger atresia reducing 
the number of primordial stage oocytes (Wu and Yu, 2012). 
The need for cohesin protection after resumption of meiosis has been well 
investigated in mice (Lee et al., 2008, Llano et al., 2008, Rattani et al., 2013). 
However, little work has been done on whether cohesin is protected during the 
prolonged prophase arrest, where cohesin is lost. My work suggests that if there is 
any protection of meiotic cohesin, it is quite likely compromised with ageing.  SGOL2 
does not appear on the chromosomes until after GVBD and while SGO1 is 
expressed, I have discovered that it becomes mislocalised with ageing, suggesting it 
could lose its function. Several criteria should be further tested to determine whether 
SGO1 provides protection. This should be done first through determining whether the 
holoenzyme PP2A is localised to SGO1 in primordial-stage oocytes, and if so, 
chromosome bound cohesin should then be quantified in an oocyte-specific SGO1-
knockout mouse.  
However, on its own these finds hint to other dysfunctions within the oocyte. BUB1 is 
necessary for SGO1 localisation and has been indicated as being partially involved in 
SGOL2 localisation, which could indicate a loss of BUB1 with age (El Yakoubi et al., 
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2017). Alternatively, this mislocalisation could indicate changes in chromatin 
structure, a well-characterised aspect of aged and cancerous cell lines in somatic 
cells (Lopez-Otin et al., 2013, Abe et al., 2016, Higgins and Prendergast, 2016). 
Other work has suggested that Sgo1 is necessary for biorentation in S. cerevisiae 
(Peplowska et al., 2014). If a similar function occurs in MII, this could mean the loss 
of SGO1 is required for accurate segregation in the second meiotic division.  
Having investigated the timing and mechanisms around loss of cohesin I next 
sought to determine whether the mouse model of cohesin loss is representative 
of the age-related increase in human oocyte segregation errors. Hitherto, studies 
on human oocytes have relied on the small percentage that are rejected from 
IVF. It is unclear why, even after a full stimulation regime, they do not proceed to 
MII by 37 hours post administration of hCG. To avoid this issue we established a 
non-patient oocyte donation scheme were the woman’s oocytes would be 
collected at shorter post hCG times. This was intended to provide more oocytes 
at GV and MI stage. We discovered that, while reducing the timeframe provided 
more oocytes at MI stage, it did not yield a greater number of GV stage oocytes. 
Also, reducing the time between hCG and oocyte collection appeared to reduce 
the number of oocytes that could be aspirated. These findings suggests that new 
techniques for oocyte collection must be developed to capture all immature 
oocytes. To determine how best to study chromosome-associated proteins in 
human oocytes, and to give an indication of how REC8 is affected by ageing, we 
set up a pilot study using air-dried chromosome spreads at MI from ICSI-rejected 
oocytes. The findings from the pilot study support previous reports in humans and 
in mouse oocytes, showing that ageing is accompanied by a loss of bivalent 
structural integrity and an increase in distance between sister centromeres (Lister 
et al., 2010, Duncan et al., 2012, Patel et al., 2015, Sakakibara et al., 2015, 
Zielinska et al., 2015, Lagirand-Cantaloube et al., 2017). However, it did not 
show a quantifiable loss of REC8 with age similar to the mouse. Instead REC8 
appears to be mislocalised onto the chromosome arms, away from the axis. 
While it was possible that this may have been a result of cytoplasmic REC8 
sticking to the chromosomes, the non-patient donor oocytes showed the same 
localisation. Importantly however, this localisation was only at the centromeres of 
the MII oocytes, suggesting this may in fact represent a biological mechanism of 
ageing.  
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The question, therefore, is whether the mouse should now be considered an 
invalid model for investigating segregation errors in humans. In my opinion, this is 
premature and it is still likely that variations on a common dysfunction could 
explain the loss of chromosomal cohesion. 
The results from Chapter 5 suggest that separase is not predominantly 
responsible for cohesin loss. This leaves the door open for other mechanisms 
such as protein damage from ROS to the cohesin ring. It is possible that 
damaged REC8 containing cohesin in mouse oocytes are removed, while in the 
humans it remains on the DNA not providing any cohesion. This could first be 
tested by staining for AcSMC3 which is required for cohesive cohesin (Zhang et 
al., 2008).  
7.2 Conclusion and future work 
 
The work in my thesis presents advances in our current knowledge of the 
mechanisms behind age-related aneuploidy in human and mouse oocytes. This 
suggests that an age related dysfunction in REC8-containing cohesin leads to a loss 
of bivalent chromosome stability. In mice this appears to occur progressively during 
oogenesis. While in the mouse this dysfunction manifests as loss of cohesin, in 
humans it results in mislocalisation. In terms of further understanding the mechanism 
by which this occurs, the role of age-related protein damage to REC8-containing 
cohesin during prophase-arrest should be investigated in mice and humans.  
My work also suggests the presence of non-REC8 containing cohesin complexes in 
primordial stage mouse oocytes. What role they play during oogenesis, and whether 
they are removed before resumption of meiosis remains unclear. This should be 
investigated by studying the proteins involved in the prophase-pathway during 
oogenesis. 
Clinically, my work supports the theory of a deterioration of oocyte quality during 
prophase arrest. If this deterioration occurs as a result of protein damage over time it 
is unlikely that there is any reversible mechanism that could be employed to help 
older women. As a result, currently, cryo-preservation of a woman’s oocytes in her 
late 20’s remains the most viable option for prolonging fertility into later life. 
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